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"Ifwe magnified a hen's egg to the size of the world (which would make
atoms rather larger than eggs and electrons barely visible) we could still
get a gene into a room and probably on to a small table. But such a
magnification being impossible, the question how to interfere with a
single gene without interfering with the others becomes serious, and
some men have already spent their lives vainly on it; many more will.
The two most hopeful methods seem to be to find chemical substances
which will attack one gene and not another; and to focus ultraviolet rays
on a fraction ofa chromosome."
J.B.S. Haldane
(1892-1964)
'The Future of Biology',
In: On Being the Right Size and Other Essays.
J. M. Smith (ed.), Oxford University Press, 1985.
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ABSTRACT
Successful modification of milk composition through genetic
manipulation requires an understanding of the role of milk constituents
in determination of its properties. Gene targeting in the mouse is a
powerful tool to analyse the in vivo function of gene products, p-casein is
one of the most abundant proteins in milk, mainly existing as a
component of casein-micelles. To find out the role of P-casein in lactation
and in the properties of milk, mice carrying mutated p-casein genes were
created through gene targeting in embryonic stem cells using a
replacement-type vector, p-casein was absent from the milk of
homozygous mutant mice, and no mRNA was detectable from the mutant
allele. The mutation was compatible with viability, fertility and lactation.
The total protein concentration of P-casein-deficient milk was reduced,
although the loss of P-casein was partially compensated by enhanced
synthesis and/ or secretion of other milk proteins. The pre-weaning
growth of pups feeding on P-casein-deficient milk appeared to be slower,
probably reflecting the reduction in the total milk protein concentration.
The reduction (in heterozygotes) or absence (in homozygotes) of p-casein
in milk resulted in smaller casein micelles, probably due to increases in
the ratios of K-casein to calcium-sensitive caseins. These results show
that P-casein is dispensable in lactation.
Targeting of subtle mutations is likely to be important for many
purposes, including the manipulation of milk structure. The 'hit and run'
iv
method for targeting of subtle mutations would be facilitated by positive-
negative selection during the first (targeted insertion) step.
To explore the feasibility of negative selection in conjunction with
insertion-type gene targeting vectors, the effects of placing terminal
heterologies on a hypoxanthine phosphoribosyltransferase (HPRT)
insertion vector were determined. The targeting was generally accurate
but the targeting efficiency was reduced by terminal heterologies. The
magnitude of reduction was dependent on the length and position of the
heterology. An increase in the length of heterology resulted in a more
pronounced decrease in targeting efficiency. Heterology on the short (0.8
kb) arm was less detrimental than heterology on the long (4.8 kb) arm.
Surprisingly, a vector with heterologies on both arms targeted with high
fidelity, and with targeting efficiencies equal to or higher than those of a
vector with heterology on the long arm only. These data imply that in
principle, it should be possible to use positive-negative selection with
insertion-type vectors; the actual advantage will depend on the level of
enrichment obtained. Further, the results indicate that terminal
sequences are removed simultaneously from both arms of the vectors,
and that the removal of at least one strand of the DNA was effected by
exonuclease(s) and was tightly coupled to the process of gene targeting.
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Milk production is an essential component of the reproduction
strategy of mammals. The development of a zygote into an organism is
accompanied by preparation of milk synthesis potential by the mammary
gland of the mother. Milk is a complex mixture ofmore than a thousand
ingredients. The main constituents of milk are water, proteins, lipids,
carbohydrates and minerals, the relative concentrations of which have
evolved in most species to meet the needs of the neonate during their pre-
weaning period. However, in farm animals the milk composition is an
outcome of artificial selection by man for higher milk yield to meet his
nutritional and socio-economic needs. Milk is processed into a variety of
products by altering its composition. The quality, yield and economics of
various milk products are dependent upon the relative amounts and the
biochemical and physical properties of individual constituents of milk.
Thus, there is strong incentive to genetically modify milk composition
(Bremel et al. 1989; Clark 1992; Hettinga 1989; Jimenez-Flores and
Richardson 1988; Mercier 1986; Muysson and Gibbins 1989).
Advances in the understanding of genetic control of milk synthesis
and the advent of transgenic technology have provided revolutionary
methods to alter milk composition. It has been possible through gene
transfer to produce novel proteins in the mammary gland of laboratory
and farm animals, and similar approaches are currently being extended
to modify milk composition to improve the nutritional and physical
properties ofmilk.
In this chapter the structure ofmilk, and the scope of conventional
breeding in the modification of milk composition, with emphasis on
bovine milk, are described. The progress in the production of novel
proteins in milk is discussed. Finally, the current status of the available
methods for manipulation of mouse genome through gene targeting in
embryonic stem cells, and their potential application in the manipulation
ofmilk composition are reviewed.
1.1. MILK COMPOSITION
There is a wide qualitative and quantitative variation among milks
from different species (Table 1.1). In a comparison of milk composition of
Table 1.1. Average concentration of major constituents of milk of
a number of species (modified from Davies et al. 1983).
Species Fat (gl-l) Protein (gk1) Lactose (mM) Calcium (mM)
Cow 37 34 133 30
Goat 45 29 114 22
Sheep 74 55 133 58
Pig 68 48 153 104
Man 38 10 192 7
Mouse NA 97* NA NA
Rat 103 84 90 80
Guinea Pig 39 81 83 41
Rabbit 183 136 60 214
See Chapter 3. NA: not available.
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30 species (Jenness 1986) protein concentration varied from 10-200 gkg-1,
fat from a trace to 500 gkg"1 and carbohydrate from a trace to 100 gkg-1.
It has been found that within a particular species genetic and non-genetic
factors influence milk composition (reviewed by Davies et al. 1983;
Mepham 1987). Non-genetic factors include the frequency of suckling,
stage of lactation and plane of nutrition. The genetic variation in cow's
milk composition is discussed in section 1.2.
1.1.1. Milk Proteins
Most of the protein secreted in milk is synthesised in the
mammary gland from transcription of a small number of genes. Variable
amounts of serum albumin, immunoglobulin and a range of enzymes are
transferred from blood to the milk in the mammary alveoli. Broadly, milk
proteins can be classified into two categories, viz. caseins which are
precipitated at acidic pH (4.5-4.6 for bovine milk), and whey proteins
which are left in the milk serum after acid precipitation of caseins. The
relative proportion of these two groups of milk proteins varies among
species (Jenness 1986). While in cow and mouse milk caseins constitute
approximately 80% of the total protein, whey proteins are the more
abundant proteins in human and Indian elephant milk.
1.1.1.1. Caseins
Caseins are a rich and balanced source of amino acids
and serve as vehicles for the transfer of calcium and phosphorus from the
mother to the neonate. Casein synthesis is initiated in the terminally
differentiated mammary gland epithelium during mid-pregnancy in
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response to peptide and steroid hormonal signals and continued
throughout the lactation (see review: Vonderhaar and Ziska 1989).
The bovine casein fraction comprises four individual
components, namely ocsi-, aS2-, p- and K-caseins. Comparisons of casein
cDNA sequences from a number of species have shown that each milk has
homologues of some or all of the four bovine caseins (Bonsing and
Mackinlay 1987) and that (3- and K-caseins are present in all milks
(Creamer 1991; Davies et al. 1983). The concentration of a particular
casein varies between milks of different species (Table 1.2).
Caseins are phosphoproteins and, in all species studied
in detail, can be grouped in two broad classes depending upon the number
of phosphorylated serine residues in them. The cow is the best
characterised species in terms of its milk proteins and their properties.
ocS2", and P-caseins have up to 9, 13 and 5 phosphorylated serine
residues, respectively, through which these proteins interact with calcium
phosphate and aggregate to form colloidal particles called casein micelles.
These proteins can be precipitated in the presence of low Ca2 +
concentration hence, are known as Ca2+-sensitive caseins. K-casein lacks a
cluster of phosphorylated serine residues, and therefore, is insensitive to
Ca2+ and acts to stabilise the growing micelles by limiting their size
(Schmidt 1982). Proteolysis of bovine K-casein by chymosin at Phe
(105)-Met (106) bond results in precipitation of caseins which leads to curd
formation. In rat and mouse K-casein, methionine 106 has been replaced
by leucine (Thompson et al. 1985).
In bovine milk, the casein micelles vary in size from
15 nm to 600 nm. The casein composition of micelles changes with the
micelle size (Dalgleish et al. 1989; Davies and Law 1983; Donnelly et al.
1984; McGann et al. 1980) and this information has been utilised to
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predict the localisation of various caseins. McGann et al. (1980) and
Donnelly et al. (1984) separated casein micelles by chromatography on
controlled-pore-glass and reported that with the decreasing micelle size
the proportion of K-casein increased and that of as- and (3-caseins
decreased. A linear relationship between the K-casein concentration and
micelle surface area-to-volume ratio was interpreted as indicating surface
Table 1.2. Milk protein composition of various milks
(modified from Lathe et al. 1986).
Milk protein Concentration in milk (g l*1)
Cow Sheep Mouse Goat Human
Caseins
asi-casein 10.0 12.0 28.0t 0.7 0.4
aS2-casein 3.4 3.8 NDA 4.0
(3-casein 10.0 16.0 21.0^ 10.0 3.0
K-casein 3.9 4.6 2.4t 6.0 1.0
Whey proteins
a-lactalbumin 1.0 0.8 trace 1.2 1.6
(3-lactoglobulin 3.0 2.8 none 2.3 none
Whey acidic protein none none 2.0 none
Serum albumin 0.4 NDA NDA 0.4
Lysozyme trace NDA NDA trace 0.4
Lactoferrin 0.1 NDA NDA 0.1 1.4
Immunoglobulins 0.7 NDA NDA 0.5 1.4
f E. Stevenson, J. Leaver and A. J. R. Law (personal communication).
NDA: No data available.
N.B.: Nomenclature of caseins follows that of bovine caseins. Mouse homologues are a-,
e- and P-casein, respectively; see review by Bonsing and Mackinlay (1987).
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localisation of K-casein. Davies and Law (1983) fractioned casein micelles
by differential centrifugation and found that K-casein proportion increased
with the decrease in micelle size. The relative proportion of asi-casein
remained constant but (3-casein fraction decreased as the micelle size
decreased. Dalgleish et al. (1989) obtained data similar to those of Davies
and Law (1983) using ultracentrifugation for the fractionation of casein
micelles and photon correlation spectroscopy for the determination of
micelle size. These authors concluded that the micelle surface has a
predominance of K-casein and ocsi-casein and small amounts of (3-casein.
A number of models have been proposed for the
structure of casein micelles (reviewed by Creamer 1991; Rollema 1992
Ruettimann and Ladisch 1987). Broadly, these can be grouped in three
categories: coat-core models, internal structure models and sub-unit
models. As per the coat-core models, casein micelles are formed by a core
of one or more caseins and the remaining caseins form the coat around the
core. In vitro spontaneous assembly of a- and p-caseins into micellar
structures, and K-casein concentration dependent size variability of these
micelles was taken as evidence in support of these models. Internal
structure models postulated even distribution of caseins inside the
micelles. Neither of these two types of models accounted for the evidence
obtained from electron microscopy that casein micelles consists of sub-
micelles (see below); and the internal structure models were not consistent
with the evidence suggesting surface localisation of K-casein (see
Ruettiman and Ladisch 1989 for the brief history of coat-core and internal
structure models).
According to the sub-unit model (Schmidt 1982; Fig.
1.1), casein micelles are thought to be assembled from the sub-micelles of







Figure 1.1. Sub-unit casein micelle model.
Redrawn from Schmidt (1982) and Mepham (1987).
A) Micelle.
B) Sub-micelle.
C) Binding between two sub-micelles.
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phosphate [Ca9(P04)6]. This model is an extension of an earlier model
proposed by Slattery and Evard (1973). The latter workers introduced the
concept of sub-micelles of variable composition and argued that K-casein
was located on the surface of micelles. However, they did not postulate
any primary role of calcium phosphate in the interactions between sub-
micelles and maintained that hydrophobic binding between caseins was
responsible for such interactions. In the model of Schmidt (1982), sub-
micelles comprise asi-, aS2-, (3- and K-caseins, the amount of K-casein being
variable. Further, most sub-micelles with K-casein are present on the
surface of the micelles and hence, the micelle size is determined by the
fraction of K-casein in micelles (see above). Ono and Obata (1989) have
proposed two types of sub-micelles in their model. By gel chromatography
these authors isolated two main types of sub-micelles; one consisting of as-
and (3-caseins and the other one included as- and K-caseins with equimolar
ratio. Ono and Obata (1989) could assemble artificial micelles of varying
sizes by modulating the relative ratio of the above two types of sub-
micelles. The implied importance of as-caseins in this model is not
corroborated by the fact that goat milk has a very small proportion of
as-caseins (see Creamer 1991). The precise structure of sub-micelles and
the relative roles of the various Ca2+-sensitive caseins remain unclear.
1.1.1.2. Whey proteins
(3-lactoglobulin and a-lactalbumin are the two major
whey proteins synthesised in the ruminant mammary gland and secreted
in milk. P-lactoglobulin may be important in vitamin A transport (Papiz
et al. 1986). This protein is absent from rodent milk. However, rodent
mammary gland synthesises another whey protein i.e whey acidic protein
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(WAP, Hennighausen and Sippel 1982). The function of this protein in
mammary gland or milk is not known, a-lactalbumin has a role in lactose
synthesis (Kuhn 1983; see section 1.1.3 below). Lactoferrin and
transferrin are iron binding proteins in milk and these are synthesised in
the mammary gland (Davies et al. 1983). Human milk is rich in
lactoferrin; rodents lack this protein and instead have transferrin. Both
of these proteins are present in ruminant milk.
Immunoglobulins in milk are derived mainly from the blood
and provide passive immunity to the offspring (Mepham 1987). In
ruminants the transfer of immunoglobulin from mother is after birth via
milk, and IgG is the main class of immunoglobulin in milk. In humans
the placenta allows prenatal transfer of IgG and IgA is the main form of
immunoglobulin present in milk. Albumin is derived from the blood
serum and is present in low levels in human and bovine milk in contrast
to rat milk where albumin is the major whey protein (reviewed by Davies
et al. 1983).
1.1.2. Milk Fat
Although milk fat levels vary considerably between species,
there is little qualitative variation: triglycerides are the predominant
component of the lipid fraction in all species examined so far (reviewed by
Davies et al. 1983 and Dils 1986). Other minor fractions include di- and
monoacylglycerols, cholesterol and its esters, phospholipids and free fatty
acids. Long-chain fatty acids utilised for synthesis of triglycerides are
derived either from blood lipids or from de novo synthesis in the
mammary gland. Short- and medium-chain fatty acids are more
abundant in most milks in contrast to other body tissues in the respective
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species. The relative abundance of short-chain fatty acids is a
characteristic feature of ruminant milks. Milk fat is secreted as
membrane bound spherical globules (from 0.1 to 20 pm in diameter in
bovine milk). Milk lipid concentration and protein concentration are
positively correlated in many species (Mepham 1987).
1.1.3. Milk Carbohydrates
Lactose, a disaccharide of glucose and galactose is the major
carbohydrate in the majority of milks. It is synthesised within the Golgi
vesicles, a-lactalbumin, a whey protein acts as a cofactor in the synthesis
of lactose by the enzyme, galactosyltransferase. Lactose complements the
role of diffusible ions in maintaining the osmotic balance of milk.
Consistent with this role of lactose, its concentration is inversely
proportional to that of diffusible ions (Jenness 1986). Milk fat and protein
concentrations are also negatively correlated with the lactose level in
various species (Mepham 1987).
1.2. MODIFICATION OF MILK COMPOSITION BY CONVENTIONAL
BREEDING
There are a number of reasons for envisaging modification ofmilk
composition. Milk is processed into a variety of milk products; the
nutritive value and economics of these products are determined by milk
composition. The physical behaviour of various milk constituents during
milk processing determines the technological properties of milk. Milk
may not be a suitable food in some circumstances; for example many
human adults are intolerant of lactose because of lactase deficiency.
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Historically, conventional animal breeding has been used to
increase the level of fat in dairy cattle but the current trend of lower fat
consumption in dairy products may require a change in breeding
objectives. Physical separation of fat from milk is a readily available
option but in the longer term if the requirement of fat is likely to be
reduced it may be desirable to breed cattle for reduced milk fat.
1.2.1. Quantitative Genetic Variation
Naturally existing genetic variation between and within
breeds is the raw material to modify a quantitative trait. Assuming that
there is sufficient economic incentive for change, the rate of genetic gain
is dependent upon the heritability (or accuracy of selection), the
generation interval, the genetic correlation among various traits under
selection and the intensity of selection (Falconer 1989).
Gibson (1987, 1989) reviewed the literature to examine the
feasibility of altering milk composition through selection in dairy cattle.
Protein and fat concentrations differ among breeds of cattle and there
exists a positive correlation between these two traits. Holstein is the most
widely used breed for milk production and if the objective is to reduce the
fat:protein ratio, there is little to gain from replacement of this breed
(Table 1.3). In the Holstein breed, fat and protein concentrations are
moderately heritable and these traits have a low coefficient of variation
(Table 1.4). Gibson (1989) argued that direct selection for change in the
fat concentration would allow alteration of the fat:protein ratio. It may
however, be noted that the low coefficient ofvariation in fat concentration
would preclude any major modification, and the positive genetic
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correlation between fat and protein concentrations would be antagonistic
to such a selection objective (Table 1.4).
No separate estimations of genetic parameters of casein and
whey protein levels are available, but a positive genetic correlation
between these two traits would not be unexpected. Assuming that is the
case, direct selection for increased milk protein or casein concentration
would be accompanied by correlated response in whey protein level. In
Table 1.3. Milk composition of five dairy breeds (from Gibson 1987).
Breed Lactation Concentration (gkg-1) Fat:
milk yield (kg) protein
Fat Protein Lactose
Holstein-Friesian 7073 37.0 31.1 46.1 1:1.19
Ayrshire 5247 39.9 33.4 46.3 1:1.20
Jersey 4444 51.3 38.0 47.0 1:1.35
Guernsey 4809 48.7 36.2 47.8 1:1.35
Brown Swiss 5812 41.6 35.3 48.0 1:1.18
Table 1.4. Genetic correlations, heritabilities and coefficients of
variation ofmajor milk constituents (from Gibson 1987).
Trait Coefficient
of variation Y F P L
Liquid yield (Y) 0.22 0.27 -0.27 -0.18 0.01
Fat concentration (F) 0.09 0.47 0.55 0.22
Protein concentration (P) 0.08 0.48 0.02
Lactose concentration (L) 0.07 0.28
The underlined values are heritabilities and the remaining values are genetic
correlations.
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milk production systems where caseins are the main basis for economic
returns such as in cheese manufacture; there would be little to gain from
increased whey proteins in milk. Similarly, the low coefficient of variation
in lactose concentration would not allow significant change in lactose
concentration of milk. Due to the sex-limited nature of milk composition
traits, it is not possible to apply direct selection in males. In conclusion,
while conventional selection has been extremely successful for increasing
milk yield, it is likely to be slow and offers limited choice in altering milk
composition.
1.2.2. Qualitative Genetic Variation
Genetically determined polymorphic variants of milk
proteins have been studied by protein gel electrophoresis to identify
variants with desirable effects on the properties and composition of milk
(reviewed by Grosclaude and Martin 1992; Lin et al. 1992). Recently, it
has become possible to identify these polymorphisms in both sexes using
DNA based-techniques (Damiani et al. 1990; Denicourt et al. 1990;
Medrano and Aguilar-Cordova 1990).
A large number of workers have investigated the effect of
various genetic variants of milk proteins on the composition and physical
properties of milk (reviewed by Lin et al. 1992). Three consistent
associations have been noted: (1) the K-casein B allele has been associated
with a higher level of K-casein and a shorter rennet time (Aleandri et al.
1990; McLean et al. 1984; Schaar et al. 1985; Van den Berg et al. 1992).
(2) the (3-lactoglobulin A allele has been associated with higher
[3-lactoglobulin and lower casein, a-lactalbumin and fat levels (Aleandri et
al. 1990; Hill 1993; McLean et al. 1984; Ng-Kwai-Hang et al. 1990;
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Schaar et al. 1985; Van den Berg et al. 1992). (3) In goats, the A, B and C
alleles at the aS2-casein locus have been associated with higher milk
casein concentration than the D, E and F alleles (Grosclaude et al. 1987;
Mahe and Grosclaude 1989). The A, B and C alleles have also been
correlated with high fat content and cheese yields, and a selection
programme is underway to increase the frequency of these alleles in the
Alpine breed (Grosclaude and Martin 1992). It may be noted that
selection for A, B and C alleles at the aS2-casein locus in goats to increase
the casein content of milk would be expected to be accompanied by
increased fat content of milk which may be contrary to long-term
breeding objectives. Similarly, decreasing the frequency of the A allele at
the p-lactoglobulin in cattle may increase the casein concentration but not
without an undesirable effect on the fat contents ofmilk.
It remains a possibility that the above described associations
may not be the primary effects of the milk protein genes themselves but
could be due to some other linked genes. Particularly, it must be noted
that all the caseins genes are linked within 200 kb of DNA in cattle
(Ferretti et al. 1990; Threadgill and Womack 1990) and therefore, it is
difficult to unequivocally dissect the effects of various casein alleles on
qualitative and quantitative properties ofmilk.
1.3. MODIFICATION OF MILK COMPOSITION BY GENE
TRANSFER
Successful introduction of functional exogenous genes into the
mouse germ line through microinjection of cloned genes into fertilised
eggs (Palmiter et al. 1982; reviewed by Palmiter and Brinster 1986) led to
the proposal that extension of similar approaches to milk protein genes
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would allow germ line modification of milk composition in farm animals
(Clark et al. 1987; Lathe et al. 1986). These authors argued that
regulatory sequences of milk protein genes fused with coding sequences
of a human protein gene of pharmaceutical importance would target the
expression of the cognate protein into the secretory epithelium of the
mammary gland, and the pharmaceutical protein could readily be
harvested from milk. Jimenez-Flores and Richardson (1988) proposed
alteration of the nutritional and physical properties of milk by over-
expression of the native milk protein genes or by expression of modified
versions of some of these genes in transgenic cows. In the following
sections the progress in the application of gene transfer to modification of
milk composition has been reviewed.
1.3.1. Expression of Heterologous Proteins in Transgenic
Mouse Milk
A number of milk protein genes and fusion genes driven by
the regulatory sequences of milk protein genes have been transferred to
the mouse genome to target expression in the mammary gland (reviewed
by Clark et al. 1993; Hennighausen et al. 1990; Rosen et al. 1989; Wilmut
et al. 1990). These studies have been undertaken to locate the putative
regulatory sequences in the rat (Lee et al. 1988), rabbit (Biihler et al.
1990) and goat (DiTullio et al. 1992; Persuy et al. 1992) (i-casein, bovine
asi-casein (Meade et al. 1990; Rijnkels et al. 1993), mouse whey acidic
protein (McKnight et al. 1992 and references therein), and sheep
p-lactoglobulin genes (reviewed by Clark et al. 1993), and to optimise the
transgene design for synthesis of foreign proteins and secretion into the
milk of transgenic farm animal.
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Milk protein genes from various species when transferred to
the mouse genome are expressed in the mammary gland (Bayna and
Rosen 1990; Lee et al. 1988; Simons et al. 1987; Vilotte et al. 1989).
Position-independent high level expression of sheep (3-lactoglobulin gene
in mice (Whitelaw et al. 1992) has suggested that this gene may have
most of the sequences necessary for overriding the position-effect
(Al-Shawi et al. 1990) generally encountered with transgenes (Jaenisch
1988; Palmiter and Brinster 1986). Casein genes, except the goat p-casein
gene (Persuy et al. 1992), are generally expressed inefficiently in
transgenic mice even when several kb of upstream and downstream
sequences are included in the transgene (Lee et al. 1988; Rijnkels et al.
1993). Thus, expression data on the casein transgenes do not exclude the
possibility of co-ordinated regulation of casein locus by elements shared
amongst linked casein genes (Rosen et al. 1989) as has been
demonstrated for (3-globin locus (reviewed by Kollias and Grosveld 1992).
It is possible to achieve a high level of WAP gene expression but the
levels are variable and the element(s) responsible for temporal regulation
and copy number-dependent expression are yet to be identified (Bayna
and Rosen 1990). Matrix attachment region sequences from chicken
lysozyme locus (reviewed by Sippel et al. 1992) can restore the
endogenous regulation pattern of the WAP transgene but are not
sufficient to overcome the position-effect (McKnight et al. 1992).
Heterologous cDNAs under the control ofmilk protein gene
regulatory sequences are expressed at extremely low levels (Biihler et al.
1990; McClenaghan et al. 1991; Pittius et al. 1988; Whitelaw et al. 1991).
Incorporation of introns from the heterologous genes into the transgenes
may enhance the level of expression (Archibald et al. 1990) as has been
found with a number of other transgenes (Brinster et al. 1988; Choi et al.
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1991; Palmiter et al. 1991) but it may be at the cost of tissue specific
expression. An a i-antitrypsin minigene, lacking its first intron and
driven by 4 kb of the (3-lactoglobulin gene upstream sequences was
expressed in 10 out of 15 lines analysed (Archibald et al. 1990). The
expressing lines had variable levels of mRNA in the mammary gland or
salivary gland or both of these tissues. Very poorly expressed cDNA-
based transgenes can be rescued by co-integration with an efficiently
expressed intact BLG gene (Clark et al. 1992). It is worth noticing that
the level of expression of the rescued transgene was at least 20 fold lower
than that of the BLG gene.
Insertion of heterologous cDNAs into the 5' untranslated
region of the WAP gene may be compatible with a reasonable level of
expression (Velander et al. 1992) in contrast to fusion genes promoted by
2.6 kb of WAP gene upstream sequences (Pittius et al. 1988). However,
expression of analogous constructs derived from the BLG gene was
extremely inefficient (McClenaghan et al. 1991). Given the very high level
of expression of the intact BLG gene (Simons et al. 1987) it is intriguing
that disruption of exon 1 of this gene by various cDNAs is detrimental to
the expression. It seems unlikely that insertion of cDNA destroys some
vital element in the BLG gene responsible for efficient expression as
intermission of exon 1 of this gene in the hybrid construct of Archibald et
al. (1990) was compatible with high level expression. Most workers have
assayed the transgene expression by examining the level of heterologous
proteins and/ or steady state mRNA levels. These data alone are
insufficient to infer that the poor expression of the cDNA based
transgenes is due to the failure of transcription. It is possible that in
some of these examples the problems may lie downstream of
transcription.
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1.3.2. Production ofHeterologous Proteins inMilk of
Farm Animals
Manipulation of the genome by pronuclear injection has
been successfully applied to produce transgenic sheep, pigs, cattle and
goats; although the efficiency of transgenesis is low and numerous logistic
problems remain (reviewed by Clark et al. 1990; Wall and Seidel Jr.
1992). A number of transgenes have been transferred to the genome of
livestock species to produce biomedical proteins (Clark et al. 1989; Ebert
et al. 1991; McClenaghan et al. 1991; Velander et al. 1992; Wright et al.
1991) or heterologous milk proteins (Krimpenfort et al. 1991; Wall et al.
1991) in milk.
Generally, the performance of hybrid genes in livestock
species reflects the expression levels achieved in the transgenic mice.
Thus a fusion gene derived from sheep BLG gene and genomic sequences
from the human ai-antitrypsin (hai-AT) gene has been expressed at high
level in sheep milk (Wright et al. 1991). The concentration of hai-AT in
sheep milk ranged from 1.5-37.5 gl"1; in one animal this protein
represented approximately 50% of the total milk protein. The hai-AT or
human anti-haemophilic factor IX cDNA inserted into exon I of BLG gene
was expressed at extremely low levels in the milk of transgenic sheep
(Clark et al. 1989) as was the case in mice (McClenaghan et al. 1991). An
analogous hybrid construct carrying human protein C cDNA within exon
1 of the mouse WAP gene directed the synthesis of protein C and
secretion into the milk of transgenic pigs (Velander et al. 1992). The level
of protein C varied from 1-1000 (igml"1 in six founder animals, and the
protein C level varied five fold between two successive lactations in the
two animals analysed. Expression of the mouse WAP gene in some
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transgenic pig lines has resulted in agalactia (Shamay et al. 1992; Wall et
al. 1991), as was the case in mice (Burdon et al. 1991). The authors have
suggested that precocious expression of WAP may be responsible for this
phenotype. However, it cannot be concluded whether this phenotype is
due to the WAP transcript or to the protein produced. This information
may have implications for the design of fusion genes incorporating WAP
genomic sequences. WAP regulatory sequences fused to human-tissue
type plasminogen activator (hTPA) cDNA and SV40 polyadenylation site
have been used to direct the synthesis of hTPA and secretion into goat
milk (Ebert et al. 1991). Consistent with the results obtained in mice with
this construct (Pittius et al. 1988) the level of hTPA in goat milk was low.
In conclusion, the literature on the synthesis of heterologous
proteins in the mammary gland and secrertion into the milk of farm
animals suggests that low level of expression in many early studies might
have been due to non-optimum design of fusion genes (Clark et al. 1989;
Ebert et al. 1991; McClenaghan et al. 1991), and the example of ai-AT
(Wright et al. 1991) clearly demonstrates that it is possible to modify the
milk composition by gene transfer. However, the low efficiency of
transgenesis in farm animals, and the unpredictable performance of
fusion genes resulting from the interaction of the transgene design and
lack of control of the site and structure of transgene locus are likely to
limit any rapid progress.
1.3.3. Modification ofProperties ofMilk
Unlike conventional animal breeding, genetic engineering
has offered the possibility of creation of new genetic variation in milk
composition (section 1.2). Existing gene transfer methods allow addition
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of novel proteins in bovine milk (see section 1.3) or an increase in the
level of a native milk protein. The emerging gene targeting technology
(discussed below in section 1.4) holds the promise for deletion of
individual constituents of milk and precise modification in endogenous
milk proteins to improve their nutritional or physical properties.
Approximately 80% of the proteins in bovine milk exist as a
colloidal complex of casein micelles (see section 1.1.1.1). The physical
behaviour ofmilk during its processing is determined to a great extent by
the properties of these micelles and their interactions with whey proteins
(reviewed by Dalgleish et al. 1993). Although the precise organisation of
the casein micelles is not understood, there is sufficient evidence to
suggest that quantitative and qualitative genetic variation in caseins
may alter the physical properties of casein micelles. Thus, a number of
proposals have been made in the literature to modify the properties of
casein micelles either by manipulating the relative proportions of various
caseins or by changing the primary structure of a given protein (Bremel
et al; 1989; Clark 1992; Jimenez-Flores and Richardson 1988; Rang and
Richardson 1985; Muysson and Gibbins 1989).
The smaller casein micelles have a higher proportion of
K-casein (Dalgleish et al. 1989; Davies and Law 1983; Donnelly et al.
1984; McGann et al. 1980), and are more heat stable (Fox 1982). Rang
and Richardson (1985) have proposed that an increase in K-casein in
bovine milk would result in heat stable milk and this would avoid
unwanted gelation during the thermal processing of milk products.
Jimenez-Flores and Richardson (1988) have suggested that the addition
of 20-30% more (1-casein may enhance curd firmness, rennet clotting time
and the rate of whey expulsion. An increase in the level of (3-casein is
likely to alter the ratio of the calcium-sensitive casein to K-casein, and in
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turn, the micelle size may also change. Thus, over-expression of the
P-casein gene in bovine germ line may not result in all the desired
changes in milk properties. Alternatively, Clark (1992) has argued that
since curd firmness and renneting properties are determined by the
extent of phosphorylation of caseins, the creation of an additional
phosphorylation site in the p-casein would achieve the same objective.
The advantage of such a modification may be that the ratio of various
caseins would remain the same. However, it is not possible to predict that
the proposed phosphorylated centre (substitution of Val with Glu in the
sequence Seri64-Leu-Ser-Gln-Ser-Lys-Vali7o) would be available for
phosphorylation; there is also an assumption that the mammary gland
would have the capacity for this additional phosphorylation. Similarly,
the extra phosphorylation may interfere with the organisation and/ or
secretion ofmicelles. Construction of additional phosphorylation sites has
also been suggested for asi-casein to increase its thermal stability (Kang
and Richardson 1985). Ripening of Cheddar cheese is thought to occur by
proteolytic disintegration of micelles by the action of chymosin on
asi-casein. Kang and Richardson (1985) have suggested that addition of
another chymosin cleavage site may enhance the rate of cheese
maturation.
Cow's milk even after considerable processing is not suitable
for many human infants. Some of the changes to make it suitable for
consumption may include removal of p-lactoglobulin (Mercier 1986) and
addition of human lactoferrin (Krimpenfort et al. 1991). Bovine milk has
relatively a low level of lactoferrin whereas in human milk this protein is
one of the major whey proteins. Krimpenfort et al. (1991) have reported
production of a transgenic bull carrying a human lactoferrin transgene
driven by bovine asi-casein gene regulatory sequences. It will be some
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time before the milk from the daughters of this bull would be available
for analysis.
Lactose intolerance is a problem in Indo-European
populations because some adults are unable to metabolise lactose present
in milk. It has been suggested that the lowering of the expression of
a-lactalbumin, a essential cofactor in the biosynthesis of lactose might
reduce the concentration of lactose in milk (Clark et al. 1992; Mercier
1986). Complete removal of lactose may be ideal for nutritional as well as
milk processing reasons but this may not be compatible with its role in
milk secretion, as lactose is responsible for the secretion ofwater into the
milk (section 1.1.3).
The preference for less fat in diet is growing and it may be
commercially desirable to reduce the level of fat in the milk. Bremel et al.
(1989) have suggested that the reduction in the level of acetyl CoA
carboxylase (ACC), a key enzyme responsible for de novo synthesis of fat
in the mammary gland, may lead to the reduction in the level of fat in
milk. As ACC is central to the fat metabolism of all cells it may not be
possible to interfere with the expression of this enzyme. One potential
way to circumvent this problem may involve deleting the expression of
ACC specifically in the mammary gland without affecting its expression
in any other tissue. This could be achieved by targeting two loxP sites
flanking an exon of ACC gene and mammary specific expression of
bacteriophage PI Cre recombinase (Orban et al. 1992).
It should be emphasised that none of the potential
applications discussed above has been realised yet. In addition to the
logistic problems associated with the production of transgenic livestock, it
is not feasible to modify endogenous genes with the existing gene transfer
methods in livestock species. Milk is a complex system and thus, the
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consequences of even the modifications which are possible with the
current technology cannot be predicted beforehand. Understanding of the
functions of individual milk proteins in determination of properties of
milk and its behaviour during processing will be necessary before
attempting modifications in milk of farm animals. The mouse has been
serving as a useful model to optimise transgene design to target
expression to the mammary gland of farm animals (section 1.3). The
availability of gene targeting technology in the mouse has offered a
powerful tool to find out the in vivo function of any gene (section 1.4). In
the short term, application of this technology to the casein genes should
help to address the role of these proteins in the organisation of casein
micelles, and in determination of physical properties of milk. In the
longer term, it may be possible to replace the various mouse milk
proteins genes with those of cattle. Such an animal model system would
allow quick and reliable evaluation of the effects of various modification
intended in the bovine caseins (Clark 1992). The current status of the
gene targeting technology has been reviewed in the next section.
1.4. MANIPULATION OF THE MOUSE GENOME BY GENE
TARGETING
Transgenesis by pronuclear microinjection of cloned DNA has
made a tremendous impact on our understanding of biology and its
potential is being realised in solving some practical problems (see section
1.3.3). However, some of the limitations associated with this technology
are: 1). There is no control over the site of integration of the injected
DNA, and generally multiple copies of transgene are integrated in
tandem arrays; both of these factors contribute to the uncertainty of the
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phenotype. 2). Normally, only gain of function mutations are feasible and
the endogenous gene expression cannot be manipulated, although it is
possible to make dominant negative modifications of multimeric proteins
(Herskowitz 1987; Levin et al. 1993) and the antisense RNA approach
has been used successfully in a few cases (Katsuki et al. 1988; Pepin et al.
1992). The above limitations of transgenic technology have been overcome
in mouse genetics by the availability of embryonic stem (ES) cells and the
ability of these cells to support homologous recombination between
chromosomal genes and extraneously introduced DNA fragments. ES
cells are pluripotential cells derived from the inner cell mass (ICM) of the
blastocyst (Evans and Kaufman 1981; Martin 1981) and can be
propagated in vitro under conditions which inhibit their differentiation,
at the same time preserving pluripotency. When injected into developing
mouse blastocysts these cells can resume normal development and
contribute to most or all cell lineages including the germ line (Bradley et
al. 1984). While in culture these cells can be genetically manipulated and
rare clones with pre-determined changes in endogenous genes can be
isolated and be used to reconstitute animals (reviewed by Baribault and
Kemler 1989; Bradley et al. 1992; Capecchi 1989a; 1989b; Evans 1989;
Roller and Smithies 1992; Robertson 1991).
During the last decade it was shown that DNA fragments when
introduced into mammalian cells could participate in homologous
recombination with the endogenous genes (reviewed by Bollag et al.
1989). Application of homologous recombination in embryonic stem cells
has meant that pre-defined mutations can be introduced in the germ line
of the mouse. Since Thompson et al. (1989) showed the germ line
transmission of the targeted correction of a null mutation in the mouse
HPRT gene in embryonic stem cells, application of gene targeting
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technology has pervaded almost every aspect of animal biology research
(reviewed by Bradley et al. 1992; Roller and Smithies 1992; Robertson
1991).
1.4.1. Mouse Embryonic Stem Cells
In 1981, two laboratories independently reported isolation of
pluripotential cells in vitro from the mouse embryo (Evans and Kaufman
1981; Martin 1981). Evans and Kaufman (1981) induced implantational
delay on day 2.5 of pregnancy by ovariectomy and hormonal (Depo-
Provera) treatment to increase the cell number and to recover blastocysts
representing early post-implantation stage. Initially, groups of embryos
were seeded on plastic dishes in drops of culture medium under paraffin
oil. The ICM cells grew out as egg-cylinder-like structures; the latter
were taken off the dishes, and seeded on mitomycin C-inactivated STO
cell feeder layers in gelatinised dishes after dispersal of cells by
trypsinisation. Subsequent passaging of cells led to the establishment of a
number of ES cell lines (originally called EK cell lines) with a normal
karyotype. The pluripotency of these cell lines was demonstrated by their
capacity to differentiate in vitro after withdrawal of feeder layers, and the
formation of teratocarcinomas in syngeneic mice (Evans and Kaufman
1981).
Martin (1981) established an ES cell line directly from the
ICM released by immunosurgery from the blastocysts. The ICMs were
grown on mitomycin C-treated STO feeder layer in culture medium
conditioned by a teratocarcinoma-derived cell line. An embryonic stem
cell line was derived from the colonies of cells grown from the ICMs. After
five passages the stem cell line could be maintained on feeder layers in
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the absence of the conditioned medium. Martin (1981) argued that the
conditioned medium contained a factor essential for the promotion of
growth of stem cells/ inhibition of their differentiation in vitro or both.
The ES cells were able to generate teratocarcinomas in vivo and
differentiated into embryoid bodies in vitro. Subsequently, Axelrod (1984)
showed that the use of conditioned medium and immunosurgery (Martin
1981) or implantational delay (Evan and Kaufman 1981) was not
necessary to isolate diploid and pluripotential ES cell lines. The author
reasoned that the use of small culture volume obviated the need for the
conditioned medium. Eistetter (1989) reported isolation of pluripotential
ES cells from blastomeres cultured on mitomycin C-treated embryonic
fibroblasts. The blastomeres were obtained by removal of zonae
pellucidae and disaggregation of morulae of approximately 16 cells.
Bradley et al. (1984) demonstrated that three independently
derived male ES cell lines could contribute extensively to the soma and
germ line when injected into the host blastocysts. Approximately 30% of
the male chimaeras tested produced ES cell derived progeny. In an
extensive study the same laboratory showed that all the 17 independent
ES cell lines tested could contribute to chimaerism and a distortion in
sex-ratio in favour of males was observed (Evans et al. 1985). A number
of germ line male chimaeras produced progeny only from the ES cell
genome. The authors proposed that such chimaeras resulted from female
blastocysts injected with male ES cells; the male ES cells converted the
sex of the female blastocysts and XX cells from the latter were excluded
from spermatogenesis. The efficiency of germ line colonization by ES cells
appears to be partly dependent upon the strain of the host blastocyst.
Blastocysts from C57/BL/6 have been shown to permit better
incorporation ofmicroinjected ES cell into the germ line as compared to
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blastocysts from outbred strains CD1, MF1 (DeChiara et al. 1990;
Schwartzberg et al. 1989), and ICR (Pease and Williams 1990). The use of
blastocysts from strains harbouring a known genetic lesion affecting
fertility may also significantly improve the prospects of germ line
transmission of the ES cell component (Evans et al. 1985).
Chimaeras have also been produced by aggregation of ES
cells with 8-cell diploid or 4-cell tetraploid embryos (Nagy et al. 1990) and
by injection of ES cells under the zona pellucida of 8-cell embryos
(Tokunaga and Tsunoda 1992). Although live animals were born from the
aggregation of ES cells with 4-cell tetraploid embryos, they failed to
survive (Nagy et al. 1990). Injection of ES cells (C57/BL/6 X CBA) into
uncompacted 8-cell eggs (CD-I) resulted in significantly higher frequency
of chimaerism as compared to injection of ES cells into blastocysts and
the degree of chimaerism was higher (Tokunaga and Tsunoda 1992). In
this study an exceptionally high proportion of 8-cell egg derived male
chimaeras produced progeny exclusively from the ES cell component. It is
not clear whether this effect reflects only the stage of the embryo or is the
outcome of the interaction of mouse and ES cell strain, and the stage of
embryo. However, the conclusion of this study is consistent with that of
Lallemand and Brulet (1990). In this study the extent of chimaerism was
measured by staining for expression of a lacZ gene carried by the ES
cells. Chimaeric embryos were generated by injection of ES cells
(129/Sv+/+) either into morulae or blastocysts (F2, BALB/c X SJL/J) and
it was found that consistently better chimaerism was obtained from
morula injections. Recently, a simple method based on a brief coculture of
ES cells and 8-cell embryos has been reported for the production of germ
line chimaeras (Wood et al. 1993). 15 pups were born from 40
manipulated embryos and 6 of these pups were chimaeric. Two male
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chimaeras transmitted the ES cell component to their progeny. The
number of ES cells populating the embryos in culture appeared to be
critical for post implantation development; higher contribution from an
ES cell line appears to be associated with abnormal development.
Replication of these experiments with a number of ES cell lines would be
required to draw firm conclusions on this association.
In 1986, two laboratories demonstrated the use of ES cells to
generate transgenic mice, using either retroviral infection (Robertson et
al. 1986) or the calcium phosphate method (Gossler et al. 1986). ES cells
selected for G418-resistance in vitro prior to injecting them into
blastocysts were demonstrated to be compatible with germ line
transmission (Gossler et al. 1986). The use of ES cells to generate mice
carrying mutations of a specific gene was shown by two different groups
(Hooper et al. 1987; Kuehn et al. 1987). To generate HPRT-deficient mice
Hooper et al. (1987) isolated ES cell clones resistant to 6-thioguanine
(6-TG). One clone carrying a spontaneous deletion of part of the HPRT
gene was used to generate chimaeras, and this clone contributed to the
germ line. Kuehn et al. (1987) inactivated the HPRT gene by retroviral
insertion and HPRT-deficient clones were selected using 6-TG selection.
Two independent ES cell clones were found competent to colonize the
germ line; one of these clones was transmitted through both the male and
female chimaeras.
A more directed approach to the generation of specific
mutations in mice involves gene targeting (see next section). This has
spurred the widespread use of ES cells. Initially, ES cells were isolated
and grown on feeder layers of either mitotically inactivated fibroblasts
(Evans and Kaufman 1981) or primary embryonic fibroblasts (Gossler et
al. 1986). The use of feeder layers is cumbersome, and the isolation of
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rare clones of ES cells using various selective media has been facilitated
by the development of feeder-free culture conditions suitable for
proliferation of ES cells. Smith and Hooper (1987) reported that culture
medium conditioned by Buffalo rat liver (BRL) cells could inhibit the
differentiation of ES cells in the absence of feeder layers. BRL cell-
conditioned medium in combination with fibroblast feeder layers was
used to isolate a diploid ES cell line (Handyside et al. 1989). The
established ES cell line could be maintained on BRL medium alone, and
cells of this line can contribute to the germ line (Hooper et al. 1987).
Subsequently, a glycoprotein (Mr=43,000) called differentiation inhibiting
activity (DIA) from the BRL medium (Smith et al. 1988) or myeloid
leukaemic inhibitory factor (LIF) (Williams et al. 1988) was found to be
sufficient to inhibit the differentiation of pluripotential ES cells in vitro
in the absence of feeder layers. ES cell lines isolated in culture medium
supplemented with purified LIF and without feeder layers have been
shown to be germ line competent (Nichols et al. 1990; Pease and Williams
1990). However, only one of the 15 ES cell lines isolated by Nichols et al.
(1990) had a completely normal karyotype. Bradley et al. (1992) have
argued that despite the simplicity of feeder-free ES cell culture systems it
may be advantageous to use feeders in experiments designed to isolate
genetically modified ES cell clones. In the absence of published
information on comparison of efficiency of these culture systems, many
laboratories prefer to use feeder layers; nevertheless germ line
transmission of a number of targeted ES cell clones has been reported in
the literature using feeder-free culture systems (Clarke et al. 1992;
Selfridge et al. 1992; Thompson et al. 1989).
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1.4.2. Gene Targeting in Mammalian Cells
The term gene targeting has been used to describe the
directed modification of endogenous genes via homologous recombination
between chromosomal DNA sequences and an extraneously introduced
DNA fragment. Development of gene targeting strategies in mammalian
cells was preceded by the demonstration that extraneously introduced
DNA molecules can participate in extrachromosomal recombination (see
review by Subramani and Seaton 1988). Although these studies
demonstrated homologous recombination in mammalian cells,
subsequently it has been shown that extra-chromosomal recombination
involves a non-conservative pathway of recombination distinct from that
of gene targeting (Lin et al. 1984; Lin et al. 1990; Seidman 1987). In the
process of extrachromosomal recombination, one of the substrates is lost,
unlike in a gene targeting reaction where both the participating
molecules are conserved (Pennington and Wilson 1991). The design of
gene targeting plasmids used in mammalian cells has been facilitated by
the knowledge gained from similar experiments in yeast. Essentially, a
targeting plasmid includes a DNA fragment homologous to the
chromosomal region of interest. In cases where the targeted modification
does not lead to a selectable phenotype a positive marker gene is placed
within homologous sequences. Depending upon the site of a double-strand
cut in the targeting plasmid two types of targeting vectors are generated.
If the cut is placed within the region of homology a insertion-type gene
targeting vector is generated (Orr-Weaver et al. 1981). Homologous
recombination of this vector with the target locus leads to the integration
of the entire vector sequences resulting in duplication of the target gene
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Figure 1.2. Schematic representation of gene targeting.
A) Targeting by an insertion-type vector. The entire targeting
vector is integrated into the target gene.
B) Targeting by a replacement-type vector. Sequences in the
target gene are replaced by those of targeting vector.
Very thick line: positively selectable marker; Thin line: plasmid
backbone.
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of a double-strand break at the junction or outside the region of homology
in the targeting plasmid results in a gene replacement-type vector
(Rothstein 1983). In these vectors the positive marker is flanked by two
arms of sequences homologous to the target gene. Homologous
recombination yields replacement of endogenous gene sequences with
those corresponding to vector sequences, including the positive marker
(Fig. 1.2B).
1.4.2.1. Early Gene Targeting Experiments in Mammalian
Cells
Initial studies on gene targeting involved correction of
mutated tk or neo genes in artificially created loci in cell lines (Lin et al.
1985; Smith and Berg 1984; Song et al. 1987; Thomas et al. 1986). Smith
and Berg (1984) stably transfected 3T6 cells with a plasmid carrying a
deleted neo gene, and isolated a cell line containing multiple copies of the
vector. Calcium phosphate transfection of this cell line with a plasmid
carrying another mutant neo gene generated functional neo genes at a
frequency of 10~3 to 10 4 per cell that integrated the transfected DNA. In
similar experiments Lin et al. (1985) provided evidence for the creation of
functional tk genes through homologous recombination between
overlapping 5' and 3' fragments of the tk gene. In this study a non¬
functional tk gene was corrected at a frequency 106-fold lower than that
of transformation frequency by a functional tk gene, in only one out of 10
cell lines tested. The lack of generation of the tk+ phenotype in the
remaining nine lines was interpreted as being due to the positions of the
loci. An alternative explanation, not considered by the authors, might
have been the difference in the precise structures of the reconstructed loci
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in these cell lines. Also their scheme of homologous recombination was
very inefficient (see below) and it is not possible to rule out that they
fortuitously isolated one cell line with higher efficiency of homologous
recombination. The low frequency might have been due to the use of
supercoiled plasmid and a small region of homology (320 bp) between the
integrated and exogenous tk gene fragments. Southern blot analysis of 9
tk+ cell lines revealed that in only one of these lines the tk gene was
corrected by insertion of the incoming plasmid (Lin et al. 1985). In the
absence of linearisation of the incoming plasmid it was possible that in
some of these lines the tk gene was reconstructed in two steps. In the
first step the targeting plasmid might have integrated into the locus via
homologous recombination at a point other than tk sequences (the
integrated and the incoming plasmids shared the same backbone) and a
second intrachromosomal recombination step generated the functional tk
gene. The loss of most of the tk gene sequences in one of the clones
appears to be consistent with this interpretation of their data.
Thomas et al. (1986) corrected a non-functional neo
gene integrated into three chromosomal sites in mouse L cells. These
authors microinjected linearised correcting plasmids. In the three cell
lines one cell per 1000 cells injected were found to have a functional neo
gene. In one experiment, the number of molecules injected was varied to
find out the effect on the gene targeting frequency. Thomas et al. (1986)
concluded that the number of molecules injected did not influence gene
targeting and went on to further suggest that the finding of homologous
sequences by the targeting vector in the cell genome was not rate limiting
in a gene targeting reaction. The number of targeting events obtained in
this experiment was very small and thus, their data were not sufficient to
support their conclusions. Similarly their conclusion on the lack of effect
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of chromosomal position on gene targeting efficiency requires caution
since only three sites were studied. Double reciprocal recombination or
gene conversion resulted in the correction of either the integrated neo
gene or the neo gene on the incoming plasmid (Thomas et al. 1986). The
lack of targeted integration of the incoming plasmids is likely to have
been due to the introduction of a double strand-break outside the neo
gene sequences in the targeting plasmids in this study rather than an
inherent preference of mammalian cells for gene conversion events.
Song et al. (1987) reported correction of integrated
non-functional neo genes in hamster and human cells. In various cell
lines the ratio of homologous recombination to non-homologous
integration varied from 1:76 to 1:500. Southern analysis revealed that
functional neo genes were created in three ways: a) targeted integration
of the incoming plasmid, b) replacement or gene conversion and c)
correction of the incoming plasmid by sequence replacement or gene
conversion and its integration elsewhere in the genome. In this study the
double-strand break in the incoming plasmid was placed in such a way
that a functional neo gene could have been created either by an
integration or a replacement-type targeting event.
Smithies et al. (1985) were the first to provide
evidence that a cellular gene in mammals can be modified through
homologous recombination. They used an insertion-type vector to target
the human (3-globin gene in EJ carcinoma cells (in which the (3-globin
gene is silent) and in a hybrid cell line, Hu 11 (in which the (3-globin gene
is active). The targeting vector included 4.6 kb of DNA from the human
[3-globin gene, the neo gene to select the cells that incorporated the vector
DNA, and a bacterial suppresser gene (supF) to facilitate cloning out of
the unique fragment generated as result of targeted integration of the
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vector in the P-globin gene. Homologous recombination of this vector was
predicted to generate a 7.7 kb Xbal fragment comprising both supF gene
and P-globin sequences which were not present in the targeting vector.
Smithies et al. (1985) screened genomic DNA from the cells transfected
with the targeting vector by rescuing the 7.7 kb Xbal fragment into a
mutant bacteriophage. The authors showed that approximately one out of
every thousand cells transformed by the targeting vector DNA had
undergone the predicted modification in the P-globin gene irrespective of
the state of transcription of this gene.
These early experiments demonstrated that cellular
genes can be modified by gene targeting but that only a minority of the
transformed cells undergo homologous recombination and emphasised
the need to further refine the techniques. Gene targeting experiments
with the HPRT gene have proved very beneficial in understanding the
parameters affecting the gene targeting efficiency in mouse ES cells.
HPRT is encoded by a single copy gene on the X-chromosome and
selection protocols have been available to select for (HAT) and against
(6-TG) the activity of this gene. Thus, targeted modification in the HPRT
gene in a male cell line leads to a selectable phenotype and the rare
targeting events can easily be identified in the background of cell clones
generated by random integration of the targeting vectors.
1.4.2.2. Targeting the HPRT Gene in ES cells.
In 1987, two laboratories introduced targeted
modification of the HPRT gene. Doetschman et al. (1987) restored HPRT
gene function by targeted integration of an insertion-type vector in an ES
cell line carrying a deletion in the 5' region of the HPRT gene. Cells
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electroporated in the presence of the vector were selected in HAT
medium, and HAT-resistant colonies were isolated at a frequency of
1.8xl0~6 per cell treated. Five independent colonies were shown to have
undergone the predicted modification at the HPRT locus (Doetschman et
al. 1987). In three out of five such clones analysed, a four base pair
insertion included near the double-strand break point in one arm of the
targeting vector was corrected by the chromosomal sequences.
Complementary experiments were described by
Thomas and Capecchi (1987). These authors disrupted the HPRT gene
via homologous recombination at this locus using both insertion and
replacement-type vectors. Their targeting vectors included a neo gene
specially constructed to achieve high level of expression in ES cells and
varying amounts of homologous sequences. The targeted clones were
isolated after selection in G418 and 6-TG. Thomas and Capecchi (1987)
concluded that a 2-fold increase in homology resulted in 20-fold
enhancement of the targeting frequency. However, only one experiment
was performed with most vectors in this study. Another of their
conclusions that insertion and replacement-type vectors targeted with
equal frequency needs qualification. First, the neo gene in the vectors
lacked a polyadenylation signal; thus, some of the clones targeted by
insertion vectors may have been lost by reconstruction of the HPRT
functional mRNA after splicing out the sequences corresponding to the
targeting vectors. Second, the design of insertion vectors in this study
was such that sequences homologous to 5' and 3' region of the HPRT gene
were joined together; the total homology was interrupted twice, by a
double-strand break and the neo gene. The relevance of this is that these
vectors are capable of targeting by both insertion and replacement
pathways. Both of the above factors could have resulted in an under-
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estimation of targeting frequency of insertion vectors. Withstanding these
observations, the absolute targeting efficiency of equivalent replacement
and insertion vectors was 0.4xl0"6 and 0.5xl0~6, respectively. Southern
analysis revealed that replacement vectors targeted in a predictable
manner. It is intriguing to note that although the structure of insertion
vectors used in this study was compatible with both insertion and
replacement targeting, the majority of the targeted clones (9/12) were the
outcome of an insertion-type event. The remaining 3 clones were
generated by replacement targeting.
In contrast to the observations made by Thomas and
Capecchi (1987), another laboratory reported that an HPRT replacement-
type vector targeted at least 5-fold less efficiently in contrast to a
corresponding insertion vector (Hasty et al. 1991c; this comparison is
based on the absolute targeting efficiency calculated from the data
presented by the authors). In this study the targeting efficiency was
expressed as the ratio of G418-6-TG-resistant clones to G418-resistant
clones while comparing the two types of vectors and it was concluded that
insertion vectors were 9-fold more efficient. The above measurement of
targeting efficiency may not be an ideal method to compare various
vectors since the frequency of G418-resistant clones would be influenced
by the design of targeting vectors. Hasty et al. (1991c) showed that the
structure of the majority of the clones targeted by their replacement
vector did not arise after sequence replacement events at the HPRT locus
but these were the product of complex events involving integration of one
or more copies of the replacement vector in the HPRT gene. Their
conclusion that replacement vectors are prone to aberrant targeting has
been challenged by Thomas et al. (1992). These authors targeted the 3'
region of the HPRT gene with a replacement vector having 9.1 kb of
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homologous sequences distributed as two arms of 6.1 and 3.0 kb. It was
observed that in all the 18 targeted clones the structure of the HPRT
locus was generated as a result of precise targeting. However, when the
short arm of homology was reduced to 0.7 kb, in five out of the 18 clones
analysed the targeting events were not the predicted replacement events.
Thomas et al. (1992) argued that reduction in the fidelity of targeting by
replacement vector may be due to the reduction in the length of the short
arm of the replacement vector in their study as well as in that ofHasty et
al. (1991c). They have further suggested that a minimum length of
homology on each arm may be required for the gene targeting reaction to
proceed and concatemerisation of the vector molecule may be
advantageous when one arm of the vector is exceptionally short. A trivial
alternative explanation may be that the aberrant targeting occurs with
low frequency at all times but when one arm of the vector is very short
the frequency of precise gene targeting events drops dramatically due to
the degradation of the short arm (and consequently loss of the neo gene
expression), and that the selection for neo gene expression during the
isolation of targeting events apparently enriches for the aberrant
targeting events.
The relationship between the gene targeting efficiency
and total homology in the targeting vector has been examined by two
groups (Deng and Capecchi 1992; Hasty et al. 1991b). Hasty et al. (1991b)
observed that the absolute targeting frequency increased by 250-fold with
a corresponding increase in homology from 1.3 kb to 6.8 kb in their
insertion vector. In this study equimolar vector DNA was not used and
the absolute targeting efficiencies were adjusted to take into account
differences in the numbers of the vector molecules. The authors compared
the targeting efficiency of replacement vectors having a homology of
38
1.3-6.8 kb. Their data suggested that although the absolute targeting
efficiency increased with an increase in the length of homology, the
relationship appeared to be linear and not exponential as suggested by
Thomas and Capecchi (1987) and subsequently demonstrated by the
latter laboratory in an extensive study (Deng and Capecchi 1992). This
difference may be reconciled by the fact that Hasty et al. (1991b) probably
overestimated the absolute gene targeting efficiencies of their smaller
vectors since they used a fixed amount of the vector DNA, and that their
replacement vectors did not always target the HPRT gene in a way
predicted for these vectors. Further, the conclusion ofHasty et al. (1991b)
that targeting efficiency did not respond to an increase in homology
beyond 6.0 kb was based on only a single vector. On the other hand Deng
and Capecchi (1992) have provided good evidence that gene targeting
efficiency increases exponentially with an increase in homology in both
replacement and insertion vectors. A plateau effect was observed when
the length of homology reached 14 kb for both insertion and replacement
vectors (Deng and Capecchi 1992). The targeting efficiency of these two
types of vectors appeared to be similar in this study but it may be noted
that the 5' and 3' regions of the HPRT gene homology in the majority of
the insertion vectors were joined together. As a result these vectors are
capable of targeting both by insertion and replacement pathways. Deng
and Capecchi (1992) did not analyse the structure of the targeted HPRT
gene of the 6-TG-resistant clones.
1.4.2.3. Strategies for Targeting Non-selectable Genes
Targeted mutations in most genes in ES cells do not
lead to selectable phenotypes. To identify ES clones transformed by the
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incoming DNA either via random integration or targeted integration, a
positively selectable marker gene is included in the targeting vector. A
neo gene cassette pMClNeo, constructed by Thomas and Capecchi (1987)
for its high level of expression in ES cells has been widely used in gene
targeting experiments. pMClNeo includes the HSV tk gene promoter and
an enhancer from the PyF441 polyoma virus in addition to the neo gene
coding sequences. The hygromycin gene is another positive selection
marker that has been used in gene targeting experiments (Te Riele et al.
1990).
Mammalian cells generally incorporate transfected
DNA at various random sites throughout their genome (reviewed by Roth
and Wilson 1988). ES cells are no exception and usually, only a small
proportion of cells transformed by the targeting vector DNA undergo
homologous recombination. Two different approaches have been utilised
to enrich for the targeting clones at the expense of clones generated as a
result of random integration of the targeting vector.
In the first approach, a promoterless selectable
marker gene is included in the targeting vector such that upon
homologous recombination the marker gene would come under the
transcriptional control of the regulatory sequences of the target gene. The
modified gene would allow selection for the marker gene if the target
gene is active in the embryonic stem cells. As the marker gene in the
targeting vector lacks its control elements random integration of the
vector into the ES cell genome would very infrequently lead to its
expression. Hence, the relative proportion of the targeted clones would be
increased. Doetschman et al. (1988) targeted the HPRT gene with a
replacement-type vector using this approach. A translation stop codon
and a translation start codon was included upstream of the neo coding
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sequences in the vector. It was envisaged that the initiation of translation
from the endogenous start codon in the mRNA from the targeted allele
would be terminated at the newly introduced in-frame stop codon and the
reinitiation of translation would result in the functional neo gene
product. Doetschman et al. (1988) were able to isolate targeted clones by
this strategy; the comparison of the transformation frequency of their
targeting vector and a functional neo gene suggested approximately
100-fold enrichment for the targeting events. Very low level of neo gene
expression was achieved from the targeted allele as demonstrated by the
failure to isolate targeted clones at the high stringency selection regime.
This was probably due to the inefficient reinitiation of translation in the
fusion mRNA. A better alternative involves construction of the targeting
vector in such a way that the fusion transcript from the targeted allele
would direct a fusion protein conferring G418-resistance (Charron et al.
1990; Schwartzberg et al. 1989). The use of a neo gene without its
polyadenylation site may further reduce the number of clones generated
by random integration (Joyner et al. 1989; Zijlstra et al. 1989) but it may
not always be possible to avoid the polyadenylation signal present in the
homologous sequences included in the targeting vector. Nevertheless, if
the objective of the experiment is to introduce a null mutation it may be
desirable to include the polyadenylation signal at the end of the marker
gene.
The promoterless selectable marker gene approach
has also been used in conjunction with insertion vectors (Jasin and Berg
1988). These authors targeted the SV40 early region in COS1 cells and
achieved 100-fold enrichment for the targeting events. It may be noted
that the targeted allele in some of the clones was unstable probably
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reflecting the weak transcription from the endogenous locus vis-a-vis
selection pressure applied to isolate these clones.
An important strategy, the positive-negative selection
(PNS) procedure for enrichment for the targeted clones relies on the
selective killing of cells that have randomly incorporated a replacement-
type targeting vector (Mansour et al. 1988). In this method a negatively
selectable marker gene is placed at one or both ends of the vector in
addition to the positive marker embedded into the region of homology.
Homologous recombination of the replacement vector with the target
gene results in the exclusion of the non-homologous terminal DNA of the
marker gene, and thus targeted clones are able to survive selection
against expression of the negatively selectable marker gene. However,
clones generated by random integration of the targeting vector would
incorporate the terminally placed marker and negative selection will lead
to the killing of cells expressing this marker. Mansour et al. (1988) chose
to target the HPRT and int-2 genes using this approach. They placed the
thymidine kinase (tk) gene from Herpes simplex virus at the end of the
replacement-type vectors, and after the first round of selection for neo
gene expression an additional selection was applied against the cells
expressing the HSV tk gene using the drug gancyclovir (GANC). In this
study the authors reported approximately 2000-fold enrichment after
negative selection. However, the extensive use of the PNS procedures by
a large number of laboratories has shown that generally 5-20-fold
enrichment is feasible (DeChiara et al. 1990; McMahon and Bradley
1990; Tybulewicz et al. 1991; and many others). The reasons for this
discrepancy are not clear. Even with the variable level of enrichment
there is a distinct advantage to this procedure. Unlike the promoterless
neo approach the PNS procedure does not require the expression of the
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target gene in ES cells. The HSV tk gene can be substituted by the
diphtheria toxin A (DT-A) gene and approximately 9-30-fold enrichment
has been obtained (McCarrick III et al. 1993; Yagi et al. 1990). The
obvious advantage of using the DT-A is that no drug is required for
negative selection. However, it should be noted that a small proportion of
ES cells may be killed by the DT-A gene even in the absence of the stable
integration of the targeting vector.
1.4.2.4. Screening for Targeting Events
Despite the various selection and enrichment
strategies, a large number of ES cell clones are generally required to be
examined to identify the clones that have undergone targeting. The
initial screening may be performed either by Southern blotting or by the
polymerase chain reaction (PCR). If PCR is used in the initial screening
the structure of the targeted gene in the positive clones is confirmed by
Southern blotting.
Typically, the targeted allele are discriminated from
the wild-type allele by Southern analysis since a number of novel
restriction fragments would be created as a result of targeting; these
fragments are detected with probes suitable for the target locus. Both the
5' and 3' sites of homologous recombination are examined with probes
corresponding to DNA sequences not included in the targeting vector.
Additional screening with a probe internal to the targeting vector is
necessary to exclude the aberrant targeting events and random
integration of the targeting vector in the targeted clones; although the
probability of the latter is extremely rare. PCR-based screening is based
on the fact that homologous recombination using a replacement-type
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vector results in a novel junction in the targeted allele. One primer is
chosen from the targeting vector sequences not present in the target gene
(usually from the positive marker gene) and the second primer
corresponds to target gene sequences not included in the targeting vector.
In theory amplification of the predicted fragment is possible only from the
targeted allele (Kim and Smithies 1988). The choice of the screening
method has implications for the vector design. For the efficient
amplification of the predicted PCR product one arm of the targeting
vector is kept short (<1 kb). This requirement may be antagonistic to the
observation that a very short arm in the targeting vector may reduce the
fidelity of gene targeting reaction involving a replacement vector
(Thomas et al. 1992). However, by using PCR targeted clones can be
selected at an early stage without the need to expand a large number of
ES cells clones transformed by targeting vectors.
1.4.2.5. The Effects on Terminal Heterologies on Gene
Targeting Efficiency
The PNS procedure (see section 1.4.2.2) is based on
the premise that blocking one or both arms of replacement-type vectors
does not adversely affect the gene targeting efficiency. The successful use
of the PNS procedure in targeting a variety of genes is consistent with
this postulation, however, few controlled experiments have been reported
in the literature. Hasty et al. (1991c) cut an HPRT gene targeting
plasmid in three different ways so that approximately 3 kb heterologous
sequences were either excised from the targeting vector or were left on
one of the two arms of homology. Gene targeting frequency was expressed
as the ratio of 6-TG to G418 clones and the authors concluded that the
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presence of heterology did not decrease the targeting frequency. However,
this conclusion is not sustained if the data are expressed in terms of
absolute targeting efficiency, in fact, the presence of heterology on the
short arm appears to increase the efficiency. The results of Hasty et al.
(1991c) are inconclusive since most of their replacement vectors targeted
the HPRT gene in an imprecise way (see section 1.4.2.1). Mansour et al.
(1988) and Deng and Capecchi (1992) have cited unpublished results in
support of the neutrality of terminal heterologies on the gene targeting
efficiency of replacement-type vectors.
A double-strand cut in the region of homology in the
insertion vectors results in a several-fold improvement in gene targeting
efficiency in ES cells (Hasty et al. 1992; Valancius and Smithies 1991a).
Hasty et al. (1992) have reported that the placement of a 2.3 kb
heterology on one of the DNA ends significantly reduced the targeting
frequency. The structure of the targeted clones revealed that the terminal
heterology had been lost in the majority of the clones. On the other hand,
blocking of both the DNA ends of an insertion vector with 13 bp of
heterology each did not appreciably affect the gene targeting frequency
but in some of the targeted clones the heterology was retained. The
authors have suggested that the small terminal heterologies were
retained as a result of ligation of the DNA ends during the gene targeting
reaction. One prediction of this argument is that the heterologies should
be retained in the targeted locus either to the 5' or 3' of the integrated
vector sequences with equal probability. However, in five of the six clones
analysed the small terminal heterology was retained 5' to the integrated
vector sequences. This would be more consistent with a preferential
cross-over on the longer of the two arms of homology after
recircularisation of the vector. In the sixth clone the altered but identical
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heterology was retained on both sides of the vector sequences. This may
have been due to the inclusion of heterology on one end in the first
instance and subsequent repair via intrachromosomal recombination
event might have transferred it to the other end (Hasty et al. 1992). In
contrast to the above results Pennington and Wilson (1991) did not find
any evidence for the inclusion of small terminal heterologies from an
insertion vector in the target locus in any of the 17 targeted clones
analysed.
1.4.2.6. Isogenic DNA and Gene Targeting Frequency
The majority of the ES cell lines used in gene
targeting experiments have been derived from the mouse strain 129
whereas the targeting vector DNA has been derived from various strains.
Te Riele et al. (1992) assayed the effect of the source ofvector DNA on the
gene targeting efficiency at the retinoblastoma susceptibility (Rb) gene.
They used either 129- or BALB/c-derived DNA vector to target this gene
in 129-derived ES cells. In one experiment with vectors bearing 10.5 kb of
Rb sequences, the targeting efficiency was 50-fold higher with the
129-derived vector. These authors then performed a more controlled gene
targeting experiment at the Rb locus. First they converted this locus into
a 'selectable locus' by targeting an HPRT minigene into the Rb gene in an
otherwise HPRT-deficient ES cell line. The modified locus was targeted
again by using either isogenic or non-isogenic vectors such that the HPRT
minigene was lost as a result of the targeting reaction. This strategy
permitted direct isolation of targeted clones using 6-TG selection. In an
extensive experiment these authors provided strong evidence that
targeting of the modified Rb allele was 20-fold more efficient when the
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targeting vector was constructed from isogenic DNA. Surprisingly, in
another experiment 78% of the colonies transformed by a hygromycin
based vector bearing 17 kb of isogenic DNA were generated by
homologous recombination. Similar conclusions have been reached by
Deng and Capecchi (1992) and Van Deursen and Wieringa (1992) for the
HPRT gene and creatine kinase M gene, respectively. In a limited
sequence analysis of their non-isogenic DNA Te Riele et al. (1992) and
Van Deursen and Wieringa (1992) found that the longest stretch of the
perfect match to the target gene was 278 nt and 255 nt, respectively. It is
yet to be understood that at what step in homologous recombination the
presence of mismatches between the targeting vector and the
chromosomal gene becomes rate limiting.
The enhancement of targeting efficiency by the use of
isogenic DNA is interesting in that the length of heterologous DNA
sequences embedded between two arms of homology in a replacement
vector does not appear to affect the targeting efficiency (Mansour et al.
1990). These workers found that the inclusion of variable lengths of
heterology (8 bp-12 kb) in the HPRT gene targeting vectors did not affect
the targeting efficiency at this locus. These differences can be reconciled
by assuming that there is a requirement for a minimum length of perfect
homology on both arms of targeting vectors.
1.4.2.7. Targeting of Subtle Mutations
Targeted disruption of mouse genes has been proved
to be of immense importance in addressing questions regarding gross
functions. Subtle mutations are likely to be important in understanding
the fine structure-function relationships of gene products, and the
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regulation of gene expression. The ability to introduce point mutations is
also vital in the generation of human disease models, and in modifying
phenotypes of complex traits of economic importance in farm animals, for
example in the properties ofmilk (see section 1.3.3). In principle a single
base pair of an endogenous gene can be modified by gene targeting with a
replacement-type gene targeting vector. In practice the isolation of the
targeted clone is not straightforward if the targeted mutation does not
lead to a selectable phenotype. Steeg et al. (1990) introduced two specific
point mutations into the RNA polymerase II gene ofmouse ES cells. The
point mutations were placed 20 bp apart on a replacement vector having
5.8 kb of homology. One of these mutations conferred resistance to the
mushroom toxin a-amanitin and was found to be incorporated into the
target locus at a frequency of 1 per 30 cells that incorporated and
expressed an equivalent vector DNA. This result demonstrated that gene
targeting can proceed in the absence of large stretches of heterology
between the two substrates. However, the second point mutation included
in the targeting vectors was corrected to the wild-type sequence in the
majority of the targeted cells, probably indicating a directional mismatch
repair (Steeg et al. 1990). Since only the minority of cells treated in
transfection experiments incorporate the DNA and a small fraction of
these undergo a gene targeting event, incorporation of positively
selectable marker gene into the targeting vector is essential to identify
the cell clones that have undergone targeting at non-selectable loci.
However, incorporation of a marker gene may also interfere with the
expression of the targeted locus. A number of gene targeting strategies
have been reported for introducing point mutations into endogenous
genes without leaving behind any selectable marker gene sequences.
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Zimmer and Gruss (1989) microinjected their vector,
designed to target a 20 bp insertion into the Hox 1.1 gene, and isolated
targeted clones by PCR. The vector did not carry a selectable marker
gene and one targeting event per 150 cells injected was observed. The
authors argued that high transfection efficiency achieved with
microinjection and a very small heterology in their targeting vector
ensured such an exceptionally high absolute targeting frequency.
Contrary to the above argument, Mansour et al. (1990) have provided
strong evidence against the effect of the length of internal heterology on
the HPRT gene targeting efficiency. The microinjection method of
Zimmer and Gruss (1989) has not found general application, possibly due
to the cumbrousness ofmicroinjection into ES cells.
Cotransformation of ES cells with a gene targeting
vector carrying a subtle mutation and a selectable marker gene (neo-
resistance) on a separate DNA fragment has been used to isolate ES cell
clones with subtle modifications in the HPRT gene by two laboratories
(Davis et al. 1992; Reid et al. 1991). Reid et al. (1991) reported that only
4% of targeted clones incorporated the neo gene elsewhere in the ES cell
genome when they identified the targeted clones without the use of
selection for neo gene expression. Although some 80-fold enrichment was
obtained, cotransformation precluded the isolation of the majority of the
targeted clones. Further, the authors could not exclude the possibility of
incorporation of the selectable marker gene into the target gene alongside
the subtle mutation. On the other hand Davis et al. (1992) obtained
subtle mutation of the HPRT gene by cotransformation at an efficiency
comparable to that of a vector with a positive marker included in the
HPRT gene targeting vector sequences. However, only 8% of the targeted
clones had the desired change in the target locus. The remaining clones
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had incorporated copies of selectable marker gene inside the target locus
in addition to the subtle modification. This method may not be of much
practical use for introducing subtle mutations in non-selectable genes.
There was a marked difference in the frequencies of
targeting the HPRT gene in the above two studies. One of the
explanations for this discrepancy may be that Reid et al. (1991) scored
their targeting events after HAT selection which needed correction of a
deletion in the HPRT gene and thus, precise homologous recombination
was required at least on one arm of their vector. Cointegration of their
HPRT gene targeting vector and the coelectroporated neo gene into the
HPRT gene could have interfered with the generation of functional HPRT
gene. Since Davis et al. (1992) scored their targeting events by observing
for the loss of the HPRT gene function they could have isolated all the
targeting events irrespective of the precision of the homologous
recombination events.
Another approach for targeting subtle mutation in
non-selectable loci involves cotransfer of a point mutation alongside a neo
gene using either a replacement vector (Deng et al. 1993; Rubinstein et
al. 1993; Shesely et al. 1991) or an insertion vector (Hasty et al. 1991a;
Valancius and Smithies 1991b). Deng et al. (1993) have suggested that
neo gene may be placed at a neutral site of a replacement vector. The
suggestion of Deng et al. (1993) that targeting by the replacement vector
occurs near its ends implied that the point mutation would be transferred
to the target locus irrespective of the distance from the neo marker gene;
however, their data did not seem to support this suggestion. On the other
hand observations of Rubinstein et al. (1993) did suggest that a subtle
mutation placed very close to the neo gene but away from the ends of the
vector was transferred to the chromosomal gene in the majority of the
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targeted clones. However, it may be almost impossible to choose a
suitable neutral site to place neo gene prior to performing the
experiment. Further, the cotransfer may be complicated by directional
correction of the point mutation after the formation of heteroduplex as
suggested by Steeg et al. (1990) or prior to initiation of the targeting
reaction if the point mutation is placed near the DNA ends of the vector.
1991a) have utilised a two step approach to introduce subtle mutations in
non-selectable genes. In the first instance the subtle mutation is
cotransferred alongside a positive marker using an insertion-type vector.
Such a targeting event results in duplication of sequences at the target
locus. In the second step intrachromosomal recombination between the
duplicated segments would excise the targeting vector; the isolation of
such rare recombination events is facilitated by selection against
expression of a negative selection marker included in the backbone of the
targeting vector. In some cases depending upon the precise recombination
site, the subtle mutation would be left in the target locus. This method is
limited by the lack of an enrichment procedure during the first targeting
step. Further, the subtle mutation placed near to the DNA ends of the
insertion vector might be lost due to degradation of terminal sequences
(Deng et al. 1993; Valancius and Smithies 1991a).
can be introduced in two successive targeting steps using replacement
vectors. In the first step the target locus was disrupted by a neo/HSV tk
gene cassette. A second gene targeting step was performed with a
replacement vector consisting of a genomic clone carrying a subtle
mutation; GANC selection against the HSV tk gene expression was
employed to isolate the targeted clones during this step. Although there
Valancius and Smithies (1991b) and Hasty et al.
Askew et al. (1993) have shown that subtle mutation
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was high background of GANC-resistant clones that were generated by
inactivation or loss of the tk gene one out every 54 clones analysed had
incorporated the subtle mutation. One major advantage of this method is
the possibility of generating a variety ofmutant alleles from the targeted
clones obtained after the first step of targeting (Askew et al. 1993).
However, prolonged culture of ES cells involving two successive
electroporation and isolation of targeting clones by this method may
compromise the germ line potential of ES cells.
The fidelity of gene targeting is crucial in an
experiment designed to introduce subtle mutations. Aberrant
modifications do occur during gene targeting reactions (Brinster et al.
1989; Doetschman et al. 1988; Hasty et al. 1991c; Thompson et al. 1989),
although some of these aberrant modifications might not be associated
with the process of gene targeting but might have arisen after gene
targeting. An extensive analysis of DNA sequences around the
recombination junctions by a method based on chemical cleavage of
mismatches has revealed that targeting of the HPRT gene by
replacement and insertion vectors can be very precise (Zheng et al. 1991).
These workers found only two mismatches in 80 kb of sequences from 44
independent targeted clones. The probability of aberrant targeting events
may increase in targeting strategies involving two successive steps (see
above).
Mostly gene targeting in ES cells has been used so far to ask
questions pertaining to the functions of a number of genes in the context
of whole-animal and numerous surprises have come to light in the fields
of immunology, oncology and developmental biology. The ability to
introduce subtle mutations into the mouse genome should allow more
precise definition of these questions. Particularly, regulation of gene
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expression is likely to be an area where the application of gene targeting
technology should find increasing usefulness. Probably one of the most
important contributions of gene targeting in biology includes the
realisation that the gene expression data may not always indicate the
indispensable in vivo function of a gene (see Erickson 1993).
1.5. AIMS OF THE PROJECT
The main aim of the project was to create a mouse strain with a
null mutation in the P-casein gene using gene targeting in embryonic
stem cells, and to study the phenotype ofmutant mice. It was anticipated
that this would allow the delineation of any essential biological function
of p-casein in lactation and in determining the properties of milk.
Further, the P-casein deficient mouse should serve as an animal model to
study the dynamics ofprotein synthesis in the mammary gland.
The second objective was to examine if it would be feasible to
enhance the gene targeting efficiency of insertion-type gene targeting
vectors by including a negatively selectable marker gene at the double-
strand break point. To address this question a series of HPRT gene
targeting experiments were performed to determine the effect(s) of
terminal heterologies included at the DNA ends of the insertion-type





2.1.1. Restriction Digestion of Plasmid DNA
Plasmid DNA was digested with various restriction enzymes
as per the manufacturers' (Boehringer Mannheim; New England Biolabs)
guidelines using the buffers supplied except that enzymes were used in a
3-5 fold excess of the recommended amounts.
2.1.2. Isolation of DNA Fragments from Agarose Gels
Small fragments (< 3kb) of plasmid DNA utilised for the
construction of various plasmid vectors or for preparation of radioactive
probes were recovered from agarose gels using the Geneclean Kit (Bio 101
Inc.) as per the method provided with the kit by the manufacturer.
Generally, 2-5 |ig plasmid DNA was digested with appropriate restriction
enzymes and electrophoresed on agarose gels (see section 2.8.1.). The
DNA fragment was visualised on an agarose gel using long-wave UV
light, excised from the gel into an Eppendorf tube and incubated in 3
volumes of Nal solution (6 M) at 50°C for 5 minutes to disolve the
agarose. Once the agarose was in solution 5-10 |il of 'Glassmilk' was
added and after mixing, the tube was left on ice for 10 minutes. The
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'Glassmilk' with bound DNA was pelleted by microcentrifugation for 10
seconds and the pellet was washed thrice with the washing solution
provided with the kit (NEW Concentrate, 140 ml ddH^O, 155 ml of 100%
ethanol). Finally, the DNA was eluted in 5-10 pi of ddH^O at 50°C and
microcentrifuged to remove the 'Glassmilk'. 40-50% of the total DNA
present in the agarose gel could be recovered by this method.
The above method proved unsatisfactory for isolation of
fragments larger than 3 kb. A 'freeze-thaw' procedure was used to isolate
DNA fragments of 3-8 kb from agarose gels. A piece of agarose gel
containing the fragment of interest was frozen and thawed several times
in an Eppendorf tube. DNA was released from the agarose gel into the
liquid phase in the tube. The liquid phase was recovered by
microcentrifugation, extracted with phenol:chloroform and the DNA was
precipitated with 2 volumes of ethanol. Finally, the DNA pellet was
washed with 70% ethanol and dissolved in ddH20. Typically, 10-15% of
the original amount of DNA fragment could be retrieved.
2.1.3. Ligation Reactions
In a typical sticky-end ligation reaction the following
mixture was incubated overnight at 14°C :
50-100 ng: Vector and insert DNA (molar ratio 1:3)
2 pi: 10x Ligation buffer (Boehringer Mannheim)
1 pi: T4 DNA ligase (1 unit/ pi: Boehringer Mannheim)
Made up to 20 pi with ddH^O
In blunt-end ligations -300 ng of DNA was used. The 3'
recessed ends created by restriction enzyme digestion of double strand-
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DNA were blunted using Klenow fragment of DNA polymerase I
(Boehringer Mannheim) in an end-filling reaction as described by
Maniatis et al. (1982).
2.1.4. Transformation of Competent Cells with Plasmid
DNA
E. coli DH5a competent cells (Genotype: F~. endAl.
hsdR17(rkmk+), supE44. thi-1. recAl. gvrA96. relAl. A(argF-
laczva)U169. (j)80dlacZAM15. X,-) purchased either from Bethesda
Research Laboratories (supplied by Life Technologies, Inc.) or from
Clontech were used to subclone various plasmid DNAs. Typically, 50 pi of
competent cells were transformed with 1 ng of purified plasmid DNA or
2-5 pi of a ligation mixture (see section 2.1.3) following supplier's
instructions.
2.1.5. Preparation of Plasmid DNA
2.1.5.1. Small-Scale Preparation
The alkali lysis method as described by Sambrook et
al. (1989) was used omitting the use of lysozyme.
2 ml LB medium (Sambrook et al. 1989), containing
50 pgml1 ampicillin in 15 ml tubes were inoculated with single bacterial
colonies and incubated overnight at 37°C in a shaking incubator
(Gallenkamp, 200 rpm). 1.5 ml of each culture was decanted into
Eppendorf tubes and centrifuged at 12,000g for 10 seconds to pellet the
cells. After complete removal of the supernatant the pellets were
resuspended in 100 pi of ice-cold TGE solution (50 mM glucose, 25 mM
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Tris.Cl pH 8.0, 10 mM EDTA pH 8.0). The cells were lysed and the DNA
was denatured by addition of 200 pi of 0.2 N NaOH 1% SDS solution to
the cell suspension. The tube was rapidly inverted several times and
stored on ice. 150 pi of ice-cold potassium acetate/glacial acetic acid
solution (3 M and 2 M, respectively) was added and mixed thoroughly.
The tube was allowed to sit on ice for 5-10 minutes and then centrifuged
at 12,000g for 5 minutes. The supernatants were removed into fresh
tubes and the DNA was precipitated with 2 volumes of ethanol at room
temperature. The tubes were centrifuged again for 5-10 minutes to obtain
the plasmid DNA pellets. The DNA was washed twice with 70% ethanol.
The last traces of supernatant were removed and the pellets were
dissolved in TE buffer (10 mM Tris.Cl pH 8.0, 1 mM EDTA) containing
DNAase-free pancreatic RNAase (20 pgmL1). Extraction of plasmid DNA
with phenol:chloroform was not necessary.
2.1.5.2. Large-Scale Preparation
Plasmid DNA from large scale bacterial culture was
prepared by a modified alkali lysis method (unpublished protocol of R.
Treisman described by Sambrook et al. 1989) followed by a caesium
chloride (CsCl)-ethidium bromide gradient centrifugation. However, the
use of lysozyme to lyse the bacterial cells was not necessary.
0.5 ml of a bacterial culture (grown overnight) was
inoculated into a 2 litre flask containing 500 ml of LB medium
(containing 50 pgmk1 ampicillin) and incubated overnight at 37°C in a
shaking incubator (Gallenkamp, 200 rpm).
The bacterial pellet was obtained from the above
culture by centrifugation at 5000 rpm at 4°C for 10 minutes in a Sorvall
GS3 rotor and resuspended in 20 ml of ice-cold TGE buffer. The cells were
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lysed by addition of 40 ml of 0.2 N NaOH, 1% SDS. The resulting viscous
solution was mixed thoroughly, but gently, and incubated at room
temperature for 10 minutes. To precipitate the proteins and chromosomal
DNA, 20 ml of ice-cold potassium acetate/glacial acetic acid solution (3 M
and 2 M, respectively) was added, mixed thoroughly, incubated on ice for
10 minutes and the supernatant was recovered after centrifugation at
4°C at 5000 rpm for 15 minutes. The supernatant containing plasmid
DNA was filtered through four layers of a nylon gauze. The DNA was
precipitated by addition of 0.6 volume of isopropanol. After 10 minutes at
room temperature the plasmid DNA was pelleted by centrifugation at
5000 rpm at room temperature for 15 minutes. The pellet was washed
twice with 70% ethanol, drained and dissolved in ~2 ml of TE buffer. 5.14
g CsCl and 250 pi of ethidium bromide solution (10 mgml"l) were added
to the DNA solution and the contents were dissolved and the final volume
was made to 6.0 ml with TE buffer.
The bacterial proteins which precipitated in the
presence of CsCl and ethidium bromide were removed by centrifugation
at 5000 rpm at room temperature for 5 minutes in a Sorvall SS34 rotor.
The clear red solution was transferred to a Beckman Quick-Seal tube and
centrifuged at 50,000 rpm at 20°C for 16-18 hours. The lower band
(distinct from chromosomal and open circular plasmid DNA) was
recovered from the tube with a needle and syringe. To avoid
contamination by the upper band, only 80% of the lower band was
retrieved. The ethidium bromide was removed from the DNA solution by
repeated extraction with butan-l-ol saturated with ddH^O and CsCl.
DNA was precipitated by addition of 3 volumes of 70% ethanol. The pellet
was drained, washed once with 70% ethanol and dissolved in 450 pi of TE
and reprecipitated with 2 volumes of ethanol in the presence of sodium
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acetate pH5.0 (50|il 3M). The supernatant was discarded and the DNA
pellet was washed twice with 70% ethanol. The liquid was completely
drained, the DNA was dissolved in TE buffer and stored at -20°C. The
DNA concentration was estimated by measurement of absorbance at 260
nm. The quality of the DNA preparation was checked by running an
aliquot of DNA solution on an agarose mini-gel in the presence of
ethidium bromide. Irreversibly denatured products of supercoiled
pMClneo (Stratagene) plasmid were frequently observed when this
plasmid DNA was prepared by the method described above. This problem
was avoided by shortening the incubation time to 5 minutes during the
alkali denaturing step.
2.2. CONSTRUCTION OF (3-CASEIN GENE TARGETING VECTORS
2.2.1. Correction of Mutation in Plasmids pMClneo and
pMClneopA
Plasmids pMClneo and pMClneopA bought from
Stratagene had the mutation reported by Yenofsky et al. (1990). To
correct this mutation, EclXI-Ncol fragments in pMClneo and
pMClneopA were replaced by the corresponding sequences from the
plasmid pSV2neo. To confirm these corrections, the transfection efficiency
of the two versions of pMClneo and pMClneopA were compared in ES
cells. The original pMClneo and pMClneopA vectors supplied by
Stratagene were approximately 10 fold less efficient than the corrected
versions [pMClneo(c) and pMClneopA(c)] in generating G418 resistant
colonies in an ES cell electroporation experiment (data not shown). The
corrected plsamids were used for all the DNA constructs reported in this
thesis.
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2.2.2. Construction of Vector ppiMClNEO/TK
A 6.6 kb EcoRI fragment of the P-casein gene from C57/BL/6
strain ofmouse (Goodman and Rosen 1990) was subcloned into the EcoRI
site of the vector pPolylllD (Lathe et al. 1987) and the resulting plasmid
was named pPolylllDp (Fig. 2.1A). A HSV tk gene cassette on a 2.1 kb
XhoI-BamHl fragment from plasmid pSPTK (a gift from Alan Clarke)
was subcloned into the corresponding sites of pPolylllDp at the 3' end of
the P-casein gene fragment to obtain plasmid pPolylllDp/TK (Fig. 2. IB).
A 1.1 kb Xhol-BamHl end-filled fragment containing the
neomycin-resistance gene from plasmid pMClneo(c) was subcloned into
the Asp 7001 site in exon 2 of the p-casein gene fragment in plasmid
pPolyIIIDp/TK such that the p-casein and neo genes were in the same
transcriptional orientation. The initiation codon of the P-casein gene is
just upstream of this Asp700I site. This vector was designated
ppMClNEO/TK (Fig. 2.1C).
To construct the targeting vector pPlMClNEO/TK (Fig. 2.1
D), the 7.9 kb Seal- BamHI fragment from the plasmid ppMClNEO/TK
was subcloned into Pvull and BamHI sites of vector pPolylllD. This
targeting vector had 4.7 kb of P-casein gene sequences distributed as two
arms of homology; 841 bp and 3.9 kb in length flanking the neo gene.
2.2.3. Construction of Vector pP2MClNEO/TK
The targeting vector pP2MClNEO/TK (Fig. 2.2D) was
similar to vector pplMClNEO/TK except that the former included an
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The 5.2 kb Sail fragment was deleted from plasmid
pPolylllDp (Fig. 2.1A). The resulting plasmid pPolyIIID(3A (Fig. 2.2A) had
the 0.75 kb Sall-EcoRl fragment consisting of part of intron 6, exon 7 and
part of intron 7 of the (3-casein gene. A 1.35 kb EcoRI fragment
comprising the remainder of intron 7, exon 8, intron 8 and part of exon 9
of the (3-casein gene (Goodman and Rosen 1990) was inserted into the
EcoRI site of plasmid pPolyIIID(3A. The orientation of this insertion was
checked to ascertain that the structure of intron 7 of the (3-casein gene
was restored in plasmid pPolyIIIDpA1.35 (Fig. 2.2B).
A Notl site, 5' to the neo gene in plasmid pPlMClNEO/TK
(Fig. 2.ID) was destroyed by end-filling of linear pPlMClNEO/TK after
partial digestion with Notl and using Klenow polymerase to obtain
plasmid pplMClNEO/TKA (Fig. 2.2C). The 859 bp Sall-Notl fragment in
the latter plasmid was substituted with the 2.2 kb Sall-Notl fragment
from plasmid pPolyIIDpA1.35 (Fig. 2.2B) and the resulting vector was
designated pp2MClNEO/TK. This vector had 6.1 kb DNA sequences
homologous to mouse P-casein gene and distributed as two arms of 841 bp
and 5.25 kb.
2.3. CONSTRUCTION OF HPRT INSERTION-TYPE GENE
TARGETING VECTORS
2.3.1. Construction of Plasmid pIV
Plasmid pMClneopA(c)AB was derived from pMClneopA(c)
by deletion of the unique BamHI site via end-filling with Klenow
fragment and recircularisation. A 5.6 kb EcoRI (intron I) - Sau 3A (exon
III) fragment from the HPRT gene (Melton et al. 1984) cloned between
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the EcoRI and BamHI sites of plasmid pGEM4 (Fig. 2.3A) was available
from Dr. J. P. Simons. A neo gene cassette on a Xhol-Sall fragment from
pMClneopA(c)AB was inserted into the Sail site of pGEM4. The resulting
plasmid pIV (Fig. 2.3B) had a unique BamHI site in the HPRT sequences
and when linearised with this enzyme this plasmid served as an
insertion-type gene targeting vector with two unequal arms of 4.8 kb and
0.8 kb homologous to the HPRT gene.
2.3.2. Construction ofHPRT Insertion-Type Targeting
Vectors with Terminal Heterologies
A unique Xhol site was introduced into the end-filled
BamHI site of pIV by cloning in an 8-merXhol linker (CCTCGAGG). The
resulting plasmid, designated pIVX (Fig. 2.3C), when opened at this Xhol
site had terminal heterologies of 5 nucleotides on one strand and a single
base on the second strand of each of its two homologous arms.
A series of insertion-type HPRT gene targeting vectors were
generated from the vector pIVX In these vectors the HPRT homology was
interrupted by incorporation of heterologous sequences of various lengths
(2.1 kb-190 bp) at the Xhol site of pIVX. By cloning each one of these
heterologous fragments in both orientations, the heterologous DNA could
be left on either of the two homologous arms of the HPRT gene targeting
vectors after Xhol digestion.
Plasmids pIVL2.1 (Fig. 2.3D) and pIVS2.1 (Fig. 2.3E) were
obtained by cloning in a HSV tk gene (a 2.1 kb Xhol-Sall fragment from
pSPTK) into the Xhol site of pIVX in both orientations. Xhol digestion of
plasmids pIVL2.1 and pIVS2.1 leaves 2.1 kb heterologous sequences on
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pIVL2.1 can also be linearised at the unique Sraal site included in the tk
gene sequences. The resulting insertion vector had its long and short
arms blocked by 0.7 and 1.4 kb heterologous sequences, respectively.
Plasmids pIVL0.7 and pIVS0.7 were constructed from
plasmids pIVL2.1 and pIVS2.1, respectively. DNA from the latter vectors
were digested with Smal and Xhol, end-filled and religated. This step
recreated the unique Xhol site in pIVL0.7 and pIVS0.7; when opened at
this site, these targeting vectors had either the long or the short
homologous arms blocked by 0.7 kb tk sequences.
Plasmids pIVL0.33 and pIVS0.33 were made from vector
pIVX. A 334 bp Xhol-Sall fragment was subcloned into the Xhol site of
pIVX in both orientations. This 334 bp fragment was obtained from a
plasmid pMClneoAA. The latter plasmid was derived by deletion of an
Xmalll-BamUl fragment from the plasmid pMClneopA(c).
A 182 bp EcoRI fragment from pMClneo was end-filled and
subcloned into the BamHl site in the polylinker of the vector pGEM4
after end-filling with Klenow fragment of DNA polymerase I. A 194 bp
Xhol-Sall fragment (containing the 182 bp EcoRl fragment) was isolated
and inserted into the Xhol site of pIVX in both orientations to generate
plasmids pIVL0.19 and pIVS0.19.
To act as a negative control for the HPRT gene targeting
experiments, pWPN (Fig. 2.3F), a replacement type vector (Mansour et
al. 1988) suitable for targeting mouse whey acidic protein (WAP) gene
was used. Briefly, this vector had approximately 6.0 kb of WAP gene
sequences interrupted by the 1.1 kb Xhol-Sall neo cassette from
pMClneopA(c) in the back bone of pSP72 (Promega). The 5' end of the
WAP sequences were flanked by 2.1 kb tk gene from pSPTK. For
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electroporation experiments the plasmid pWPN was opened at an Xhol
site just 5' to the tk gene.
2.4. PREPARATION OF GENE TARGETING VECTOR DNA FOR
ELECTROPORATION EXPERIMENTS
Gene targeting plasmid DNAs were digested with the appropriate
restriction enzyme(s). The completion of digestion was checked on an
agarose mini-gel stained with ethidium bromide (0.5 ggml"1; see section
2.8.1 for details of electrophoresis of DNA). The digested DNA was
extracted once with phenol (equilibrated with 0.5 M Tris.Cl pH 8.0)
followed by an extraction with chloroform. The DNA was precipitated
from the aqueous phase by addition of 0.1 volume sodium acetate (pH 5.0)
and 2 volumes of ethanol at room temperature for 10 minutes and the
DNA was pelleted by centrifugation at 12000g for 10 minutes and washed
twice with 70% ethanol. The last traces of liquid were removed taking
care not to over dry the DNA. The pellet was dissolved in TE buffer by
treating at 65°C for 10 minutes. The concentration ofDNA was measured
by reading the absorbance at 260 nm and the DNA was stored at -20°C
until needed.
2.5. CULTURE OF EMBRYONIC STEM CELLS
Gene targeting experiments in mouse embryonic stem (ES) cells
were performed at the IAPGR, Roslin and the Cancer Research
Campaign (CRC) Laboratories, Department of Pathology, Medical School,
University of Edinburgh. The ES cell culture conditions employed at the
IAPGR, are described in detail and any significant differences between
the two laboratories are highlighted at the end of this section.
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E14 embryonic stem cells (Handyside et al. 1989) at passages 13-
15 and EFC-1 embryonic stem cells (Nichols et al. 1990) at passage 15
were obtained as frozen aliquots from Dr. Martin Hooper, Department of
Pathology, Medical School and Dr. Austin Smith, AFRC Centre for
Genome Research, University of Edinburgh, respectively. These cells
were expanded for 3-4 passages and refrozen again in several aliquots in
liquid nitrogen until needed (see section 2.5.4). The ES cell culture
methods described by Robertson (1987) were used with modifications.
ES cells were cultured under strict aseptic conditions including
regular wiping of work surfaces with 70% ethanol and Microzid (Sterling
Medicare). Mycoplasma infection of cells was monitored by a variety of
methods by Moredun Animal Health Ltd, Edinburgh. Mycoplasma
infection was not detected during the investigations reported in this
thesis.
2.5.1. Tissue Culture Equipment, Glassware and
Plasticware
Cell culture work was performed in a vertical laminar flow
cabinet (Medical Air Technology Ltd) under aseptic conditions. Culture
vessels and medium bottles were handled in the vicinity of Bunsen
burner flame inside the flow cabinet. Other important pieces of
equipment in the tissue culture facility included three humidified CO2
incubators set at 5% CO2 and 37°C, an inverted phase contrast
microscope (Nikon Diaphot; magnification: x400, xlOO and x40) and a
bench-top centrifuge (Jouan).
All the glassware was soaked in water overnight, cleaned with 7X-
PF (Flow Laboratories), washed thoroughly several times with water to
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remove the detergent, rinsed in deionised distilled water (ddH^O) and
drained. Glass pipettes and Pasteur pipettes were heat sterilised at
180°C for four hours. All other glassware was autoclaved.
2.5.2. Culture Media and Solutions for Tissue Culture
Complete Medium for ES cells (IAPGR, Roslin)
500 ml Dulbecco's Modification ofEagle's Medium
(DMEM; High glucose formulation; Life
Technologies)
jji;
28 ml Foetal calf serum
28 ml Newborn calf serum
5.6 ml Non-essential amino acids (lOOx; Life Technologies)
5.6 ml L-Glutamine (200 mM; Life Technologies)
4.4 (il (3-Mercaptoethanol (Sigma)
0.25-1.0 ml Differentiation inhibiting activity/leukaemia
inhibitory factor (DIA/LIF) medium1'
All ingredients except the DMEM were mixed and filtered through
0.22 pm filters (Millipore) into the bottle containing DMEM. The
complete medium was stored at 4°C and supplemented with fresh
L-glutamine if the medium was in use for more than a week. No
antibiotics were added to the media used for routine ES cell culture.
Penicillin and streptomycin (@ 100 IUml"1 and 100 pgmh1 of culture
media, respectively: Life Tecnologies) were added to culture media used
A number of serum batches were tested for cloning efficiency and their ability to
support undifferentiated ES cell proliferation by Ray Ansell (see Robertson 1987 for
details). Serum batches giving at least 20 % cloning efficiency were used.
"I" Medium conditioned by Cos-7 cells transfected (see Chen & Okayama 1987 for
transfection method) with pLIF-D, a mouse LIF-D cDNA in an expression vector pMT2
(see Rathjen et al. 1990), was provided by Ray Ansell. The amount of LIF medium used
varied depending upon the differentiation inhibitory activity of a given batch of
conditioned medium.
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in all the HPRT gene targeting experiments and one of the P-casein gene
targeting experiments.
CMp: Complete Medium for ES cells (CRC Laboratories)
45.0 ml lOx Glasgow Modification ofEagle's Medium (Flow
Laboratories)
25.0 ml Foetal calf serum*
25.0 ml Newborn calf serum*
16.5 ml NaHC03 (7.5% Flow Laboratories)
5.0 ml Non-essential amino acids (lOOx; Flow Laboratories)
5.0 ml L-Glutamine (200 mM; Flow Laboratories)
5.0 ml Sodium Pyruvate (100 mM Flow Laboratories)




100 ml 2.5% Trypsin (Flow)
0.5 g EGTA (Sigma)
150 mg PVA (Sigma)
7.0 g NaCl





1.0 ml 1% Phenol Red
The above constituents were dissolved in 950 ml of autoclaved
AnalaR water (BDH), adjusted to pH 7.6 with HC1, made up to 1,000 ml,
filter sterilised through 0.22 pm filter (Millipore) and stored in 20 ml
aliquots at -20°C.
Sera already tested for their suitability to support ES cells proliferation without any
overt differentiation were available from the CRC Laboratories (see Robertson 1987)
^ LIF medium was available from CRC Laboratories. The amount varied depending
upon the differentiation inhibitory activity of a given batch of LIF medium.
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TVP (Cell Disaggregation Solution)
0.025% (w/v) trypsin (Flow Laboratories 2.5% solution)
1 mM EDTA
1% (v/v) chick serum (Flow Laboratories)
in Ca2+, Mg2+-free PBS (Dulbecco's; Flow Laboratories)
Filter sterilised through 0.22 pm filter (Millipore) and stored in 20
ml aliquots at -20°C.
Gelatin (0,1%)
0.1% gelatin (Sigma) solution was prepared in AnalaR water
(BDH), autoclaved twice and stored at room temperature (IAPGR).
At CRC laboratories 1% stock solution of gelatin (Sigma) was
prepared, autoclaved twice and stored at 4°C. The stock solution was
diluted lOx just prior to use.
HEPES Buffered Saline (HBS)





Adjusted to pH 7.05, sterilised by autoclaving and stored at RT.
Phosphate Buffered Saline (PBS)
Ready to use Ca2+ and Mg2+-free PBS tablets (Oxoid or Flow
Laboratories) were dissolved in AnalaR water (BDH) autoclaved and
stored at RT.
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2.5.3. Maintenance of ES Cell Cultures
Embryonic stem cells were cultured on gelatin (0.1%) coated
Nunclon plastic dishes without feeder cells in complete Dulbecco's
Modification of Eagle's Medium (see section 2.5.2). The medium was
supplemented with recombinant differentiation inhibiting activity/
leukaemia inhibitory factor (DIA/LIF) medium (Smith et al. 1988) to
maintain the undifferentiated phenotype of ES cells. In the experiments
undertaken to isolate (3-casein gene-targeted ES cell clones for production
of chimaeric mice no antibiotics were included in the cell culture medium
at any stage except G418 in the selective media.
The cells were fed with fresh medium on alternate days and
passaged at an interval of 2-3 days. To passage a confluent 25 cm2 flask
the medium was aspirated and the cell surface was washed gently twice
with 5 ml of PBS (Section 2.5.2). The cells were covered with 0.5 ml of
TEG (trypsin EGTA solution; Section 2.5.2) and monitored using a phase
contrast microscope. The flask was tapped after two minutes to dislodge
the cells and medium was added. Large clumps of cells were broken by
pipetting the contents through a drawn-out Pasteur pipette a number of
times. The cells were collected in a 10 ml centrifuge tube (Sterilin) and
pelleted by centrifugation at 1000 rpm for 5 minutes. The medium was
aspirated and the cell pellet was resuspended in a suitable amount of
medium. Normally, the cells were split at 1 in 5 ratio.
2.5.4. Freezing and Thawing of ES Cells
Cells were harvested from a 25 cm2 flask as described in
section 2.5.3 and resuspended in 0.75 ml of complete medium. While
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working on ice, 0.75 ml of ice-cold freezing medium (60% complete
medium, 20% foetal calf serum, 20% dimethyl sulfoxide; Sigma) was
added drop-wise with continuous mixing of the contents. The mixture was
dispensed in 3x1.5 ml pre-cooled screw cap tubes (Sarstedt), placed inside
a polystyrene box and left in a -70°C freezer to cool slowly. The tubes
were transferred to liquid nitrogen after a few days.
To thaw the cells, the vial was quickly transferred from
liquid nitrogen to a water bath at 37°C and agitated until the contents
had thawed. The contents of the tube were added to -15 ml of complete
medium in a universal tube pre-warmed to 37°C. The cells were pelleted
by centrifugation, suspended in 5 ml of fresh medium, plated out in a 25
cm2 flask and placed in the CO2 incubator.
2.5.5. Electroporation
Growing cells were harvested by trypsinisation, and
resuspended at high density in either HBS or PBS (see section 2.5.2). The
cells were counted using an improved Neubauer haematocytometer.
Normally, the cell concentration was adjusted to 108 ml"1. 0.8 ml cell
suspension containing 25 pg to 150 pg of targeting vector DNA was
placed in a Bio-Rad Gene Pulser cuvette (width 0.4 cm). The mixture was
given a single pulse either at 800V, 3pF or 230V, 500pF. The
electroporated cells were allowed to stay at room temperature for 10
minutes and then transferred to the complete medium and plated out in
suitable petri dishes. The details of electroporation conditions, plating
densities, selection regimes etc. followed in each individual
electroporation experiment are described in the relevant sections of the
following chapters.
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2.5.6. Isolation and Expansion of Individual ES Cell Clones
Following electroporation and selection, individual ES cell
colonies with an undifferentiated ES cell phenotype were picked up with
a drawn out Pasteur pipette while working under a low magnification
microscope (Olympus Zoom Stereo; x7-x40) in a still-air cabinet. Each
colony was incubated briefly in a small drop (-50 pi) of trypsin-EGTA
solution and was disaggregated using a finer diameter drawn-out Pasteur
pipette to achieve an almost single cell suspension. The cell suspension
from each colony was plated in a well of a 24-well tissue culture plate
containing 1.5 ml of complete culture medium per well and was placed in
the CO2 incubator. The following day the cells were fed with fresh
medium. At confluence, generally within a week, the cells were
trypsinised and sequentially plated into larger vessels to obtain sufficient
cells for preparation of genomic DNA and freezing of cells for future
retrieval.
2.5.7. Chromosome Analysis
Chromosome spreads of targeted ES cell clones were
analysed by the method described by Robertson (1987) except that the
growing ES cells were not treated with colcemid. Cells growing in a sub-
confluent 25 cm2 flask were trypsinised as described in sub-section 2.5.3.
Pelleted cells were resuspended in hypotonic solution (0.56% w/v KC1) for
5 minutes at room temperature and were recentrifuged at 500 rpm for 5
minutes to remove the supernatant. The cell pellet was finger flicked to
resuspend the cells and the cells were fixed by adding dropwise 1 ml of
ice-cold fixative (3 volume of absolute methanol: 1 volume of glacial acetic
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acid; freshly prepared). More fixative was added and the tube was left at
room temperature for 5 minutes. At least two more washes were
performed with the fixative. The metaphase plates were prepared on dry
and clean microscopic slides previously stored in 70% ethanol at 4°C. The
slides were air dried, stained in 3% (v/v) Gurr's Giemsa stain (BDH) in
PBS for 10-15 minutes and the chromosome number was counted by
examination of slides under oil immersion objective (xlOOO total
magnification).
2.5.8. ES Cell Culture at the CRC Laboratories
The ES cells were cultured on Costar (Northumbria
Biological Ltd) tissue culture dishes. The cell culture medium
composition (CM(3: section 2.5.2) was different from the one in use at the
IAPGR, Roslin. The trypsin concentration in cell disaggregating solution
(TVP: section 2.5.2) was only one tenth of that in the trypsin solution
(TEG) used for trypsinising ES cells at the IAPGR laboratory. The
trypsinisation was performed by incubating the PBS washed growing ES
cells in a tissue culture dish with TVP for 3-5 minutes at 37°C.
In electroporation experiments each selected colony was
expanded to a super-confluent well of a 24-well plate. The cells were
trypsinised with 2-3 drops of TVP and trypsinisation was stopped by
adding 1 ml of freezing medium (80% CM(3:complete medium, 10%, foetal
calf serum, 10% dimethyl sulfoxide; Sigma). One half of the cell
suspension was frozen in Nunclon 1 ml freezing ampoules and the other
half was processed for the preparation of genomic DNA. The simplicity of
this method proved critical in analysing a large number of ES cell clones
for the identification of targeted clones.
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2.6. ISOLATION OF GENOMIC DNA FROM EMBRYONIC STEM
CELLS
2.6.1. Large Scale Preparation
Genomic DNA from ES cells grown to confluence in tissue
culture flasks (25 cm2, 80 cm2 and 175 cm2) was prepared by the method
of Blin and Stafford (1976) with modifications as described by Sambrook
et al. (1989).
Typically, a 25 cm2 tissue culture flask with ES cells grown
to confluence was washed twice with PBS and incubated at 37°C for one
hour after addition of 5 ml of extraction buffer (10 mM Tris.Cl pH 8.0,
0.1M EDTA pH 8.0, 20 pgml"1 pancreatic RNAase, 0.5% SDS). The flask
was incubated for a further 3 hours after addition of proteinase K (100
pgml"1; final concentration). The contents of the flask were transferred to
a 15 ml centrifuge tube and extracted once with phenol (equilibrated with
0.5 M Tris.Cl pH 8.0) and once with chloroform. The genomic DNA was
precipitated from the aqueous phase with 2 volumes of ethanol after the
addition of 0.1 volume of 10 M ammonium acetate. The precipitate was
recovered on a hook made from a Pasteur pipette and washed twice with
70% ethanol. The last traces of liquid were removed from the DNA
without over drying the pellet. Finally, the DNA pellet was suspended in
200 pi of TE buffer in an Eppendorf tube and left at 4°C for several days
before measuring the absorbance of the DNA solution.
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2.6.2. Small Scale Preparation
Genomic DNA from ES cell clones isolated in the
electroporation experiments was prepared by a simplified method
described by Laird et al. (1991).
Cells harvested from wells of 24-well tissue culture plates
were pelleted by centrifugation in Eppendorf tubes and the medium was
removed. 0.5 ml of lysis buffer (100 mM Tris.Cl pH 8.5, 5 mM EDTA,
0.2% SDS, 200 mM NaCl, 100 pgrnk1 proteinase K) was added to the cells
and the tubes were incubated overnight in a shaking incubator at 37°C.
The DNA was precipitated by addition of one volume of isopropanol. The
DNA precipitates were recovered by centrifugation for 10 minutes, and
washed twice with 70% ethanol. 100 pi ofTE was added to each tube. The
tubes were incubated at 65°C for 10 minutes and then left at 4°C for 2-3
days for complete dissolution of the DNA. One third of this DNA solution
was sufficient for analysis by Southern blotting after digestion with an
appropriate restriction enzyme. Restriction digestion reactions included
0.1 mg BSA/ ml of reaction volume (Laird et al. 1991).
2.7. ISOLATION OF MOUSE TAIL DNA
Five week-old mice were anaesthetised (Flecknell 1983) and 1-2 cm
tail biopsies (by Frances Thomson or Roberta Wallace) were taken for the
preparation of genomic DNA. The tails were incubated in 0.75 ml buffer
(10 mM Tris.Cl pH 7.9, 1 mM EDTA pH 8, 0.3 M sodium acetate, 1% SDS
and 200 pgml"1 proteinase K) overnight in a shaking incubator (37°C).
0.5 ml of this tail digest was extracted with phenokchloroform once and
DNA was precipitated by addition of 1 volume of isopropanol at room
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temperature. The DNA was pelleted by centrifugation (12000g for 10
minutes), washed twice with 70% ethanol and dissolved in TE buffer as
described in section 2.6. The DNA concentration was obtained by
measuring the absorbance of the DNA solution at 260 nm.
2.8. ANALYSIS OF GENOMIC DNA
2.8.1. Electrophoresis of Genomic DNA
DNA samples (10 |ig DNA per lane) digested with the
appropriate restriction enzymes were electrophoresed on a 0.7-0.8% (w/v)
agarose gel either at 1-2 voltcm"1 overnight or at 4 voltcnr1 for 3-5 hours
in a continuous buffer system (40 mM Tris-acetate, 2.5 mM EDTA pH
7.7, with 0.5 pgmT1 ethidium bromide). A loading buffer (0.1 volume of a
solution containing 40 mM EDTA, 0.1% SDS, 30% ficoll, 1.2 mgmT1
bromophenol blue) was added to DNA samples before applying onto the
agarose gels.
After completion of electrophoresis the gel was placed on a
transilluminator (wavelength 302 nm) and photographed using Polaroid
film (667).
2.8.2. Transfer of DNA onto Hybond-NMembranes
The DNA was transferred from the agarose gel onto the
Hybond-N membrane (Amersham) using the blotting method described
by Southern (1975).
The electrophoresed DNA was depurinated by gently
shaking the gel in 0.2N HC1 for 7-15 minutes. The latter solution was
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replaced with a DNA denaturing solution (1.5 M NaCl, 0.5 M NaOH).
After two 15 minutes treatments in this solution the gel was rinsed with
ddH20 and neutralised by shaking in two changes of neutralising
solution (1.5 M NaCl, 0.5 M Tris.Cl pH 7.5, 1 mM EDTA) for 15 minutes
each.
The gel was placed on two sheets of Whatman 3 MM paper
on a glass plate and the paper was connected to a reservoir of 20x SSC
solution (3 M NaCl, 0.3 M sodium citrate). A Hybond-N membrane cut to
the size of the gel was prewetted in 3x SSC and placed on the top of the
gel. Two sheets of wet (soaked in 3x SSC) and one sheet of dry 3 MM
paper (all cut to the size of the gel) were placed on the filter. Any air
bubbles trapped between gel, membrane and 3 MM papers were carefully
removed by rolling with a sterile pipette. Paper towels were placed on top
of 3 MM papers followed by a glass plate and a 0.5 -1 kg weight was
placed on glass plate to draw liquid through the gel by capillary action
into the paper towels. The transfer of DNA from the gel onto the
membrane was allowed to proceed for more than 20 hours. The
membrane was removed, rinsed in 3x SSC and the DNA was immobilised
onto the membrane in an automatic UV linker (Stratagene).
2.8.3. Preparation ofRadioactive Probes
Radioactive-labelled DNA probes were synthesised using a
Multiprime DNA Labelling Kit (Amersham) based on the methods
described by Feinberg and Vogelstein (1983, 1984).
25-50 ng of linear double-strand DNA in 28 pi of ddH20 in
an Eppendorf tube was denatured by boiling for 2 minutes. The following
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were added in this order and the tube was incubated at room
temperature for 3-5 hours:
5 pi Primer solution
10 pi Unlabelled dNTPs except dCTP
5 pi 32P labelled dCTP (Amersham: Sp. Activity 3000
Ci/mM)
2 pi Klenow fragment ofDNA polymerase 1 (lunit/1 pi)
The extent of incorporation of radioactivity was measured by
the TCA precipitation method described by Sambrook et al. (1989). The
probe was extracted with phenokchloroform, denatured by addition of 0.1
volume of a denaturing solution (1.5 M NaOH, 0.1 M EDTA) and added to
the hybridisation solution after 5 minutes.
2.8.4. Hybridisation of Genomic DNA
Homologous probes were used to analyse the structure of the
P-casein and HPRT genes in ES cell clones. The hybridisation conditions
described by Church and Gilbert (1984) were used with modifications.
Membranes (usually 20x20 cm2) were prehybridised in 30-40
ml of hybridisation solution (0.5 M phosphate buffer pH 7.2, 7% SDS, 1
mM EDTA) in a sealed perspex box at 65°C for a minimum of 30 minutes.
The solution was replaced with the same amount of fresh hybridisation
solution containing denatured probe (see above). Hybridisation was
continued for at least 12 hours at 65°C. To remove unhybridised probe
the membranes were washed twice for 15 minutes each in a washing
solution (40 mM phosphate buffer, 1% SDS, 1 mM EDTA) at 65°C.
Occasionally, a further more stringent wash (20 mM phosphate buffer,
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1% SDS, 1 mM EDTA) was used to remove background signal.
Membranes were wrapped in Saran Wrap after draining and exposed to
X-ray film (AGFA; CURIX RP1) placed between intensifying screens in
an autoradiography cassette at -70°C. Generally, it was possible to obtain
sufficient signal from a single copy gene fragment after 24 hours of
exposure; otherwise, the exposure duration was extended for up to two
weeks. If necessary, the probe was stripped by adding the membrane to
boiling 0.1% SDS. The solution was allowed to cool to RT and complete
removal of the probe from the membrane was checked by exposing it to
film for several days prior to hybridisation with another probe.
2.9. PRODUCTION OF CHIMAERIC MICE
Injections of ES cells into mouse blastocyst (3.5 d.p.c.) were carried
out by Dr. Martin Hooper's laboratory, and the injected blastocysts were
implanted into the uteri of pseudo-pregnant mice by Roberta Wallace.
ES cells carrying targeted mutations were injected into 3.5 day
C57/BL/6/01a x CBA/Ca/Ola F2 blastocysts as described by Bradley
(1987). The manipulated blastocysts were transferred to the uteri of
pseudo pregnant MF1 female mice (2.5 d.p.c.). The genotypes of the
blastocysts and E14 ES cells for their respective coat colour phenotypes
are presented in Table 2.1. The parents of the host blastocysts segregated
at the A locus resulting in agouti and non-agouti mice. Any contribution
from ES cells was easily manifest as light yellow patches on an otherwise
dark coat colour. Chimaeras were bred with MF1 mice and the germ line
contribution from ES cells was identified by the presence of light
chinchilla offspring.
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Table 2.1. Coat colour genotypes and phenotypes of mice from
host blastocysts, embryonic stem cells and tester females.
Genotype Coat Colour ofProgeny
Host Blastocyst C/C Agouti or black
F2 (C57/BL/6/01a x P/P
CBA/Ca/Ola) AA, A/a, a/a
Stem Cells Cch/Ceh Chinchilla
129/Ola p/p
aW/aw
Tester Female c/c Albino
MF1 a/a
Modified from Thompson et al. (1989).
2.10. RNA ANALYSIS
2.10.1. Isolation of Total RNA from Mouse Tissues
All solutions and plastics used for RNA analysis were
treated with DEPC (Sambrook et al. 1989).
Nursing female mice were sacrificed by cervical dislocation
on day-11 of lactation. Approximately 0.5 g of mammary tissue was
removed, placed in 2 ml of 'RNazol B' (Biogenesis) and thoroughly
homogenised. 0.1 volume of chloroform was added to the homogenate,
mixed well and the mixture was kept on ice for 15 minutes. The aqueous
phase was recovered by centrifugation (12,000g, 4°C, 15 minutes) and
RNA was precipitated from it by addition of 1 volume of isopropanol.
After 15 minutes at 4°C the RNA was pelleted (12000g for 15 minutes at
4°C), washed twice with 70% ethanol and dissolved in either 1 mM EDTA
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pH 7.0 or formamide (Chomczynski 1992) and stored at -70°C or -20°C,
respectively.
2.10.2. Electrophoresis of RNA
Total RNA samples were electrophoresed on a 1% agarose
gel prepared in MOPS buffer (0.02 M 3-N-{morpholino} propanesulfonic
acid, 5 mM sodium acetate) containing 6.8% formaldehyde, essentially as
described by Sambrook et al. (1989).
10 jig of RNA in 10 (il was mixed with 39 (il of sample buffer
(500 (il Formamide, 100 jil lOx MOPS, 160 jil of -40% Formaldehyde),
denatured at 65°C for 5 minutes, mixed with 5 jil of loading dye (50%
glycerol, 0.1 mgml"1 bromophenol blue) and electrophoresed in MOPS
buffer.
2.10.3. Northern Blotting and Hybridisation
RNA from the gel was transferred onto Hybond-N
(Amersham) membrane according to the methods described in section 2.8,
omitting pre treatment of the gel.
2.11. MILKING OF MICE
Milk was obtained from nursing mothers on day 11 of lactation by
Frances Thomson and Roberta Wallace as described by Simons et al.
(1987). The pups were removed three hours before milking. 0.3 IU of
oxytocin (Sigma) was injected intraperitoneally to mothers. After 10
minutes the mice were anaesthetised by the method of Flecknell (1983).
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100 pl-200 pi of milk was recovered from each mouse into capillary tubes
by gentle massage ofmammary glands.
2.12. MILK PROTEIN ANALYSIS
Qualitative analysis ofmouse milk samples was performed by SDS
polyacrylamide gel electrophoresis according to the method of Laemmli
(1970). Milk samples were diluted 1:8 in ddH^O and defatted by
centrifugation for 5 seconds in Eppendorf centrifuge. Defatted milk was
further diluted (final dilution 1:200) in sample buffer (62.5 nM Tris.Cl
10% Glycerol, 2% SDS and 5% p-mercaptoethanol, 0.006% bromophenol
blue) and a 15 |il aliquot of diluted milk was electrophoresed at a
constant current of 32 mA for first hour and 48 mA for a further 5 hours
on a 4% stacking gel and 15% resolving gel (gel thickness 1.0 mm). After
electrophoresis the gel was fixed and stained overnight in a Coomassie
Blue solution (0.04% Coomassie Blue, 2% TCA, 7.5% acetic acid, 50%
methanol). Finally, the gel was bathed in destaining solutions (1st wash:
7% acetic acid, 23% ethanol for 30 minutes; second wash: 30% ethanol for
3-4 hours) to reveal individual milk proteins.
2.13. ESTIMATION OF MILK PROTEIN CONCENTRATION
Protein concentration of whole milk and whey was estimated by
the micro-Kjeldahl method (Rowland 1938) as described by Davies and
Law (1983) except that the N value was multiplied by 6.38 instead of 6.51
to obtain protein concentration.
Briefly, 25 pi of whole milk (or whey from 100 pi of whole milk),
was hydrolysed by boiling in 3 ml of H2SO4 (nitrogen-free, 98% w/w:
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BDH) in the presence of 2.0 g of potassium sulphate-selenium mixture
(100 g of potassium sulphate and 1 g of selenium powdered together:
BDH) in a graduated micro-Kjeldahl flask. The boiling was continued for
20 minutes after the sulphuric acid had started refluxing in the neck of
the flask. When the flask had cooled, the contents were diluted to 70 ml
with ddH20. The nitrogen concentration in the diluted acid hydrolysate
was determined by the colorimetric method of Reardon et al. (1966) as
described below.
To 1 ml of hydrolysate, 2.5 ml of reagent A (30.0 g NaOH per litre:
BDH), 5.0 ml of reagent B (37.03 g sodium salicylate and 0.26 g sodium
nitroprusside per litre: BDH) and 2.5 ml of reagent C (0.54 g sodium
dichloroisocyanurate per litre: BDH) were added and mixed thoroughly.
After 30 minutes, the absorbance of this solution was measured at a
wavelength of 667 nm and compared with that of a standard (0.6604 g of
ammonium sulphate per litre; 1 ml is equivalent to 0.14 mg N).
To obtain whey, caseins were removed from whole milk by acid
precipitation (reduction of pH to 4.27 by addition of 0.2 M sodium acetate,
0.2 M acetic acid buffer) and followed by centrifugation (2560g for 10
minutes) at room temperature. The supernatant whey was filtered
through a 0.22 pm filter prior to acid hydrolysis.
2.14. MEASUREMENT OF CASEIN MICELLE SIZE
The casein micelle size distribution was determined by Drs J.
Leaver and D. Home of Hannah Research Institute, Ayr, using photon
correlation spectroscopy (Home 1984; Home and Dalgleish 1985).
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2.15. STATISTICAL METHODS
Weaning weight data were analysed by ANOVA and the effects of
P-casein genotype and sex of the pups were considered. To find out the
influence of P-casein genotype on casein micelle size, ANOVA (one-way
classification) was performed.
The significance of differences between P-casein genotypes with
respect to weaning weight, milk protein concentration, casein micelle size
and litter size was tested using Student's £-test (Snedecor and Cochran
1967).
To examine the effect of maternal genotype at the p-casein locus on
the growth performance of pups, the litters were weighed thrice a week
up to eleven days of age. To account for the variation due to the non-
genetic effects (litter size and age at weighing), the following linear
regression model was fitted by Anthea Springbett for each genotype
separately:
Y = a + piXi + P2X2 + P3X1X2+ £
where:
Y = litter weight, Xi = age at weighing, X2 = litter size,
and a, Pi, p2 and P3 were constants, and £ represented the residual
effect.
More than 95% of the variation in litter weight was
explained by the equation fitted for each genotype. The significance of
differences between predicted values of litter weights was tested using
Student's Ctest (Snedecor and Cochran 1967).
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CHAPTER THREE
GENERATION AND CHARACTERIZATION OF
(3-CASEIN-DEFICIENT MICE
3.1. INTRODUCTION
(3-casein is a major milk protein and it exists as a component of
casein micelles in all species studied so far (Creamer 1991; Davies et al.
1983). The amino acid sequences of (3-caseins have been very poorly
conserved during evolution; although there are no major deletions and
insertions unlike in a-caseins (Bonsing and Mackinlay 1987; Holt and
Sawyer 1988). Mouse (3-casein is an approximately 26 kD phosphoprotein,
and in common with [3-caseins of various other species, it has a strongly
hydrophobic C-terminal region and a cluster of serine phosphate residues
in the hydrophilic N-terminus (Bonsing and Mackinlay 1987; Yoshimura
et al. 1986; E. Stevenson and J. Leaver unpublished). Bonsing and
Mackinlay (1987) have proposed that the overall architecture of (3-casein
molecule has been preserved in various species despite the high level of
divergence, and that this may reflect functional constraints imposed on
the structure of this protein during evolution. Further, the comparison of
[3-casein sequences from several species has shown conservation of a
number of individual Gin, Pro and Lys residues (Holt and Sawyer 1988); it
has been suggested that these residues may be important in the
determination of the secondary structure and have functional
implications. Pearse et al. (1986) reported that addition of partially
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dephosphorylated (3-casein to artificial casein micelles in vitro affected
their coagulation time and curd formation reaction. Their interpretation of
these data was that (3-casein had a role in determining the surface
properties of casein micelles.
The mouse p-casein gene, like its counterparts in cattle (Bonsing et
al. 1988), rat (Jones et al. 1985), and rabbit (Thepot et al. 1991), is a single
copy gene consisting of nine exons (Yoshimura and Oka 1989). In mouse it
maps on chromosome 5 and is closely linked with the a-casein gene (Gupta
et al. 1982; Geissler et al. 1988; Rosen et al. 1989). Another mouse casein
gene, y-casein (the corresponding protein in mouse milk is yet to be
identified) also maps on this chromosome. In cattle asl-, as2-, P- and
K-casein genes have been found physically linked within 200 kb of DNA on
chromosome 6 (Ferretti et al. 1990; Threadgill and Womack 1990). The
presence of Ca2+-sensitive casein genes as a close linkage group and
conservation of 5' and 3' noncoding regions and sequences corresponding
to signal peptides and phoshorylation sites in these genes have led to the
suggestion of a casein gene family which arose by successive duplication of
an ancient casein gene (Jones et al. 1985; Yu-Lee et al. 1986). By analogy
with the P-globin locus (reviewed by Kollias and Grosveld 1992) it has
been speculated that Ca2+-sensitive casein genes might be regulated as a
complex locus by common control elements (Rosen et al. 1989). However,
any such shared regulatory elements are yet to be located in the casein
gene complex of any species.
Cloning of major milk protein genes from various species has
provided a novel way for production of heterologous proteins through
transgenesis in the mammary gland of laboratory and farm animals
(reviews: Clark et al. 1987; Hennighausen et al. 1990; Chapter 1: section
1.3). Expression of high levels of heterologous proteins in mammary gland
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can be achieved by this approach (Archibald et al. 1990; Simons et al.
1987; Velander et al. 1992; Wall et al. 1991; Wright et al. 1991), but the
site of integration and structure of the transgene arrays cannot be
controlled a priori, and thus, the level of transgene expression is mostly
unpredictable (Clark et al. 1990; Palmiter and Brinster 1986; Wall and
Seidel Jr. 1992). Every transgene, in principle, represents an insertion
mutation; it may not always be possible to breed the transgene to
homozygosity if a vital endogenous locus were disrupted (Jaenisch 1988;
Smith et al. 1987). These inherent problems of transgenic technology are
further accentuated in farm animals due to the lower efficiency of
transgenesis and the high cost of transgenic procedures in these species
(Clark et al. 1990; Wall and Seidel Jr. 1992). The availability of
pluripotential mouse embryonic stem cells (Evans and Kaufman 1981;
Martin 1981) has allowed the introduction of targeted modifications into
the mouse genome (reviewed by Bradley et al. 1992; Capecchi 1989a,
1989b; Evans 1989; Hooper 1992; Roller and Smithies 1992). Bradley et al.
(1992) and Wilmut et al. (1991) have suggested that some limitations of
transgenic technology could be overcome by placing the coding sequences
of a heterologous protein under the control of the regulatory elements of
an appropriate endogenous gene through homologous recombination. It is
expected that the pattern of expression of the heterologous protein would
be similar to that of the original target locus (Nandi et al. 1988; Mansour
et al. 1990; Mouellic et al. 1990). The above technology should be useful to
introduce quantitative and qualitative modifications in the endogenous
milk proteins to either enhance the nutritional value of milk or to change
its physical properties to suit the needs of the dairy industry (see Chapter
1: section 1.3.3).
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To date, the mouse is the only vertebrate species in which targeted
genetic changes into the endogenous genes have been feasible, and
obviously, the availability of ES cells from farm animals may be crucial to
effect similar modification in these species. An ideal target locus to
achieve mammary gland specific expression of a heterologous protein
through gene targeting would have to satisfy at least two important
criteria. First, the level of expression of the endogenous protein must be
sufficiently high; second, a null mutation in the targeted locus would
have to be compatible with the well-being of the animal and normal
physiology ofmammary gland, p-casein meets the first requirement as it
is the most abundant protein in many milks (Davies et al. 1983).
However, the biological consequences of a null mutation in this locus will
need to be assessed. The information on any essential in vivo function of
the native protein will be equally important prior to targeting any subtle
genetic changes into the endogenous p-casein to modify physical
properties of milk of farm animals (Clark 1992; Jimenez-Flores and
Richardson 1988).
Casein mRNAs have been detected in mouse cytotoxic T
lymphocyte (CTL) cell lines and in thymus (Grusby et al. 1990). These
workers have speculated that casein micelles play a role in CTL function
and have proposed that the casein micelles may act as a vehicle for the
delivery of perforin to the target cells (see review: Yagita et al. 1992 for
the role of perforin in CTL function); the absence of free Ca2+ in the
casein micellar environment would insure against the premature
polymerisation of perforin. However, casein micelles or individual caseins
are yet to be positively recognised in CTLs, CTL cell lines or thymus and
thus, the functional significance of casein gene expression in thymus is
not known.
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To gain knowledge of the biological function of P-casein, I have
generated P-casein-deficient mice through embryonic stem technology
(Bradley et al. 1992; Capecchi 1989a; Evans 1989; Hooper 1992). The
p-casein-deficient mice may be a suitable in vivo system to evaluate the
physical properties of genetically engineered bovine P-casein and effects
of such modifications on the characteristics of milk (Clark 1992).
Expression of sheep P-lactoglobulin in the mouse mammary gland has
revealed that the total protein concentration of milk did not increase
inspite of the fact that P-lactoglobulin constituted 29% of milk protein
(Wilde et al. 1992). Thus, there is a limitation to the level of milk proteins
in mouse milk. The P-casein-deficient mice may be a useful animal model
to understand the limits and dynamics of protein synthesis in the
mammary gland.
This chapter describes the generation and characterization ofmice
lacking P-casein in their milk. It is shown that P-casein is not essential in
either survival or lactation. The effects of this mutation on the milk




3.2.1. Targeted Disruption of the Mouse P-Casein Gene in
Embryonic Stem Cells
3.2.1.1. Gene Targeting Vectors and Scheme ofTargeting
A P-casein gene targeting plasmid pPlMClNEO/TK,
based on the positive-negative selection protocol ofMansour et al. (1988),
contained the 4.7 kb Seal (intron I) -EcoRl (Exon 7) non-isogenic DNA
fragment of the mouse P-casein gene. The neomycin gene expression
cassette from plasmid pMClneo(c) was inserted into exon 2 of p-casein
gene sequences just 3' of the initiation codon of the p-casein gene, and in
the same transcriptional orientation. Plasmid pPlMClNEO/TK, when
opened at a unique Sfil site, served as a replacement type gene targeting
vector with two arms of homology of 841 bp and 3.9 kb flanking the neo
gene (Fig. 3.IB). The herpes simplex virus thymidine kinase (HSV tk)
gene from pSPTK was included at the 3' end of the p-casein gene
sequences in the targeting vector pplMClNEO/TK to select against
random integration of the targeting vector into the ES cell genome. A
second p-casein gene targeting vector pP2MClNEO/TK was derived from
the vector pplMClNEO/TK after the addition of a further 1.35 kb of the
p-casein gene sequences on the long arm of homology. Construction of the
above vectors is described in Chapter 2 (see Figs. 2.1 & 2.2).
Homologous recombination of either of the above two
gene targeting vectors with one of the P-casein alleles in the mouse
embryonic stem cells would result in insertion of 1.1 kb neo gene into
exon 2 of the P-casein gene (Fig. 3.1). This insertion would disrupt







































Figure3.1.Schematicrepresenta ionoft mous( -cas ing near t ginESlls. A)Restrictionmapofwild-typeouseP-caseingen ;thtranslatioiniti t ondju5' fAsp7001si exon2. B)RestrictionmapofP-caseigenereplacement-typetarg t gv torp(3lMClNEO/TKw tht ounequ lmsof homologyof841bpand3.9kb.TheHSVtkgeneseinclud th3' ndft ivectorallowsel ti nwith GANCagainstrandomintegrati nofthevect rmoleculeESc llgenome. C)PredictedrestrictionmapoftheP-ca ingenf rtarge gbyv ctopplMClNEO/TK. Thinline:P-caseingenendflanki gsequences;box sumb red1-9and(2):P-c s ie oddisrupt byneog ne,resp ctively.NEO;n omycinnca settfropMClNEO(c);TK:HSVtkg ncas t efrompSPTK; PLASMID:pPolylllvectorsequences.Thi klin s:ositionofDNAprobesusediSouth rblott ganaly isf P-caseinlo us.A:sp700I;B̂EII;EoRHindlll)Sac ;nde l.
identification of the targeted clones after selection for neomycin gene
expression with the drug G418. If transcription from the p-casein gene
promoter were not affected by this mutation, a fusion pre-mRNA would
be transcribed from the targeted P-casein allele. As the neo sequences in
this fusion transcript would lack their own polyadenylation signal, this
transcript should be processed into an mRNA species which would be 1.1
kb larger than the P-casein mRNA, assuming that splicing is not affected
by insertion of the neo gene into exon 2 of the P-casein gene. Translation
from the authentic P-casein AUG codon in this hybrid message would be
terminated within the neo gene cassette sequences as there is a stop
codon 240 nt downstream in this reading frame. The peptide which could
be generated in this way would bear no resemblance to P-casein. There
were premature translation termination codons in the other two reading
frames as well.
3.2.1.2. Experiment-I: Targeting the P-Casein Gene in
High Passage E14 ES Cells
A preliminary experiment was performed to test and
characterise the targeting vector ppiMClNEO/TK. E14 ES cells
(Handyside et al. 1989) at passage 35 were electroporated in the presence
of linearised vector DNA (Table 3.1). Double selection with G418 and
GANC resulted in approximately 15-fold fewer ES cell colonies as
compared with the number of colonies generated after G418 selection
alone. Although 15-fold enrichment after GANC selection was much
below than the levels of enrichment reported by Mansour et al. (1988), it
was still considered reasonable to use this selection regime for further
experiments with P-casein gene targeting vectors.
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Table3.1.rgetingth(3-caseingeneinmouseembryo icst mcell . ExperimentEScelllin andpassage No.Cells Electro- poratedVector DNA (gg)Cells plated
G418- resistantc oloniest
G418-GANC- resistant colonies
Enrichment factorafte GANC selection
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3.2.1.2.1. Screening for targeting at the P-casein
locus
Nineteen out of a total of 50 G418-GANC-
resistant ES cell clones generated with the targeting vector
pPlMClNEO/TK were expanded individually. To examine the structure
of the p-casein locus in these clones, Sacl-digested genomic DNA was
analysed by Southern blotting using a p-casein genomic DNA probe
(Hindlll-Scal fragment from the 5' region of the P-casein gene: Probe 1;
Fig. 3.1). This probe was predicted to hybridise to a 2.7 kb SacI fragment
from wild-type allele and to a 3.8 kb fragment from the targeted allele.
Randomly integrated molecules of the targeting vector would not be
recognised by probe 1 because the corresponding DNA sequences were
not included in the targeting vector pPlMClNEO/TK.
Probe 1 hybridised to a 2.7 kb SacI DNA
fragment from all of the nineteen clones and control E14 cells as was
expected from the structure of the non-targeted allele. However, DNA
from two of the nineteen clones pi.2 and pi.3 had an extra band of
approximately 3.8 kb (Fig. 3.2A). The presence of the 3.8 kb band in
addition to the 2.7 kb wild-type band suggested that one of the P-casein
alleles in each of these two clones had undergone modification.
To confirm that these two clones were modified
as a result of targeting events at the P-casein locus, DNA from these
clones was restricted with EcoRI orHindlll and hybridised with probe 1.
This probe was expected to hybridise to a 9.8 kb EcoRI fragment of the
endogenous P-casein gene (Fig. 3.2C). There are two EcoRI sites in the
neo gene sequences included in the targeting vector pPlMClNEO/TK
(Fig. 3.1). These two sites would be incorporated into exon 2 of one of the
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Figure 3.2. Targeting of the P-casein gene in high passage E14 ES
cells - Screening for targeting events and confirmation of the
structure of the targeted P-casein gene.
A) Sacl-digested genomic DNA from nineteen G418-GANC-resistant ES
cell clones were analysed by Southern blotting with probe 1 (see Fig. 3.1).
Two clones pi.2 and pi.3 gave a novel 3.8 kb fragment diagnostic of
targeting of one of the P-casein alleles. The 2.7 kb Sad fragment in these
clones and control E14 cells corresponds to wild-type allele.
B) Confirmation of targeting in clones pi.2 and pi.3 by analysis ofEcoRI
and iTjndlll-digested DNA with probe 1; the 6.1 kb EcoRI and 5.0 kb
Hindlll fragments are diagnostic of targeting.
C) Map of wild-type p-casein gene showing fragments obtained from
digests diagnostic of targeting using probe 1.
D) Map of the predicted structure of targeted p-casein gene showing
fragments diagnostic of targeting using probe 1.
Boxes: Exons 1 to 7. Thick line: Position of P-casein genomic probe. E:
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P-casein alleles after homologous recombination and thus, probe 1 should
hybridise to a 6.1 kb EcoRI fragment from the targeted allele (Fig 3.2D).
Southern blot analysis revealed that the clones (31.2 and pi.3 both had an
approximately 6.1 kb EcoRI fragment in addition to the 9.8 kb EcoRI
fragment from the wild-type allele (Fig. 3.2B). This observation indicated
that clones (31.2 and pi.3 were generated as a result of successful
targeting into one of the p-casein alleles in E14 cells by the vector
pPlMClNEO/TK. Similarly, analysis of the DNA from these two clones
with HindHI gave the novel 5.0 kb fragments in contrast to the 3.9 kb
fragments from the non-targeted alleles (Fig. 3.2B), as was expected after
targeted modification of the P-casein locus. All of these observations were
consistent with the incorporation of the 1.1 kb neo gene cassette into exon
2 of the P-casein gene through homologous recombination between the
targeting vector pPlMClNEO/TK and one of the P-casein alleles in E14
ES cells.
Finally, the Sacl-digested pi.2 and pi.3 DNA
was electrophoresed in duplicate on the same gel and transferred onto
Hybond-N membrane. One half of the membrane was hybridised with
probe 1 and the other half with a 917 bp {EcoRl-Sall) DNA probe from
the neo gene (Probe 2; see Fig. 3.1). An indistinguishable 3.8. kb Sacl
fragment was revealed by probes 1 and 2 confirming that the neo gene
had been included in the p-casein locus through homologous
recombination (data not shown). Further, the absence of any other bands
in the DNA of targeted clones upon hybridisation with the neo probe
indicated that the targeting vector did not integrate randomly into the
genome of these clones.
The above electroporation experiment was
planned to check the enrichment level that could be obtained with the
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vector pplMClNEO/TK upon negative selection with GANC and to serve
as a pilot exercise to aid in the design of further gene targeting
experiments. Nevertheless, two ES cell clones out of a total of nineteen
clones analysed had undergone a targeting event at the (3-casein locus.
Taking into account the level of enrichment obtained by GANC-selection,
this value represented one targeting event per 140 colonies generated by
random integration of the vector (Table 3.1).
3.2.1.2.2. Chromosomal analysis of clones (31.2 and
(31.3
Metaphase chromosomal spreads were
prepared from the (3-casein gene-targeted clones (31.2 and (31.3.
Unfortunately, both of these clones had 42 chromosomes. It was thought
very unlikely that these targeted clones would be able to populate the
germ line of the mouse and form functional spermatozoa (Bradley 1987).
The passage number of ES cells used in this experiment was relatively
high (passage 35). Probably, a large proportion of these cells had
aneuploid chromosomal profiles at the time of the electroporation
experiment. As the aim of the project was to introduce the mutation into
the mouse germ line and study the resulting phenotype, more
experiments were undertaken to target the (3-casein gene using low
passage ES cells.
3.2.1.3. Experiment-II: Targeting the (3-Casein Gene in Low
Passage EFC-1 ES Cells
It has been reported that the targeting efficiency at
the HPRT locus increases exponentially with a linear increase in the
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extent of homology between the target locus and the gene targeting vector
within the range of 2-14 kb (Deng and Capecchi 1992; Thomas and
Capecchi 1987). The vector ppiMClNEO/TK, used in gene targeting
experiment-I, had only 4.7 kb of DNA sequences homologous to the
endogenous gene. To take advantage of increased homology, another
P-casein gene targeting vector pP2MClNEO/TK (see Chapter 2: Fig. 2.2D)
was used in a gene targeting experiment with EFC-1 ES cells (Nichols et
al. 1990). The structure of the vector pP2MClNEO/TK was identical to
that of the vector ppiMClNEO/TK except for the inclusion of an
additional 1.35 kb of P-casein gene sequences on the long arm of
homology. The vector pP2MClNEO/TK, when opened at a unique Sfil
site, had a total of 6.1 kb homology distributed as two arms of 841 bp and
5.25 kb flanking the neo gene.
EFC-1 ES cells (Nichols et al. 1990) were grown and
electroporated at passage 21 in the presence of linearised
PP2MC1NEO/TK DNA and cells were selected with G418 and GANC
(Table 3.1). Double selection gave ~5-fold fewer colonies than G418
selection alone. One hundred and sixty eight individual colonies from 25
independent plates were picked into 24-well tissue culture plates and
expanded. From each clone, one confluent 25 cm2 flask was frozen in
three aliquots and another 25 cm2 flask was processed for the
preparation of DNA to screen for the identification of the targeted ES cell
clones.
3.2.1.3.1. Screening for targeting at the p-casein locus
To screen for homologous recombination at the
P-casein locus, the Sacl-digested DNA samples from 168 G418-GANC
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colonies were analysed by Southern blotting using probe 1 as described in
section 3.2.1.2.1. All of these clones had a 2.7 kb Sad fragment released
from the non-targeted endogenous (3-casein allele (data not shown). The
absence of any additional band with probe 1 was taken as evidence that
none of these ES cell clones had undergone targeted modification at the
(3-casein locus. The level of enrichment in this experiment was only 5-fold
in contrast to the 15-fold enrichment observed in experiment-I with the
vector p(3lMClNEO/TK. (Table 3.1). In spite of the increased homologous
sequences included in the vector p(32MClNEO/TK in contrast to the
vector p(31MClNEO/TK, and a large number of G418-GANC clones
screened in experiment-II (equivalent to 840 G418-resistant clones), it
was surprising not to find even a single targeting event in this
experiment. However, this result was not directly comparable to that of
the experiment-I because both the ES cell lines and targeting vectors
used in these two experiments were different.
3.2.1.4. Experiment-Ill: Targeting the (3-Casein Gene in
Low Passage E14 ES Cells
A third series of (3-casein gene targeting experiments
was performed with low passage E14 cells at the CRC Laboratories,
Department of Pathology, University of Edinburgh. ES cells grown to
passage 19 and 20 were electroporated in the presence of three different
concentrations of the vector p(3lMClNEO/TK DNA (Table 3.1).
Genomic DNA from 473 individual G418-GANC-
resistant ES cell clones was analysed by Southern blotting to identify
clones carrying the targeted (3-casein gene (see section 3.2.1.2.1) Sacl-
digested DNA samples from these clones were hybridised with probe 1
(for an example see Fig. 3.3). The presence of the novel 3.8 kb SacI
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Figure 3.3. Targeting of the P-casein gene in low
passage E14 ES cells: Screening for targeting events
at the P-casein locus by Southern analysis.
Lanes 1-12: Sacl-digested DNA from G418-GANC-
resistant E14 clones; lane 13: Sad-digested positive control
DNA from P-casein gene targeted clone pi.2 (see Fig. 3.2).
The blot was hybridised with probe 1 (see Fig. 3.1). The 3.8
kb fragment was diagnostic of targeting (e.g. lane 8).
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fragment in contrast to the 2.7 kb Sac I fragment from the endogenous
P-casein gene was diagnostic of targeted modification. Nineteen clones
were identified as having undergone modification of one of their P-casein
alleles.
Overall, one targeting event per 25 G418-GANC-
resistant ES cell colonies screened was recorded in experiment-Ill with
the targeting vector pplMClNEO/TK using low passage E14 cells (Table
3.1). After correcting for the level of enrichment, this value represented
one targeting event per 125 random integration events and was close to
the targeting efficiency observed with this vector using high passage E14
ES cells in Experiment-I (the significance of this comparison is limited by
small size of Experiment-I). Thus, with this vector, there is no evidence
for an effect of passage number on targeting efficiency, although Roller et
al. (1991) have suggested that late passage cells might be easier to target.
Three different concentrations of targeting vector DNA were used in the
electroporation mixtures in this experiment. The targeting efficiency was
~2-fold higher when 25 (ig of vector DNA was used than when 75 (ig or
150 pg ofDNA was used. The latter two levels ofvector DNA gave similar
targeting efficiencies. It should be noted that the effect of the vector DNA
concentration on gene targeting efficiency was examined only in one
experiment and, therefore, while there may be an effect of DNA
concentration on targeting efficiency it is not possible to draw any firm
conclusions about this.
3.2.1.4.1. Chromosomal analysis
Seven out of the nineteen P-casein gene
targeted clones identified in experiment-Ill were thawed and expanded
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for chromosomal analysis and to allow freezing of a number of aliquots of
cells per clone. One of these clones differentiated spontaneously and could
not be recovered. Metaphase chromosomal spreads were prepared from
the six remaining clones (Table 3.2). Two independently isolated clones
were selected for confirmation of the structure of their targeted P-casein
alleles and production of chimaeric mice. Clone B256 had approximately
80% of cells with 40. Clone A77 had 40 chromosomes in approximately
60% of its cell population.
Table 3.2. Chromosomal analysis of the P-casein gene targeted ES
cell clones.
ES cell clone Chromosome number
A32 40, including one metacentric chromosome (20)*
A77 40 (12); 40? (3); 41 (2); 42 (2); 39(1)
Bill 40 (11); 41(9)
B116 40 (13); 41(6); 31(1)
B256 40 (16); 39 (2); 4nt (2)
C128 variable, 38-42 (20)
j|(
The figure in the parenthesis shows the number of metaphase spreads. Twenty
metaphase spreads per clone were examined to determine the chromosome number.
^ 4n: Tetraploid.
Clones A77 and B256 were selected for production of chimaeras.
3.2.1.4.2. Structure of the 5' end of targeted P-casein
allele in clones A77 and B256
Correct targeting by the vector
pPlMClNEO/TK at the 5' end of the P-casein locus was expected to
generate a 3.8 kb Sacl and a 5.0 kb Hindlll fragment from the modified
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P-casein allele in addition to 2.7 kb and 3.9 kb respective fragments from
the non-targeted allele (Fig. 3.4C & D). The novel 3.8 kb Sad and 5.0 kb
Hindlll fragments should hybridise to both probe 1 from 5' region of the
p-casein gene and probe 2 from the neo gene (Fig. 3.4D). Randomly
integrated copies of the targeting vector would not be detectable using
probe 1. Following random integration of the targeting vector probe 2
would hybridise to Sad and Hindlll fragments of unpredictable lengths.
DNA from clones A77 and B256 was digested
with Sad or Hindlll and hybridised with either probe 1 (Fig. 3.4A) or
probe 2 (Fig. 3.4B). Again probe 1 hybridised to a 2.7 kb and a 3.8 kb Sad
fragments in both of these clones as opposed to the 2.7 kb Sad fragment
from the control E14 cells (Fig. 3.4A). Similarly, this probe highlighted
3.9 kb and 5.0 kb Hindlll fragments from clone A77 and B256 in contrast
to the single 3.9 kb Hindlll fragment in the control E14 DNA. The
presence of the 3.8 kb SacI and 5.0 kb Hindlll fragments in these two
clones suggested that the 5' end of the targeting vector had correctly
recombined with the 5' end of one of the P-casein alleles.
The 3.8 kb Sad and 5.0 kb Hindlll fragments
from A77 and B256 DNA detected by probe 1 also hybridised to the probe
2 from the neo gene (Fig. 3.4B) confirming that the neo gene had been
inserted into the 5' end of one of the P-casein alleles in these clones as
was envisaged.
3.2.1.4.3. Structure of the 3' end of the targeted
p-casein allele in clones A77 and B256
To analyse the structure of the 3' end of the
targeted p-casein allele in clones A77 and B256, DNA was restricted with
Bs^EII or Seal and probed with a 642 bp Sail-Sad P-casein genomic
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Figure 3.4. Targeting of the P-casein gene in low passage E14 ES
cells: Structure of the 5' end of the targeted allele in clones A77
and B256.
A) SacI and i/mdlll-digested genomic DNA was probed with probe 1
(Fig. 3.1). The 3.8 kb SacI and 5.0 kb Hindlll fragments from A77 and
B256 DNA are diagnostic of correct targeting at the 5' end of P-casein
gene.
B) SacI and ifmdIII-digested genomic DNA was probed with probe 2
(Fig. 3.1). The 3.8 kb SacI and 5.0 kb Hindlll fragments from A77 and
B256 DNA are diagnostic of correct targeting at the 5' end of P-casein
gene.
C) Map of wild-type P-casein gene showing fragments obtained from
digests diagnostic of targeting using probe 1.
D) Map of the predicted structure of the targeted P-casein gene showing
fragments diagnostic of targeting using probes 1 and 2.































































probe which contains (most of) exon 7 (probe 3; see Fig. 3.1). These
sequences were included in the targeting vector. The results of Southern
analysis have been shown in Fig. 3.5A. The probe was stripped off and
the filters were reprobed with the neo probe (Fig. 3.5B).
BstEll digestion ofE14 DNA generated a 5.3 kb
fragment with probe 3 (Fig. 3.5C). The targeting vector has two BsfEII
sites; one in the short arm of homology and the second in the tk gene (Fig.
3. IB). Random integration of the targeting vector into the ES cell genome
would result in a 7.1 kb BstEll fragment capable of hybridising to both
probes 2 and 3. However, correct targeting of the (5-casein gene at the 3'
end would generate a 6.4 kb Bs^EII fragment with both of these probes
(Fig. 3.5D).
Probing ofBs^EII-digested DNA from clone A77
and B256 with probe 3 revealed the expected 6.4 kb fragment in addition
to the 5.3 kb fragment from the non-targeted allele (Fig. 3.5A). The 6.4 kb
Bsffill fragment was also recognised by the neo probe as was predicted if
the 3' end of the targeting vector recombined with the (3-casein gene (Fig.
3.5B). The presence of the 6.4 kb Bsffill fragment with these two probes
suggested that one of the (3-casein allele had undergone a correct targeted
modification at its 3' end.
The above interpretation of results was
supported by analysis of Seal-digested DNA from the targeted clones
(Fig. 3.5). Correct targeting at the 3' end was expected to increase the size
of wild-type 7.0 kb Seal fragment to 8.1 kb (Fig. 3.5C & D). Random
integration was predicted to generate a Seal fragment of unknown size
(>8.2 kb). Seal digestion of A77 and B256 DNA gave 7.0 kb and 8.1 kb
fragments hybridising to probe 3 in contrast to a single 7.0 kb fragment
from the E14 control (Fig. 3.5A). The novel 8.1 kb Seal fragment from
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Figure 3.5. Targeting of the P-casein gene in low passage E14 ES
cells: Structure of the 3' end of the targeted allele in clones A77
and B256.
A) Bs£EII and Seal-digested genomic DNA was probed with probe 3 (Fig.
3.1). The 6.4 kb fis^EII and 8.1 kb Seal fragments from A77 and B256
DNA are diagnostic of correct targeting at the 3' end of P-casein gene.
B) Bsffill and Seal-digested genomic DNA was probed with probe 2 (Fig.
3.1). The 6.4 kb Bs^EII and 8.1 kb Seal fragments from A77 and B256
DNA are diagnostic of correct targeting at the 3' end of p-casein gene.
C) Map of the wild-type P-casein gene showing fragments obtained from
digests diagnostic of targeting using probe 3.
D) Map of the predicted structure of the targeted P-casein gene showing
fragments diagnostic of targeting using probes 2 and 3.


























































A77 and B256 DNA also hybridised to probe 2 (Fig. 3.5B). These
observations were consistent with the precise modification of one of the
P-casein alleles of these clones through replacement targeting by the
vector pplMClNEO/TK.
Southern blot analysis of A77 and B256 DNA
after digestion with a number of restriction enzymes and hybridisation to
neo probe as described above, invariably lit up a single band of the size
consitent with a homologous recombination event between the
endogenous P-casein gene and the targeting vector (Figs. 3.4 & 3.5). Thus,
there was no evidence for random integration of the targeting vector
molecules in the genome of these clones.
3.2.2. Production of Chimaeras and Germ line Transmission
of the Mutation
To produce chimaeric mice from the P-casein gene targeted
clones, mouse blastocyst injections were performed by Dr. Martin
Hooper's laboratory at the Medical School, University of Edinburgh and
the manipulated embryos were transferred to the uteri of
psuedopregnant mice by Miss Roberta Wallace at Roslin.
P-casein gene targeted clones All and B256 were injected
into F2 C57/BL/6/01a x CBA/Ca/Ola blastocysts (Thompson et al. 1989).
The blastocysts were transferred to psuedopregnant MF1 female mice.
The ES cell contribution to mice that developed from injected blastocysts
was visually scored by observing for the patches of lighter coat colour in
the pups at three weeks of age. The host blastocysts segregated at the A
(agouti) locus resulting in agouti and non-agouti mice and any




Figure3.6.Prod ctionofchimaericm cefromtp-cas ng eta g tedESc ll cloneB256.Alitterfpupsderiv dfr mF2C 7/BL/6/01axCBA/Ca Olablastocystsafter injectionofB256ESells.Sevenofthni epupsit isli terwerechimaerica demonstratedbythepatchesoflight rcoatlourt pupsbornfr mthmanipulated blastocysts.
The efficiency of chimaera production is presented in Table
3.3. Clone A77 was relatively inefficient in generating chimaeras; only 8
out of 30 mice scored were chimaeric. The extent of the ES cell
contribution was generally very poor in these chimaeras. Further, there
was no distortion of sex-ratio in favour of males as was anticipated after
injection of male ES cells into the unsexed blastocysts. However, clone
B256 produced extensive chimaeras contributing up to 90% to the coat
colour of the pups. More than 50% of the progeny were chimaeric and
there was a clear bias in the sex-ratio among these chimaera in favour of
males, indicating that some of the males might have resulted from sex
conversion of female host blastocysts (Table 3.3).
Table 3.3. Production of chimaeric mice from the (3-casein gene














A77 40 30 2 6 1-65
B256 90 57 23 10 1-90
Table 3.4 shows the breeding performance data of the
chimaeras mated to MF1 albino mice. The germ line contribution from ES
cells was identified by the presence of light chinchilla offspring in the
litters of chimaeric males and females. None of the A77 chimaeras
produced any light chinchilla mice. Out of a total of 16 fertile male and 6
fertile female B256 chimaeras, nine males and one female produced
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Table 3.4. Breeding performance of chimaeras produced from








No. of germ line
chimaeras
Male Female Male Female Male Female
A77 2 6 2 6 0 0
B256 21 6 16 6 9* 1
One male chimaera produced progeny only from ES cells.
progeny from the ES cell component (e.g. Fig. 3.7). Five of the B256 male
chimaeras tested were sterile; four of these had approximately a 90%
contribution from ES cells. Among the germ line chimeras, the extent of
the ES cell contribution in their coat colour ranged from 5-90%. Chimera
56 produced only light chinchilla progeny which suggested that this male
had a XX-XY chromosomal constitution. The extent of coat colour
chimaerism was a poor indicator of germ line transmission potential from
a particular chimaera (Table 3.5).
Tail DNA of the light chinchilla offspring from the germ line
chimeras was analysed by Southern blotting to confirm that some of
these animals had inherited the disrupted P-casein allele. Fig. 3.9 shows
results from such an analysis. The Sad-digested DNA samples were
analysed with probe 1. Approximately 50% of these mice had the 3.8 kb
SacI fragment corresponding to the targeted P-casein allele in addition to
the 2.7 kb fragment from wild-type allele. The mutant allele was
designated csnb'.
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Figure3.7.Germl ntra smissionofthtargetedp-ca inllele.Alitt rf om onefthgermlinmalechimaerasB256/30(shownti s t)atedMF1 female.Agoutiandnon-agoutip psrefr mthh sbl stocy ts(F2C57/BL/6/01ax CBA/Ca/Ola).Lightchinchillapupsrefromtp- s ingenetarge edESc lls;50%of suchp pscarriedthargetP- s inll le.
Table 3.5. Extent of coat-colour chimaerism in male germline













9 75 135 8
18 40 177 27
30 10 100 37
42 5 94 11
43 90 50 6
45 90 30 33
55 50 5 60
56 55 12 100
57 20 112 7
*
The ES cell contribution to the coat colour of chimaeric mice was judged by visual
appraisal.
3.2.3. Mice Homozygous for the Mutation were Viable and
Fertile, and the Females Appeared to Lactate
Normally
Mice heterozygous for the targeted mutation in the (3-casein
gene were mated to produce homozygous mice (csnb'/csnb"). Matings
amongst full sibs and half sibs were avoided since the mutation was in an
outbred genetic background and any inbreeding at this stage could have
introduced a bias in the subsequent analysis of phenotypic effect of the
mutation.
Tail DNA of pups born from heterozygous intercrosses (Fig.




Figure3.8.Prod ctionfmicehomozyg usf rthmutant(3-cas inall le. Heterozygousmutanticewerb edprod ceho ozygousmutantic .T p: heterozygousmutantoused rivedf mthp-caseinge etar t dESc llloneB256. Bottomrow:Alit erfrointer-sematingfhet r zygousmuta tice;w fhesepup arehomozygousmutant .
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—3.8 kb
—2.7 kb
Figure 3.9. Germ line transmission of the targeted P-casein
allele. Southern blot analysis of Sacl-digested DNA from the tail
biopsies of the light chinchilla progeny of one of the male
chimaeras mated to MF1 females. Lane 1: Control DNA from the
ES cell clone B256 carrying the targeted P-casein allele; lanes
2-14: tail DNA from the light chinchilla offspring of the male
chimaera. The filters were hybridised with probe 1 (see Fig. 3.1).
The 2.7 kb fragment is released from wild-type allele in all lanes,
and the presence of an additional 3.8 kb fragment in lanes 2-5, 8,
9, 12, and 13 is diagnostic of transmission of the targeted P-casein
allele originating from ES cell contribution to the germline of the
chimaera.
3 4 5 6 7 8 9 10 11 12 13 14
-3.8 kb
-2.7 kb
Figure 3.10. Generation of mice homozygous for the
targeted P-casein allele. Southern blot analysis of Sacl-
digested DNA from the tail biopsies of progeny from inter-se
matings of mice heterozygous for the targeted p-casein allele.
Lane 1: Control DNA from the E14 cells; lane 2: control DNA from
the targeted clone B256; lanes 3-14: tail DNA from the offspring
from heterozygous matings. The filters were hybridised with probe
1 (see Fig. 3.1). The 2.7 kb Sacl band is from wild-type allele and
the 3.8 kb band is from the targeted allele. Approximately 25% of
the progeny screened were homozygous for the mutant allele as in
lanes 3, 7 and 11.
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single 3.8 kb Sacl fragment corresponding to the disrupted (3-casein allele
in appoximately 25% of the animals in contrast to a 2.7 kb band from
wild-type allele. Heterozygous animals (csnb+/csnb~) were identified by
the presence of both the 2.7 kb and 3.8 kb fragments. The relative
numbers of wild-type homozygotes (csnb+/csnb+), heterozygotes
(csnb+/csnb~) and mutant homozygotes (csnb'/csnb") were in agreement
with the expected Mendelian ratio of 1:2:1, respectively (Table 3.6). Thus,
the mutation in the (3-casein gene was compatible with normal
development. The average weight of the (3-casein-deficient pups at
weaning was not different from that of wild type pups (Table 3.6)
indicating that the mutation in the (3-casein gene did not compromise the
preweaning growth of the pups. However, the pups heterozygous at the
(3-casein locus weighed more than the mutant homozygous pups (p <
0.05). It was difficult to reconcile how the superiority of the heterozygotes
observed in the present study could result from the interaction of the
targeted and wild-type (3-casein alleles.
The wild-type, heterozygous, and mutant homozygous
females were mated to mutant homozygous, heterozygous and wild-type
males, respectively. The three groups of females produced litters of
similar sizes (Table 3.7). The preweaning growth of the pups feeding
(3-casein-deficient milk appeared to be slightly slower than that of pups
feeding milk from either wild-type or heterozygous mothers (Fig. 3.11A &
B), probably indicating the reduced total milk protein in (3-casein-
deficient milk (see section 3.2.6 below).
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Figure 3.11B. The effect of the mother's genotype at the[3-casein
locus on the pre-weaning growth of the pups.
For each genotype a linear regression model was fitted to the litter
weight data considering the age at weighing and the litter size as
independent variables (R2 > 95%; see Chapter 2: section 2.15). The graph
has been drawn from the predicted values of litter weights assuming a
litter size of eight. The homozygous mutant (csnb'/csnb') mothers
produced significantly lower litter weight on day 11 of lactation than that
of heterozygous mutant (csnb+/csnb~) and wild-type (csnb+/csnb+)
mothers (p < 0.001, t-test). Note that assuming litter sizes of seven, nine
and ten also results in statistical significance. The heterozygous mutants
were not different from the wild-type except for litter size of 10 (p < 0.05).
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3.2.4. Transcription of the Mutant (3-Casein Gene
The targeted allele csnb' was created by insertion of 1.1 kb
neo gene sequences into exon 2 of the P-casein gene in the same
transcriptional orientation (see section 3.2.1.1). As the neo gene lacked its
own polyadenylation signal, a fusion transcript of 2.3 kb was expected
from the targeted allele which should hybridise to the P-casein cDNA
probe. Fig. 3.12 shows a Northern analysis of total RNA from the
mammary gland of lactating (day 11) females. A cDNA probe (Gupta et
al. 1982) homologous to exons 7 and 9 of the mouse P-casein gene failed to
detect any corresponding transcript in the mammary gland RNA of
homozygous mutant lactating mice (Fig. 3.12A). Consistent with this
observation, heterozygous females had approximately half the amount of
the P-casein mRNA present in the mammary gland of homozygous
wild-type mice. Northern blot analysis of mammary gland RNA from
homozygous mutant females with the neo probe gave diffuse
hybridisation reminiscent of partially degraded RNA (Fig. 3.12B). Control
hybridisation with a rRNA probe gave discrete bands as expected
showing that the RNA preparations were not degraded (not shown).
Given that the neo hybridisation was specific to mice carrying the mutant
allele, these data indicate that the targeted locus was being transcribed
in the mammary gland at some level. However, it is not possible to know
without further characterization whether the transcription was from the
p-casein gene promoter or from the neo promoter included in the modified
exon 2 of the targeted P-casein gene. It is also possible that the
transcripts detected originate from the other strand. Nevertheless, failure
to detect any signal from the mutant allele {csnb') with the p-casein
cDNA probe even after exposure of the film for several days (data not
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Figure 3.12. Expression of the targeted p-casein gene in
the mammary gland.
A) p-casein probed Northern blot. Lanes 1 & 4: wild-type;
lanes 2 & 5: mutant homozygote; lanes 3 & 6: mutant
heterozygote.
B) Neo probed Northern blot. Lanes 1 & 2: wild-type; lanes 3
& 4: mutant homozygote.
The controls for the amount of RNA loaded are shown at the
bottom of panels A & B (visualised by ethidium bromide
staining). N.B. The intensities of signal in panels A and B are
not comparable.
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shown) as opposed to the one hour exposure needed to detect P-casein
mRNA from wild-type allele indicated that csnb' is effectively a null
allele.
3.2.5. Homozygous MutantMice Lack P-Casein in their Milk
Fig. 3.13 shows representative milk protein profiles from
wild-type homozygote, mutant heterozygote, and mutant homozygote
females as revealed by SDS-PAGE and staining with Coomassie Blue.
P-casein was not detected in the milk samples from the homozygous
mutant mice (lanes 1 and 4) as expected. Milk from heterozygous females
had lesser P-casein than that from wild-type females. These observations
are consistent with the absence of any P-casein message from the
targeted allele csnb' (see section 3.2.4). Thus, the P-casein allele csnb'
represents a true null mutation, and the reduction in the amount of
P-casein in the heterozygous mice shows that there is a gene dosage-effect
at this locus.
3.2.6. Reduced Total Protein Concentration and Partial
Compensation for the Loss of P-Casein in the Milk of
Homozygous Mutant Females
The micro-Kjeldahl method in conjuction with colorimetry
(see Chapter 2: section 2.13) was used to estimate the nitrogen (N)
concentration in whole milk and whey samples (day 11 of lactation) from
homozygous mutant and homozygous wild-type mice. Protein
concentrations were then calculated from the estimated N value.
Although the micro-Kjeldahl method overestimates the protein
concentration due to inclusion of non-protein nitrogen (NPN), this should
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Figure 3.13. Protein composition of milk from (3-casein
mutant mice. Lanes 1 & 4: milk from homozygous mutant mice;
lane 2: milk from wild-type control mouse; lane 3: milk from
heterozygous mutant mouse. Lane 5: molecular weight
standards.
Diluted and defatted milk (equivalent to 75 nl of the whole milk
per lane) was electrophoresed into a 15% polyacrylamide gel
under denaturing conditions and the proteins were visualised
after staining with Coomassie Blue.
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not affect the comparison of milk protein concentration in various
genotypes in the present investigations. [In bovine milk NPN constitutes
3-8% of total N; Grappin and Ribadeau-Dumas 1992], For each genotype,
the milk samples from 12 mice were pooled, and four independent
estimates of protein concentration were obtained for each of the two
pools. In addition, total protein concentrations were also measured in
individual mouse milk samples. The average protein concentration in
mutant mouse milk was approximately 10% lower than that in wild-type
mouse milk (Table 3.8). [3-casein represented over 21% ofmilk proteins in
wild-type mice used in the present investigations (E. Stevenson, J. Leaver
and A. J. R. Law, unpublished). Thus, reduction in the level of milk
protein in the (3-casein-deficient mice was much smaller than what was
anticipated after the loss of (3-casein. These data indicate that the loss of
[3-casein in the mutant mice was being compensated by up-regulation of
synthesis and/ or secretion ofmilk proteins other than [3-casein.
To test whether this compensatory bio-synthesis and/ or
secretion of proteins in the mammary gland was spread across caseins as
well as whey proteins, the whey was isolated from the pooled [3-casein-
deficient milk and the pooled control milk after acid precipitation of the
caseins. The complete removal of caseins from the whey fractioned was
confirmed by SDS-PAGE (data not shown). Whey protein concentrations
were measured and the values were expressed mgmL1 of whole milk. The
casein concentrations were calculated by subtraction of the value for the
whey protein from that of the total milk protein (Table 3.8). The mutant
mouse milk had approximately 19% more whey protein than that from
the control milk (it may be stressed that only one experiment was
performed to estimate whey protein concentration and to draw firm
conclusions, there is need to replicate this experiment). The casein level
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in the milk from the control mice was 78.6 mgml-1. As (3-casein
constituted 27% of this value (see above), the casein concentration in the
mutant mice was expected to be approximately 57.6 mgml-1. Instead, the
concentration of caseins in the milk from the mutant mice was 65.3
mgml"1 (Table 3.8). Taken together, the data on total milk protein and






1. Total milk protein
(pooled sample from
12 mice in each
group; estimated 4
times)
97.0 ±0.97 89.1 ±0.12




97.3 ± 2.96 83.0± 1.55
3. Total milk protein
(weighted average of
1 and 2)
97.1 ± 1.71 87.310.89
4. Whey protein
(whey prepared from










The total milk protein and whey protein concentrations were affected by the (3-casein
genotypes (p < 0.001; <-test).
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whey protein levels in mutant mice were consistent with the hypothesis
that the loss of p-casein was being compensated by enhanced synthesis
and/ or secretion of other proteins in the mammary gland.
3.2.7. p-Casein is not Essential forMicelle Assembly and
Secretion but the Average Micelle Size is Reduced in
the [}-Casein-Deficient Milk
Casein micelle sizes were determined by dynamic light
scattering spectroscopy and the results are presented in Table 3.9
(measurements performed by J. Leaver and D. Home of Hannah
Institute, Ayr). The reduction of the P-casein level in the milk of the
heterozygous animals or the absence of P-casein in the milk of the mutant
mice resulted in significantly smaller casein micelles. Also, casein
micelles of the mutant mice were significantly smaller than those of the
heterozygous animals. Caseins other than P-casein were being organised
as micelles, and thus, P-casein is not essential in either formation or
secretion of these micelles.
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3.3 DISCUSSION
3.3.1 Targeting (3-Casein Gene in ES Cells and Germ line
Transmission of the Mutation
The mouse (3-casein gene was disrupted in E14 ES cells
through homologous recombination using a replacement-type gene
targeting vector p|3lMClNEO/TK. This vector was based on the positive-
negative selection protocol and included approximately 4.7 kb of non-
isogenic DNA of the (3-casein gene. GANC selection gave 4-15 fold
enrichment in various experiments. This level of enrichment is far below
the 2000-fold enrichment originally reported by Mansour et al. (1988) but
is in agreement with the results of a number of other workers (DeChiara
et al. 1990; McMahon and Bradley 1990; Tybulewicz et al. 1991; and
many others). Twenty one out of 492 GANC-G418-resistant ES cell clones
(one targeting event per -24 colonies screened) had one of their (3-casein
alleles targeted (Table 3.1). It is well established that the gene targeting
efficiency increases exponentially with the linear increase in the length of
homology included in the targeting vector (Deng and Capecchi 1992), and
isogenic DNA targets more efficiently than non-isogenic DNA (Deng and
Capecchi 1992; Te Riele et al. 1992; and Van Deursen and Wieringa
1992). Despite the comparatively small and non-isogenic [3-casein DNA
fragment in the vector p(31MClNEO/TK the targeting efficiency of this
vector in the present study was relatively high. The absence of a
polyadenylation signal from the neo gene in a targeting vector has been
shown to indirectly enrich for the targeting events by suppressing the
frequency of random integration (Joyner et al. 1989; Zijlstra et al. 1989).
The neo gene in p(31MClNEO/TK lacked its own polyadenylation site but
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the presence of a polyadenylation signal in the HSV tk gene placed at the
3' end of this targeting vector could have enhanced the efficiency of the
neo gene expression.
To take advantage of increased homology, a P-casein gene
targeting experiment was performed in EFC-1 ES cells using another
targeting vector pP2MClNEO/TK. This vector had 1.35 kb more P-casein
gene sequences on its long arm of homology in contrast to the vector
pPlMClNEO/TK. Unexpectedly, no targeting events were detected in 168
G418-GANC colonies obtained after electroporation of EFC-1 ES cells
with the vector pP2MClNEO/TK (Table 3.1). The additional 1.35 kb
p-casein gene sequences in this vector were upstream of the HSV tk gene
and it was possible that these sequences could have adversely affected
the tk gene expression and thus lowered the level of enrichment. The
similar level of enrichment achieved with both the above targeting
vectors would discount this possibility (Table 3.1). The comparison of
these two vectors is limited by the fact that the experiments were done at
different times using different cell lines; although there is no evidence to
suggest that EFC-1 cells are refractory to targeting (my unpublished
results). A relatively high level of G418 selection regime (500 mgmh1)
was used in the experiment with pP2MClNEO/TK. It may be noted that
in an experiment with E14 cells, the P-casein gene targeted clones were
isolated using the same concentration of G418 (see section 3.2.1.2). On
the other hand, if the sensitivity of E14 and EFC-1 cells to G418 differed
it is possible that the P-casein gene targeted EFC-1 clones could not
survive the above level of G418 selection.
The failure to detect any targeting events with
PP2MC1NEO/TK may also be reconciled assuming that 1.35 kb additional
p-casein gene sequences in this vector had a number of polymorphic sites
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with respect to the p-casein locus in ES cells. Thus, regional
polymorphism may be responsible for very poor targeting efficiency of
this vector (Deng and Capecchi 1992). There are likely to be still
uncharacterised factors that influence the gene targeting efficiency of a
vector since the repeatability of targeting efficiency of a given vector in
experiments performed under similar conditions but on different days is
very poor (Hasty et al. 1992; Roller et al. 1991; Piedrahita et al. 1992;
Chapter 4: Table 4.1A). If in further controlled experiments the
comparative gene targeting efficiencies of P-casein gene targeting vectors
pPlMClNEO/TK and pP2MClNEO/TK remain similar to that observed
in the present experiments it is tempting to suggest that such data may
shed some light on the mechanism(s) of gene targeting with replacement
vectors.
E14 cells used in experiment-I were obtained originally from
Dr Martin Hooper's laboratory at an early passage and were frozen after
these were grown for about 12-15 passages at the IAPGR Roslin. At the
time of electroporation the cells were at passage 35. It is very likely that
these cells may have drifted to aneuploidy while these were grown at the
IAPGR because both targeted clones had 42 chromosomes.
A number of P-casein gene targeted clones identified in the
subsequent experiments using low passage E14 ES cells were also found
to be aneuploid (Table 3.2) The consistency of the chromosomal
abnormality in clone A32 would suggest that the abnormality might have
existed in the cells prior to electroporation. The E14 ES cell line has been
characterised as a euploid cell line with a good efficiency of chimaera
formation and of germ line transmission from selected clones (Clarke et
al. 1992; Handyside et al. 1989; Thompson et al. 1989). However, it
appears that the low passage cells used in the above experiments had
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accumulated chromosomal abnormalities at some stage. Two independent
(3-casein gene targeted clones were microinjected into blastocysts to
produce chimaeric mice. One of these clones A77 had 60% of metaphases
with a modal number of 40 chromosomes. Upon microinjection into
blastocysts, this clone showed limited capacity for differentiation and
failed to contribute to the germ line. The modal chromosomal count may
be an important prerequisite for germ line transmission but it may not be
sufficient. The other clone B256 had 80% of cells with 40 chromosomes. It
proved to be very efficient in chimaera formation and several chimaeras
produced progeny from the ES cell component (Table 3.3 & 3.4). Germ
line transmission of the ES component was observed from one female
chimaera in the present experiments in common with the observations of
other workers (A. Clarke personal communication; Selfridge et al. 1992;
Stewart et al. 1992).
A number of ES cell clones modified at different loci through
gene targeting have contributed to the mouse germ line (reviewed by
Hooper 1992). However, the factors rendering some of the ES clones
incompatible with germ line transmission are not well understood. It has
been suggested that the use of the feeder layers is critical for the growth
of ES cell, and LIF alone may not be sufficient (Bradley et al. 1992).
However, no controlled experiments have been reported in the literature
comparing the various culture conditions. Chromosomal instability is
noticed even when ES cells are grown on feeder layers (my unpublished
observations). A better understanding of the factors responsible for
diversion of karyotype of ES cells in culture and for the loss of their
ability to populate the mouse germ line would obviously improve the
efficiency of introducing a planned change in the mouse genome.
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3.3.2. NullMutation in the Mouse (3-Casein Gene
The absence of [3-casein from mutant mouse milk as
revealed by SDS-PAGE (Fig. 3.13) and the failure to detect any
corresponding mRNA from the mammary gland of lactating mutant mice
(Fig. 3.12) are two strong lines of evidence in support of the conclusion
that the csnb~ represents a null mutation.
The lack of any signal with the (3-casein cDNA probe in
Northern blot analysis was (naively) unexpected, and instead a fusion
message was anticipated since the neo gene lacked its own
polyadenylation signal. It appears that either transcription or stability of
RNA or both are reduced. Formally, it is possible that transcription may
have been terminated prematurely within the fi-casein transcription unit
or the fusion transcript may include cryptic polyadenylation sites such
that the processed transcript would contain only the neo message.
Skipping of (3-casein exons during processing of the hybrid transcript
could be another explanation. In the targeted p-casein allele there is an
in frame translation stop codon in exon 2 upstream of the neo gene coding
sequences. Premature nonsense mutations have been documented to
cause reduction in the amount of nuclear and cytoplasmic mRNA without
affecting transcription (Cheng and Maquat 1993). Nonsense mutations
have also been associated with skipping of exons containing these
mutations (Dietz et al. 1993).
3.3.3. Structure ofCasein Micelles
In cow's milk, micelles comprise asi-, as2-, P- and K-caseins
in addition to calcium phosphate and small amounts of magnesium,
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sodium, potassium and citrate. Most studies concerning the structure of
the casein micelles have been performed on cow's milk. However, a
similar electron microscopic structure of casein micelles has been
documented in a number of species (see review by Rollema 1992). As in
cow's milk (Dalgleish et al. 1989; Davies and Law 1983; Donnelly et al.
1984; McGann et al. 1980) the inverse relationship observed between
micelle size and K-casein concentration in human (Azuma et al. 1985) and
goat (Ono and Creamer 1986) milk would tend to support the argument
that similar broad principles of micelle organisation exist in various
milks. However, it should be kept in mind that the caseins are one of the
most poorly conserved families of proteins (Bonsing and Mackinlay 1987).
There is also wide variation in the relative concentrations of different
caseins across the species (see Chapter 1: Table 1.2). No information
exists in the literature on the structure of mouse casein micelles, and
therefore, for the purpose of the following discussion it has been assumed
that the casein micelle in this species has an organisation similar to that
in the cow.
The organisation of at least some kind of micelles in
(3-casein-deficient mouse milk immediately demonstrates that this protein
is not essential in the organisation or secretion of these micelles into
mouse milk. The currently accepted models of bovine micelle structure
(Slattery and Evard 1973; Schmidt 1982) neither predict nor exclude any
specific or essential role of a- or (3-caseins in the organisation of sub-
micelles or in the association of sub-micelles into micelles. However,
there are a number of explicit and implicit suggestions in the literature
indicating some special role of (3-casein in the organisation ofmicelles. 1)
In spite of the lack of conservation of the primary amino acids sequences
of caseins the overall architecture of (3-casein has been conserved, and
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unlike a-caseins, no rearrangements have occurred (Bonsing and
Mackinlay 1987; Holt and Sawyer 1988). 2) P-casein is present in all
milks examined; on the other hand goat and human milk have a very
small proportion of a-caseins (see Creamer 1991) 3). Addition of
dephosphorylated P-casein to artificial milk micelles increased the rennet
coagulation time and decreased the extent of syneresis (Pearse et al.
1986). The latter authors have argued that these results reflected the
importance of P-casein in curd formation in the stomach. Bonsing and
Mackinlay (1987) have further suggested that P-casein may have a role in
determining the surface properties of the casein micelles. However, in the
present investigations no overt health problems were noticed in the pups
feeding on P-casein-deficient milk. The slightly slower growth rate of
these pups (Fig. 3.1 IB) could suggest such a role of P-casein, but this is
more likely due to the reduction in the total protein concentration of
p-casein-deficient milk (Table 3.8). Without further characterization of
the properties of p-casein-deficient micelles it is not possible to know the
role of p-casein either in the organisation or the properties of the native
micelles but it is very likely that the composition of sub-micelles reflects
the available proteins in a particular milk rather than any specific
organisation involving a- and P-caseins as suggested by Ono and Obata
(1989). The above argument is consistent with the fact that the altered
ratio of a- : P-casein in the heterozygous mutant mouse milk (Fig. 3.13)
does not affect micelle formation per se.
The total casein concentration in the homozygous mutant
mouse milk is approximately 17% lower than that of wild-type milk
despite the compensation for the loss of p-casein (Table 3.8). Although the
concentrations of individual caseins were not measured in the present
experiments, the loss of P-casein concurrent with the decreased casein
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concentration in the mutant mouse would mean that the ratio of K-casein
to the remaining caseins has increased in the homozygous mutant mice
(Table 3.8). The observation that in the p-casein-deficient mouse milk
there is a compensatory increase in the level of other proteins (including
whey proteins) would suggest that even the absolute concentration of
K-casein may have increased. The ratio of the K-casein to the remaining
caseins has an inverse relationship with the micelle size (Dalgleish et al.
1989; Davies and Law 1983; Donnelly et al. 1984; McGann et al. 1980)
and these results have been the basis for localising most of the K-casein
on the surface of casein micelles in various models of micelle structure.
These studies were performed after physical separation of casein micelles
differing in sizes and subsequent determination of protein composition of
various fractions. The present investigations provide the first in vivo
evidence that the size of casein micelles is dependent upon the relative
concentration of K-casein in milk of a species (Table 3.9). An alternative
interpretation of these results may be that reduction of micelle size in the
homozygous mutant mouse milk reflects merely the absence of p-casein;
there is suggestion that the outer layer of the micelle may include a small
amount of p-casein (Dalgleish et al. 1989). However, the reduction in
micelle size in the heterozygous mutant milk as compared with that of
wild-type milk would not support this explanation (Table 3.9). Thus, the
present results provide sustenance to the casein micelle models of
Slattery and Evard (1973), and Schmidt (1982) that most of the K-casein
is present in or on the surface of the micelle. However, these results
would argue against any essential role of p-casein in the protein-protein
interactions between sub-micelle as envisaged in the model of Slattery
and Evard (1973).
144
3.3.4. Limit toMilk Protein Biosynthetic Capacity of the
Mammary Gland
High level expression of a heterologous milk protein gene in
the mouse mammary gland does not lead to the increased total protein
levels in milk (Wilde et al. 1992). Although the heterologous protein
(ovine P-lactoglobulin) constituted 29% of the total milk protein, the total
protein concentration of transgenic mouse milk was not different from
that of control milk indicating some physiological limit to milk protein
level (Wilde et al. 1992; M. McClenaghan personal communication). The
corollary of the above results would be that the removal of an endogenous
protein may enhance the level of the remainingmilk proteins.
In the present studies, the significantly lower milk protein
concentration of p-casein-deficient milk (Table 3.8), and the lack of
P-casein mRNA in the mammary gland of the mutant mouse (Fig. 3.12)
would suggest that the steady-state level of mRNA is limiting in the
synthesis of milk proteins in the mammary gland of these mice. It is not
known if the loss of p-casein mRNA has been compensated by the
enhanced transcription or stability of other milk protein mRNAs. The
reduction in P-casein concentration (Fig. 3.13) and in the corresponding
mRNA level in the heterozygous mutant mouse (Fig. 3.12) also shows
that the P-casein mRNA is limiting in the mammary gland of the
heterozygous mutant mouse. The partial compensation of the loss of
P-casein by enhanced synthesis and/or secretion of the remaining milk
proteins (see section 3.2.6) is consistent with the in vivo results ofWilde
et al. (1992) that there is an physiological limit to the bio-synthetic
capacity of the mammary gland of the wild-type mouse. Disruption of
P-casein gene probably releases that limit but now mRNA has become
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limiting. Further characterization of the (5-casein-deficient mouse in
terms of steady-state mRNA levels of other milk proteins, and
transcription rates of all milk protein genes including that of the mutated
P-casein would be required to address the nature of limit seen in the wild-
type mice.
The (3-casein-deficient mice are not suitable to address questions
concerning the co-ordinated expression of the casein locus as
hypothesised by Rosen et al. (1989) because the targeted P-casein locus is
transcriptionally active as evident from the Northern analysis of
mammary gland RNA using the neo gene probe (Fig. 3.12B). Targeted
mutations in the promoters of various casein genes may be informative in
this respect.
The (3-casein-deficient animals born to heterozygous mothers did
not show any overt abnormality. Given the fact that casein micelles can
be organised in the absence of P-casein, it is not possible to exclude the
functional significance of casein gene expression in the thymus as
proposed by Grusby et al. (1990). Targeted deletion of other milk proteins
would be necessary to examine the proposed role of casein micelles in the
delivery of perforin, one of the effector molecules in T-cell mediated
cytotoxicity.
In a number of species (3-caseins have been shown to contain
peptide sequences with opioid activities (reviewed by Teschemacher and
Koch 1991). During the present studies the pups feeding on (3-casein-
deficient milk appeared to grow slower than the wild-type control pups.
This difference is likely to be due to the reduction in the total protein in
p-casein-deficient milk. To address the non-nutritional significance of
P-casein it would be necessary to substitute for the loss of this protein in
milk of these animals (see below).
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The fact that the loss of p-casein has been compensated by the
increased level of the remaining milk proteins (including whey proteins)
may be useful to enhance the level of heterologous/pharmaceutical
protein in the milk of transgenic farm animals (Velander et al. 1992;
Wright et al. 1991; I have crossed p-casein-deficient mice with transgenic
mice secreting BLG in milk to examine whether BLG expression is
up-regulated to compensate for the loss of P-casein). Little information is
available on the effect of expression of a foreign protein on total milk
protein level in farm animals. There is some genetic evidence in cattle to
suggest that protein bio-synthetic capacity may be limiting (Hill 1993).
The A allele at the p-lactoglobulin locus in cattle is associated with a
significantly high level of this protein in milk but this increase is at the
expense of a-lactalbumin and casein concentrations (Hill 1993). Ideally, if
most of the endogenous milk proteins can be deleted from the 'milk' of
animals secreting pharmaceutical protein(s) such an approach may even
be useful in the purification procedures needed to harvest these proteins.
However, this may very well be an oversimplification as there is some
evidence to suggest that 3' UTR of differentiation specific RNAs may be
required in the maintenance/ promotion of differentiation (Rastinejad and
Blau 1993) and thus, deletion of some of the milk protein genes may be
incompatible with lactation.
To conclude, I have described the production and characterization
of the phenotype of P-casein-deficient mice in this chapter. The mouse
P-casein gene in embryonic stem cells was disrupted through homologous
recombination, using a replacement-type gene targeting vector based on
the positive and negative selection protocol. Germ line transmission of
the mutation was obtained. The intercrossing of heterozygous animals
resulted in viable and fertile homozygous mutant offspring. The females
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appeared to lactate normally and suckled their pups successfully.
Analysis of the (3-casein-deficient milk revealed that (3-casein is not
required in the formation and secretion of casein micelles; however, the
reduction (in mutant heterozygote) and absence of P-casein (in mutant
homozygotes) result in significantly smaller casein micelles. These data
provide the first in vivo evidence in support of the surface localisation of
K-casein in casein micelles. Finally, the synthesis and or secretion ofmilk
proteins other than p-casein were up-regulated to partially compensate
for the loss of P-casein in milk of these mice; this may be useful in




THE EFFECTS OF TERMINAL HETEROLOGIES ON
GENE TARGETING BY INSERTION VECTORS:
TOWARDS 'POSITIVE-NEGATIVE' SELECTION
4.1. INTRODUCTION
If bovine embryonic stem cells were to become available, removal of
a major protein from milk by targeted disruption of the corresponding
gene may be beneficial to modify nutritional properties and the
processing behaviour of milk, P-lactoglobulin being an obvious example
(Bremel et al. 1989; Clark 1992). However, subtle changes in the
structure ofmilk caseins have been suggested to be more important for
modifying industrial properties of milk (Clark 1992; Jimenez-Flores and
Richardson 1988).
A two step approach involving targeted deletion of an endogenous
milk protein gene (see Chapter 3) and reintroduction of the subtly
modified gene into the germ line by pronuclear microinjection (see
Chapter 1: section 1.3) may be useful in the manipulation of milk
structure. However, such an approach is likely to be hampered by the
lack of control of transgene expression levels and other limitations of
transgenic technology (reviewed by Clark et al. 1990; Wall and Seidel Jr.
1992). Direct targeting of subtle mutations into most endogenous genes
do not lead to a biochemically selectable phenotype in ES cells, and
therefore, it is necessary to include some positively selectable marker
gene into the targeting vector. Incorporation of a marker gene alongside a
149
subtle mutation might interfere with the subsequent expression of the
targeted locus. Recently, a number of strategies have been reported
which either obviate introduction of extraneous sequences into the
targeted locus (Davis et al. 1992; Reid et al. 1991; Zimmer and Gruss
1989) or allow excision of the marker gene in a second homologous
recombination step (Askew et al. 1993; Hasty et al. 1991a; Valancius and
Smithies 1991b) [reviewed in Chapter 1: section 1.4.2.7]. A two step 'hit
and run' (Hasty et al. 1991a) or 'in-out' (Valancius and Smithies 1991b)
method seems to be the most promising approach for targeting subtle
mutation into non-selectable loci. One desirable refinement of the 'hit and
run' strategy would be an enrichment procedure for targeting events
during the first step which involves targeted integration of an insertion-
type vector.
Targeting with an insertion vector is stimulated by a double-strand
break or a gap (Orr-Weaver et al. 1981) in the region of homology in
yeast, and this has also been found to be the case in mouse ES cells
(Hasty et al. 1992; Valancius and Smithies 1991a). A positive-negative
selection enrichment procedure in conjunction with insertion-type
vectors, similar to that available for replacement-type gene targeting
vectors (Mansour et al. 1988), would require blocking of the DNA ends at
the double-strand break point with some negatively selectable marker
gene. This would be an apparent contradiction with the observation that
recombination is stimulated by double-strand break in the region of
homology. However, no evidence existed in the literature on the effect
and fate of large heterologous sequences included in an insertion vector
at the double-strand break point. Therefore, I examined the targeting
efficiency of a number ofHPRT insertion-type gene targeting vectors with
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variable lengths of heterologous sequences -from 0.19 kb to 2.1 kb-
included at the point of double-strand break in these vectors.
In this chapter, I provide evidence for differential effects of
heterology on the targeting efficiency of insertion-type vectors depending
upon the precise design of such vectors. While large heterology on the
longer of the two arms of homology of the targeting vectors significantly
reduced the efficiency the effect of identical heterology included on the
shorter arm was less pronounced. Mostly, these heterologous sequences
were excluded from the targeted locus as revealed by Southern analysis.
Surprisingly, an insertion vector with both homologous arms blocked by
large heterologies targeted with high efficiency and fidelity. The data
provide some information about the way in which targeting vectors are
processed. Thus, it may be possible to include a negatively selectable
marker gene at the double-strand break point in insertion vectors to
enrich for targeted clones. These results have also been reported
elsewhere (Kumar and Simons 1993: see appendix).
4.2. RESULTS
4.2.1. HPRT Gene Targeting Vectors and Strategy
Plasmid pIV (Fig. 4.IB; see Chapter 2: section 2.3 for
construction) comprises 5.6 kb of the HPRT sequences, neo resistance
selectable gene and a pGEM4 plasmid backbone. When opened at the
unique RamHI site in the HPRT sequences this plasmid yields an
insertion-type gene targeting vector with arms of 4.8 kb and 0.8 kb.
Homologous recombination of this vector with the HPRT gene is
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as depicted in Fig. 4.1C. As a consequence the 5.6 kb HPRT gene
sequences included in the targeting vector would be duplicated. The
duplicated sequences would be separated by the pGEM4 backbone and
neo sequences disrupting the endogenous HPRT gene. The
polyadenylation signal in the neo gene would further ascertain against
the possibility of regeneration of functional HPRT mRNA from the
modified locus, which could in principle occur by splicing of exon 2 from 5'
of the neo gene to down-stream exon 3 of the HPRT gene. An ES cell clone
modified by targeted integration of pIV DNA should be selectable with
G418 (for integration) and 6-TG (for the loss ofHPRT gene function).
Plasmid pIV served as the basis for construction of targeting
vectors which carried terminal heterology, and as a positive control
targeting vector. The predicted modification by other HPRT gene
targeting vectors having terminal heterologous sequences (see Chapter 2:
section 2.3.2 for construction) should be similar to that shown for pIV in
Fig. 4.1C, assuming that the heterologous sequences were removed from
these vectors before their targeted integration. Alternatively, the
targeted integration of the latter vectors without removal of heterologous
sequences would also be predicted to result in the loss of the HPRT gene
function.
4.2.2. G418, 6-TG-Resistant Colonies Were Targeted for the
HPRT Gene
E14 ES cells electroporated in the presence of vector DNAs
were selected for G418 resistance from 1 or 2 days until 5 days after
electroporation. G418, 6-TG selection was applied for the next nine days
to assess the number of the HPRT gene targeted colonies (Table 4.1A).
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The positive control HPRT gene targeting vector pIV and a negative
control vector pWPN (see Chapter 2: section 2.3) gave G418-resistant
colonies at a comparable frequency (Table 4.IB). However, in ten
electroporation experiments the vector pIV generated 1018 6-TG-
resistant colonies in contrast to only four such colonies detected with
pWPN (Table 4.1A). Thus, it was concluded that most 6-TG-resistant
colonies in these experiments were generated by the targeted integration
of insertion vector pIV into the HPRT locus rather than by random
inactivation or deletion of the HPRT gene. To confirm this conclusion,
Southern analysis of 6-TG-resistant colonies generated by vector pIV was
performed.
A 340 bp Hpall-HincII fragment from the mouse HPRT
cDNA (Konecki et el. 1982), essentially corresponding to exons 2 and 3
(Melton et al. 1984) should hybridise to an 8.0 kb Pstl fragment from
wild-type HPRT gene in E14 ES cells (Fig. 4.1A). Targeted integration of
vector pIV into the HPRT gene was predicted to yield two Pstl fragments
of approximate sizes of 10.4 kb and 6.4 kb (Fig. 4.1C). The 10.4 kb Pstl
fragment should also hybridise with the pGEMneo probe (neo gene in the
backbone of the plasmid pGEM4).
Genomic DNA from thirteen pIV-generated G418, 6-TG-
resistant ES cell clones was analysed to assess the structure of the HPRT
locus (Fig. 4.ID). The HPRT cDNA probe hybridised to an 8.0 kb Pstl
fragment from control E14 ES cells. In all thirteen clones, the 8.0 kb Pstl
band was absent as was expected after successful targeting of the HPRT
gene by pIV. Eleven clones gave two fragments of 10.4 and 6.4 kb. These
sizes are consistent with modification of the HPRT locus by integration of
pIV as shown in Fig. 4.1C. To confirm this structure, the PsH-digested
DNA was probed with pGEMneo DNA (Fig. 4.IE). The presence of a
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single 10.4 kb fragment with this probe in these eleven clones was taken
as a further evidence of correct targeting by pIV.
One clone gave the above described 10.4 and 6.4 kb
fragments with the cDNA probe, and an additional 8.7 kb signal with
both the cDNA and pGEMneo probes (Fig. 4.ID & E: lane 5). The
intensity of the 8.7 kb band was higher than that of 10.4 kb band
indicating integration of multiple copies of the targeting vector. The
probable modification in this clone was the targeted integration of a
head-to-tail tandem array of pIV into the HPRT gene (Fig. 4. IF). Another
clone gave an intense band of approximately 11 kb and a 6.4 kb band
with the cDNA probe (Fig. 4.ID: lane 2). The larger band was also
recognised by the pGEMneo probe (Fig. 4.IE: lane 2). These observations
taken together with the absence of the 8.0 kb wild-type signal indicated
that this clone had undergone precise modification on the long arm only.
The nature of the recombination event on the short arm of the vector
cannot be determined from these data.
Thus, all the thirteen 6-TG-resistant pIV clones analysed
were generated as a result of targeted integration of pIV into the HPRT
gene. The above results demonstrated that frequency of 6-TG-resistant
colonies was a valid measurement of targeting efficiency of pIV.
4.2.3. Comparison of Targeting Efficiency of Different
HPRT Gene Targeting Vectors
Ten gene targeting experiments (Table 4.1A) were
performed with HPRT vectors to determine the effects of terminal
heterologies on gene targeting efficiency. Each experiment included the
positive control vector pIV and the negative control vector pWPN in
addition to various HPRT vectors carrying terminal heterologies. In every
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case, an approximately same number of ES cells was electroporated in
the presence of 5 nM of the respective vector DNA (see legend to Table
4.1A). To allow comparison between experiments, the targeting frequency
(number of 6-TG-resistant colonies per cell electroporated) of each HPRT
vector in a given experiment was expressed relative to the targeting
frequency of vector pIV (Table 4.1A) [The relative targeting efficiency of
pIV = 1.0]. The absolute targeting frequency of a given vector varied
between experiments. However, the relative targeting efficiency of a
vector was fairly consistent across the experiments. Variable targeting
frequency of a particular targeting vector has also been observed by other
workers (Hasty et al. 1992; Roller et al. 1991; Piedrahita et al. 1992). The
targeting frequency in the present experiments did not bear any
relationship with passage number of cells at electroporation (data not
shown) as suggested by Roller et al. (1991).
The frequency of random integration, measured by the
number of G418-resistant colonies per cell electroporated varied from
experiment to experiment for a given vector (Table 4.IB). This value also
varied among different targeting vectors in a particular experiment.
However, the latter variability was not unexpected because there were
major structural differences between the various HPRT targeting vectors
(see Chapter 2: section 2.3) which may influence the expression of the neo
gene. In some studies (Hasty et al. 1991c; Hasty et al. 1992) the
comparison of the gene targeting efficiency of a number ofHPRT vectors
has been made after expressing targeting frequency as the number of
targeting events (number of 6-TG-resistant colonies) per number of
random integration events (number of G418-resistant colonies). Hasty et
al. (1991b) compared the absolute targeting efficiency of various vectors
but did not use equimolar vector DNA. Such comparisons across targeting
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vectors could be misleading. Therefore, in the present study the number
of 6-TG-resistant colonies per cell electroporated in the presence of
equimolar vector DNA was used as an estimate of the absolute targeting
frequency.
4.2.4. Targeting Efficiency Was Not Appreciably Affected
by Small Heterologies at the Double-Strand Break
Point
Plasmid pIVX was derived from plasmid pIV by insertion of
XhoI linker in a unique BamHI site of the latter (see Chapter 2: Fig.
2.3C). When opened at this Xhol site, pIVX was similar in structure to
the positive control vector pIV except for the presence of five terminal
heterologous nucleotides on one strand and a single nucleotide on the
second strand of each of the two homologous arms. The relative targeting
efficiency of pIVX in two experiments was 0.98 and 0.88 (Table 4.1A).
Thus, small heterologies on both homologous arms did not appreciably
affect the targeting efficiency.
4.2.5. Targeting Efficiency Was Differentially Affected by
Large Heterologies Included on One Arm
Targeting efficiencies of a series of HPRT vectors (see
Chapter 2: section 2.3) carrying different lengths of heterologous
sequences (2.1 kb - 0.19 kb) on one of their arms and a small heterology (5
nucleotides & 1 nucleotide) on the other arm were compared with that of
the positive control vector pIV (Table 4.1A). The heterologies reduced the
targeting efficiencies of these vectors and the effect was dependent on the
position and length of such heterologous sequences. When 2.1 kb
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heterology was placed on the long arm, pIVL2.1 targeted the HPRT gene
with relative efficiencies ranging from 0.28 to 0.36 (Table 4.1A). When
the same 2.1 kb sequences were included on the short arm (vector
pIVS2.1) the targeting efficiencies were 0.64, 0.71 and 0.72 in three
different experiments. This positional effect was consistent for each pair
of targeting vectors with the terminal heterologies of 0.7 kb, 0.33 kb and
0.19 kb (Table 4.1A); in each case the relative targeting efficiency was
higher when the heterologous sequences were placed on the short arm.
The targeting efficiency was also sensitive to the length of
heterology on a given homologous arm. As the length of heterology on the
long arm decreased from the 2.1 kb in vector pIVL2.1 to 0.19 kb in
pIVL0.19 the relative targeting efficiencies increased (Table 4.1A). This
trend was also noticeable when a similar comparison was made within
the vectors carrying heterologies on the short arm but the corresponding
changes were small. This was not unexpected as the largest heterology on
the short arm led to a relatively low decrease in targeting efficiency.
4.2.6. Terminal Heterologous Sequences Were Excluded
from Most Clones Targeted by pIVL2.1 and
pIVS2.1
Targeting of the HPRT gene by pIVL2.1 (Fig. 4.2.A) or
pIVS2.1 (Fig. 4.3A) with removal of the 2.1 kb terminal heterology is
predicted to result in a structure identical to that obtained after targeting
by pIV (Fig. 4.1C). Pstl digested DNA from such a targeted clone should
give the 10.4 kb and 6.4 kb fragments with the HPRT cDNA probe, and a
10.4 kb fragment with the pGEMneo probe. On the other hand, if
targeting occurs without removal of the 2.1 kb heterology from a
recircularised pIVL2.1 or pIVS2.1 molecule the 2.1 kb heterology would
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be incorporated into the HPRT gene either 5' or 3' of the vector sequences
depending upon the point of cross-over in the recircularised vector. As
there are two PstI sites in the tk gene, the incorporation of these
sequences into the targeted HPRT locus would result in Pstl fragments
which would be much smaller than 10.4 kb or 6.4 kb (for example see Fig
4.3F)
Ten G418, 6-TG-resistant ES cell clones generated using
pIVL2.1 were analysed for the structure of their HPRT locus. Southern
analysis revealed that in eight clones, pIVL2.1 targeted the locus
resulting in the same structure that was generally obtained following
targeting with pIV. The PsH-digested genomic DNA from these clones
gave two fragments of 10.4 kb and 6.4 kb which hybridised to the HPRT
cDNA probe (Fig. 4.2C). The 10.4 kb fragment was also recognised by the
pGEMneo probe (Fig. 4.2D). There was no evidence of retention of the 2.1
kb heterologous sequences (tk) in these clones (data not shown).
One clone (Fig. 4.2C: lane 3) gave a third 5.1 kb Pstl
fragment with the cDNA probe in addition to the 10.4 kb and 6.4 kb
fragments. The 10.4 kb and 6.4 kb fragments are consistent with
targeting via both long and short arms of the vector after removal of
terminal heterology. A 5.1 kb Pstl fragment can be explained by either
targeting by a dimer of pIVL2.1 or random integration of a second copy
pIV. Targeting by a head-to-tail dimer would be predicted to give a Pstl
fragment of 4.8 kb which should hybridise with pGEMneo (Fig. 4.2F)
Random integration would yield a fragment of >3.8 kb, the size of which
would depend on the structure of the integration site. Probing of Pstl-
digested DNA with pGEMneo sequences gave a 10.4 kb band as expected
after correct targeting by the short arm, and an additional 4.8 kb
fragment. The latter fragment indicated that targeting had probably
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occurred by a vector dimer as shown in Fig. 4.2F, and a randomly
integrated vector molecule was not the likely source of the 5.1 kb Pstl
band detected by the cDNA probe. The presence of the 5.1 kb PstI
fragment predicted retention ofat least some of the tk sequences. Probing
of the Pstl and RaraHI-digested DNA with 3' HSV tk gene sequences (1.5
kb EcoRV fragment from pSPTK) revealed a 1.0 kb and a 2.1 kb
fragment, respectively (Fig. 4.2E: lanes 2 & 4). The above observations
suggested the participation of more than one vector molecule in the
targeting reaction.
Another clone (Fig. 4 2C: lane 5,) revealed three Pst I
fragments of 10.4 kb, 7.4 kb and 5.1 kb when hybridised with the HPRT
cDNA probe. The 10.4 kb Pstl fragment suggests precise targeting by the
short arm of the vector. The absence of the 8.0 kb wild-type fragment is
also consistent with targeting of the HPRT gene. However, the absence of
a 6.4 kb fragment indicated the lack of correct recombination by the long
arm of the vector. The presence of the 5.1 kb fragment is evidence for
retention of terminal heterology in this clone. The 7.4 kb Pstl fragment
detected by cDNA probe could not be explained and thus from these data,
it is not possible to deduce the precise nature of the modification of the
HPRT locus in this clone. The pGEMneo probe hybridised to a 10.4 kb
Pstl fragment consistent with correct targeting by the short arm (Fig.
4.2D: lane 5). A 1.0 kb Pstl fragment hybridising with HSV tk probe
confirmed retention of terminal heterology but a 7.0 kb BamHl signal
suggested rearrangement/ loss of tk sequences in this clone (Fig. 4.2E:
lanes 3 & 5).
The structure of the HPRT gene of six pIVS2.1-derived
clones was examined (Fig. 4.3). Detection of the 10.4 kb and 6.4 kb Pstl
fragments with the HPRT cDNA probe in four of these clones indicated
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targeted recombination by the short and the long arms of the vector,
respectively, with removal of terminal heterology (Fig. 4.3C). The wild-
type 8.0 kb fragment was absent. Hybridisation with the pGEMneo probe
also revealed the expected 10.4 kb fragment in these clones (Fig. 4.3D).
In two other clones a 6.4 kb Pstl fragment was detected with
the HPRT cDNA probe, suggesting targeting by the long arm of the
vector. However, an approximately 8 kb fragment instead of the expected
10.4 kb fragment was inconsistent with targeted recombination by the
short arm and removal of the terminal heterology. It may be noted that
wild type HPRT gene gives the 8.0 kb Pstl fragment with this probe.
Probing of the PsH-digested DNA with the pGEMneo probe is predicted to
give a 3.7 kb fragment if the terminal heterology has been retained and
indeed a 3.7 kb band was detected (Fig. 4.3D). However, the 3.7 kb band
could result either from targeted or random integration of pIVS2.1
without removal of terminal heterology (Fig. 4.3B). Similarly, 1.0 kb Pstl
and 2.1 kb BamUl fragments with tk probe were consistent with either of
these two possibilities (Fig. 4.3E). However, an additional 7.8 kb Pstl
fragment with the tk probe (Fig. 4.3E: lanes 2 & 3) could be explained by
targeted integration of pIVS2.1 into the HPRT gene without removal of
the terminal heterology (Fig. 4.3F). The structure depicted in Fig. 4.3F is
also consistent with the 8 kb Pstl fragment observed with the cDNA
probe. Taken together, the data suggested the targeted integration of the
vector pIVS2.1, including the terminal heterology, into the HPRT gene of
the above two clones. The higher intensity of the 8 kb fragment in one of
these clones (Fig. 4.3C: lane 1) could be due to the presence of multiple
copies of pIVS2.1.
In twelve of the sixteen pIVL2.1 and pIVS2.1 clones, the
terminal heterology present on one arm of these vectors was excluded
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from the targeted HPRT locus. At least, in one of the remaining four
clones there was evidence to suggest that terminal heterology was
removed from one of the two copies of the vector participating in the
targeting reaction.
4.2.7. Targeting by an InsertionVector with Both of its
Arms Blocked by Large Heterologies
Plasmid pIVL2.1 was opened at a unique Smal site included
in the 2.1 kb heterologous sequences. The resulting targeting vector
pIVL0.7Sl.4 had 0.7 kb heterology on the long arm and 1.4 kb on the
short arm (Fig. 4.4A). Surprisingly, this vector targeted the HPRT gene
with a reasonable efficiency. In five experiments the relative targeting
efficiency varied between 0.54 to 1.1 (Table 4.1A). It may be noted that
the total length of heterology in vectors pIVL2.1, pIVS2.1 and
pIVL0.7S1.4 was the same. However, the targeting efficiency of
pIVL0.7S1.4 was always greater than that of pIVL2.1 (0.28 - 0.36) and
comparable to that of pIVS2.1 (0.64 - 0.72).
The above unexpected observation was reinforced by
comparison of the relative targeting efficiency of pIVL0.7 and pIV0.7S1.4.
pIVL0.7 had 0.7 kb heterology on the long arm while pIVL0.7Sl.4 had 1.4
kb on the short arm in addition to 0.7 kb on the long arm. Having
observed the reduction in targeting efficiency by blocking either the long
or short arm with large heterologies, it was expected that pIVL0.7S1.4
should target less efficiently than pIVL0.7. However, in five experiments,
the relative targeting efficiency of pIVL0.7Sl.4 ranged from 0.54 to 1.10;
when compared with targeting efficiency of pIVL0.7 (from 0.40 to 0.59). It
is clear that when the long arm carried 0.7 kb heterology, the presence of
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1.4 kb of heterology on the short arm had little effect or may even have
enhanced targeting. These results show that the effects on targeting
efficiency of blocking two arms of homology with large heterologies were
not cumulative.
4.2.8. Terminal Heterologies Were Excluded from the
Clones Targeted by pIVL0.7S1.4
pIVL0.7S1.4 could, in principle, integrate into the HPRT
gene in four different possible ways with respect to the terminal
heterologies: 1) Integration of the recircularised vector without the loss of
terminal heterologies. 2) The loss of terminal heterology from the short
arm and retention of heterology on the long arm. 3) The loss of terminal
heterology from the long arm and retention of heterology on the short
arm. 4). Removal of terminal heterologies from both arms. The HSV tk
gene fragments on both the short and long arms of pIV0.7S1.4 have one
Pstl site each (Fig 4.4B). Probing of the PsH-digested DNA of clones
targeted by this vector with the HPRT cDNA would readily distinguish
the fourth possibility from the remaining three. Removal of heterologies
from both arms prior to targeted integration of pIVL0.7S1.4 would lead to
a 10. 4 kb and 6.4 kb Pstl fragments, similar to those obtained by pIV
targeting. A 5.1 kb Pstl fragment is predicted from either of the first two
possibilities (as in the case of random integration of the vector, see Fig.
4.4B). Retention of heterology on the short arm (possibilities 2 and 3)
would lead to a 7.0 kb Pstl fragment detectable with the cDNA probe (not
shown).
Twenty three G418, 6-TG-resistant ES cell clones generated
by pIVL0.7S1.4 were analysed for their HPRT locus structure. 22 clones
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gave the 6.4 kb and 10.4 kb PstI fragments with the HPRT cDNA probe
(Fig. 4.4C). These sizes are characteristic of correct targeting by this
vector with removal of terminal heterologies from both arms. Probing
with pGEMneo highlighted the 10.4 kb fragment (Fig. 4.4D) confirming
the results obtained from the cDNA probe.
One remaining clone had in addition to the 6.4 kb and 10.4
kb bands, an 8.7 kb band of higher intensity which hybridised with both
the cDNA probe (Fig. 4.4C: lane 6) and the pGEMneo probe (data not
shown). The absence of any signal upon hybridisation with the tk probe
confirmed that terminal heterologies had been removed from the vector
before targeting (data not shown). It may be recalled that head-to-tail
concatemerisation of pIV generates 8.7 kb Pstl fragment with the cDNA
and pGEMneo probes (see Fig. 4.IF). The 8.7 kb band might have
resulted from amplification of the duplicated HPRT sequences after
targeted integration of the vector. The alternate explanation of targeting
by an array of vector molecules seems less likely because there was no
evidence of retention of terminal heterologies which would have been
expected at least in some of the internal copies of pIVL0.7S1.4 array.
4.2.9. Insertion Vectors and Positive-Negative Selection?
The above results provided ample evidence to conclude that the
presence of terminal heterologies does not exclude the insertion vector
from the gene targeting pathway. Moreover, the fidelity of the targeting
reaction was not compromised. Targeting vectors pIVL2.1 and pIVS2.1
had HSV tk gene on the long and short arm, respectively. The HSV tk
gene would permit GANC selection against ES cells transformed by
random integration of these two vectors (Mansour et al. 1988). Two
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experiments were undertaken to determine the level of enrichment with
GANC selection. ES cells were electroporated in the presence of either
pIVL2.1 or pIVS2.1 DNA. Electroporated cells were selected for G418,
GANC-resistance and G418-resistance. Both of these vectors gave similar
but very low (~2-fold) enrichment after GANC selection.
4.3. DISCUSSION
Inclusion of a negative selection marker gene at the double-strand
break point of an insertion-type gene targeting vector would be useful to
select against the random integration of the vector provided that blocking
of the DNA ends does not interfere with the efficiency and fidelity of
homologous recombination. Data presented in this chapter show that
terminal heterologies included on the two arms reduced the targeting
efficiency of the vector but the extent of reduction depended upon the
length and position of the heterology. Longer heterology tended to
decrease the targeting efficiency to a greater degree. Heterology limited
to a few base pairs did not appreciably influence targeting efficiency.
Surprisingly, while a 2.1 kb heterology on the long arm of the vector was
considerably detrimental, the same piece ofDNA either on the short arm
or distributed on two arms resulted in a much smaller reduction in the
targeting efficiency.
Hasty et al. (1992) found that heterologies of 13 bp on each of the
two arms of an HPRT insertion vector did not appreciably affect its
targeting efficiency. However, 2.3 kb heterology on the long arm
significantly reduced the targeting efficiency. In another study a 37 bp
heterology was compatible with gene targeting by an insertion vector in
Chinese hamster ovary cells (Pennington and Wilson 1991). These
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observations are consistent with the present results obtained for cognate
vectors.
Out of 39 clones generated by HPRT targeting vectors carrying
large terminal heterologies, 35 clones did not carry the heterologous
sequences into the target locus. This is a strong evidence against
recircularisation of these vectors before their participation in homologous
recombination. These results also exclude a non-conservative gene
targeting pathway via a multimerised vector and support the conclusions
of Pennington and Wilson (1991) that, in mammalian cells, gene
targeting by insertion vectors proceeds by a conservative pathway. In
principal, the structure of two plVS2.1 clones (Fig. 4.3C: lanes 1 & 5)
could have arisen by homologous recombination of a recircularised vector
molecule with the chromosomal gene. However, the relatively high
targeting efficiency of pIVS2.1 (Table 4.1A) would suggest against this
being the major path of recombination as it is well established that
circular vectors target very inefficiently (Hasty et al. 1992; Orr-Weaver et
al. 1981; Valancius and Smithies 1991a). The majority of randomly
integrated vector molecules during the present investigations retained
the terminal heterologies (data not shown). A number of previous studies
(Folger et al. 1982; Macleod et al. 1991; Roth et al. 1985; Thomas et al.
1986; Toneguzzo et al. 1988;) have also shown that randomly integrated
single copy DNA molecules more or less preserve their terminal
sequences. Thus, the targeting efficiency and Southern analysis data
reported in this chapter could only be explained by postulating removal of
terminal heterologies from targeting vectors in conjunction with
homologous recombination.
Double-strand-break repair (DSBR) model (Fig. 4.5) is the













Figure 4.5. Schematic representation of the
Double-Strand Break Repair model of homologous
recombination (Redrawn from Szostak et al. 1983).
A) A double-strand break is enlarged into a double-strand gap by
exonucleases and 3' single-strands are exposed on both sides of
the gap.
B) One of the 3' single-strands invades the homologous
double-strand DNA and one strand from the latter is looped out.
C) The invading 3' single-strand is extended by repair-synthesis
and the loop is enlarged. The second 3' end now anneals to the
enlarged loop.
D) Repair-synthesis from the second 3' end converts the looped
single-strand into double-strand and two Holliday junctions are
formed.
E) Resolution of the two Holliday junctions by two cuts in either
the outer or the inner strands results in non-crossover products.
F) Crossover products result if one of the Holliday junctions in
resolved by a cut in the outer strand and a second cut in the inner
strand.
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(Sun et al. 1989, 1991; Szostak et al. 1983; Zenvirth et al. 1992). This
model proposes that a double-strand break in the targeting vector is
extended by a 5'—>3' exonuclease concurrently from both the DNA ends.
One of the resulting 3' ends of the vector invades the target duplex and
displaces the corresponding strand from it. The displaced strand is
primed by the second 3' tail of the invading molecule. The 3' ends of the
vector are extended by copying information from the target duplex
resulting in two Holliday junctions. Resolution of these junctions can lead
to either cross-over or non-cross-over products. The double-strand break
repair model (Szostak et al. 1983) predicted 3' tails at the double-strand
break point on both the ends of the invading molecule and indeed,
indirect (Lichten et al. 1990) and direct (Sun et al. 1991) evidence exists
for association of 3' tails with a meiosis specific double-strand break at
the ARG4 locus in yeast. It has been suggested that these tails are
generated by 5'—>3' exonuclease digestion. A purified strand exchange
protein (SepI) from yeast mitotic cells has been demonstrated to have this
activity (Johnson and Kolodner 1991).
Gene targeting by insertion-type vectors in the mouse ES cells
appears to be consistent with the DSBR model (Valancius and Smithies
1991a). These authors observed that small heterologies and deletions
embedded in the homologous sequences of insertion vectors were co-
converted to the chromosomal sequences, particularly if such heterologies
were within 600 bp from the point of the double-strand break in the
vector. In these experiments the ends of various targeting vectors were
always in the region of homology. To explain the directional correction,
the authors argued against the inclusion of heterologies into the
heteroduplex DNA and instead suggested extension of double-strand
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break by exonucleases. The proposed exonucleases would have to degrade
both strands of the targeting vector.
4.3.1. Mechanism(s) ofRemoval of Terminal Heterologies
It is very unlikely that double-strand endonuclease(s)
removed the terminal heterologies from HPRT insertion vectors in the
present study. Such a proposition would have to assume at least one
endonuclease site in each of the two arms of homology. There is no direct
evidence for the presence or absence of these sites. However, double-
strand endonuclease(s) cannot account for differential effect of the length
and position of heterology on targeting efficiency of the various HPRT
vectors (Table 4.1A).
Two alternative mechanisms could be envisaged: 1)
digestion of both strands by 5'—>3' and 3'—>5' exonucleases, and 2)
exonuclease digestion of one strand followed by non-random removal of
second strand by a single-strand endonuclease.
Removal of both strands of the terminal heterologies by
exonucleases is compatible with differential effects of heterologies on
targeting efficiency. The structure of pIVL0.7S1.4 targeted clones is a
proof that terminal heterologies are removed from both arms (Fig. 4.4C &
D). If exonuclease reactions proceed concurrently in both directions from
the double-strand break point removal of 2.1 kb heterologous sequences
from the long arm of vector pIVL2.1 would be accompanied by complete
degradation of the 0.8 kb short arm. The vector processed this way would
not be compatible with targeting in the manner observed. In some cases if
the reactions on both arms are not completely synchronous, partial
homology may be left on the short arm when the removal of heterology
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from the long arm is complete. Such a vector would still be able to
participate in a targeting reaction assuming repair of the gap (Valancius
and Smithies 1991a). The above arguments can explain reduced targeting
efficiency of pIVL2.1. On the other hand removal of 2.1 kb heterology
from the short arm of vector pIVS2.1 is not likely to be accompanied by
complete removal of 4.8 kb homology from the long arm. Thus, there
would be a smaller effect on the targeting efficiency of pIVS2.1 and the
same has been observed experimentally (Table 4.1A). A similar
explanation could easily account for targeting efficiency data obtained
with vector pIVL0.7S1.4. Heterology on the small arm in this vector
would protect the homologous sequences on this arm, and thus, the
targeting by this vector would be apparently less sensitive to the presence
of terminal heterologies.
The above interpretation of the experimental data is based
on the premise that the reduction in targeting efficiency of vectors
carrying heterologies on the long arm is not merely the consequence of
blockage of homology on the long arm of these vectors. This assumption is
validated by the observation that reduction in efficiency of vectors
carrying heterologies on the long arm is responsive to change in the
length of heterology (Table 4.1A).
A 5'—> 3' exonuclease, central to the DSBR model, has been
copurified with a multiprotein recombinational complex (RC-1)
preparation from calf thymus nuclei (Jessberger et al. 1993). This protein
complex can catalyse repair of double-strand gaps and deletions via
recombination in vitro (Jessberger et al. 1993). Low level of 3'—>5'
exonuclease potency has also been detected in association with RC-1 by
these workers. Assuming that similar activities exist in mouse ES cells,
the removal of terminal heterologies (the present study) and internal
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heterologies (Valancius and Smithies 1991a) could be effected by such
exonucleases.
A single-strand exonuclease degradation followed by the
action of a single-strand non-random endonuclease is another possible
mechanism for the removal of terminal heterologies. According to the
DSBR model, the polarity of the exonuclease activity would have to be
5'—>3'. The action of such an exonuclease on different targeting vectors
would determine their efficiencies in exactly the same way as has been
explained above for degradation of both strands by exonucleases.
Exonuclease could completely remove one strand of homology from the
short arm of the vector pIVL2.1 before one of the strands of 2.1 kb
heterology is removed from the long arm of the vector. Single-strand
homologous sequences would still be left on the short arm. However,
double-strand homology on both arms would be necessary for the
formation of two Holliday junctions (Fig. 4.5). If after the action of single-
strand exonuclease the vector retains some double-strand homology on
both arms and the second strand of heterology is removed by a single-
strand endonuclease activity, the intermediate vector molecule could
easily be assimilated in homologous recombination reaction after gap
repair. Recently, Fishman-Lobell and Haber (1992) have invoked a
single-strand endonuclease to explain removal of non-homologous ends
during extra-chromosomal recombination in yeast.
A mechanism for enlargement of double-strand break by
exonuclease digestion of both strands will be consistent with homology
search by the vector either before or after exposure of homologous ends. It
may be noted that a recombinase activity from human cell extract needed
homologous ends for homology search (Hsieh et al. 1986). On the other
hand single-strand exonuclease and endonuclease based mechanism
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would require homology search at least prior to the removal of the second
strand of terminal heterology (Fishman-Lobell and Haber 1992). The
latter workers have suggested that paranemic base pairing (Schutte and
Cox 1987) could achieve the homology search in the absence of
homologous ends on the invading DNA molecule. However, paranemic
base pairing as a mechanism of homology search is yet to be
demonstrated in eukaryotic cells.
In conclusion, the results presented in this chapter show that it
may be possible to include a negative selection marker gene at the
double-strand break point. Negative selection against HSV tk gene
included in replacement-type gene targeting vectors can provide a
significant level of enrichment against random integration of targeting
vectors (Mansour et al. 1988). In preliminary experiments, poor
enrichment was obtained with HPRT insertion vectors pIVL2.1 and
pIVS2.1. Poor enrichment is not uncommon (Itohara et al. 1993;
Mombaerts et al. 1991; Tybulewicz et al. 1991). Some important points
emerged from the present investigations; these should be helpful in the
design of insertion-type gene targeting vectors to be used in tandem with
negative selection against random integration. The length ofmarker gene
should be kept as short as possible to minimise the reduction of targeting
efficiency. Equal distribution of total homology on two arms of the vectors
may be advantageous. Finally, it may be desirable to block each arm of
homology with a different negative marker gene. Although the absolute
targeting efficiency of such a gene targeting vector may be slightly
reduced, the probability of finding a targeting event can significantly
increase depending upon the level of enrichment obtained after selection




In principle, any endogenous gene can be manipulated through
gene targeting in embryonic stem cells. It is not yet known whether there
are regions of the genome that are refractory to targeting, although
successful targeting of a wide variety ofmouse genes so far would suggest
that most of the genome may be amenable to targeting.
The availability of mouse ES cells has provided impetus to studies
intended to understand the process of gene targeting in mammalian cells
and as a result of these studies better design of gene targeting vectors is
now possible. These methods will find immediate application in farm
animals provided germ line-competent ES cells are available from these
species.
ES-like cell lines have been isolated from day 7-9 post-oestrus
blastocysts of pigs (Evans et al. 1990; Notarianni et al. 1990, 1991, and
Piedrahita et al. 1990a, 1990b). Morphologically these cells appeared as
flattened epithelial cells. When grown to high density or in suspension
culture, cells from one cell line differentiated into a variety of cell types
indicating pluripotency (Evans et al. 1990). One ES-like cell line from a
day 8 post-oestrus sheep blastocyst has been reported (Notarianni et al.
1991); spontaneous differentiation of this cell line on reaching confluence
into various cell-types reflected pluripotency. To date, there are no
published reports of chimaeras generated with ES cells from livestock
(reviewed by Anderson 1992). In part this is due to the difficulties of
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working with livestock species and may reflect species differences in early
development (Evans et al. 1990).
Recently, the establishment of ES-like cell lines from mouse
primordial germ cells (PGC) has been demonstrated (Matsui et al. 1992;
Resnick et al. 1992). While these EG (embryonic germ) cells may not be
strictly identical to ES cells, their isolation has opened up the intriguing
possibility of similar experiments in livestock species as an alternate
source of pluripotential cell lines (Resnick et al. 1992; reviewed by
Rossant 1993). The use of basic fibroblast growth factor (bFGF) in
combination with the transmembrane form of steel factor and LIF is
critical in the establishment of cell lines from PGC. Matsui et al. (1992)
have demonstrated that once established these EG cell lines can be grown
on STO feeders in the absence of any additional factors, and that they are
pluripotent. Two independent lines contributed to chimaerism when
injected into blastocysts (Matsui et al. 1992). However, it is yet to be
shown whether EG cell lines are germ line-competent, a prerequisite for
use in genetic manipulation experiments; the potential of EG cell lines
may depend on the state of genomic imprinting in these lines (see
t
Rossant 1993).
As the technology stands at present considerable time must elapse
between the creation of a mutation in ES cells and having a mutant
animal because the manipulated ES cells can only be used to produce
chimaeric animals in the first generation. Therefore, the progress in
using gene targeting in the improvement of farm animals is likely to be
slow. A possible solution may involve nuclear transfer from the
genetically manipulated ES cells to enucleated oocytes. Nuclear transfer
from inner cell mass (ICM) cells to enucleated oocytes has been used to
produce a live lamb (Smith and Wilmut 1989). Although ES cells are
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derived from the ICM, the nature ofmodification that allows the in vitro
propagation of these cells is not known. If we assume that ES cell nuclei
would be able to support development to term, nuclear transfer would
facilitate generation of live animals from the genetically manipulated ES
cells without the need to produce chimaeric intermediates. Consecutive
targeting of both alleles of a given gene in ES cells before nuclear transfer
would allow production of animals homozygous for the mutation in the
first generation.
Another possible approach for the manipulation of endogenous
genes that requires consideration involves microinjection of targeting
vectors into eggs. Successful manipulation of an endogenous gene in
mouse eggs in one study has suggested that eggs may have cellular
machinery capable of supporting gene targeting (Brinster et al. 1989).
Extrachromosomal homologous recombination has also been
demonstrated in mouse eggs (Pieper et al. 1992). Although Brinster et al.
(1989) observed only one targeting event out of 500 transgenic mice
screened and a number of new mutations were introduced in the target
locus in addition to the intended modification, it is very likely that this
frequency may represent an underestimation because there were
numerous polymorphisms between the target gene and the targeting
vector DNA. It is yet to be established whether additional mutations
introduced in the target locus represented the inherent imprecision of
gene targeting machinery in eggs in contrast to that in ES cells or
whether this discrepancy was the result of the extensive mismatches
between the target gene and vector DNA. Nevertheless, the error-prone
targeting may still be suitable for generating null mutations.
The use of isogenic DNA in the construction of gene targeting
vectors has been shown to significantly improve gene targeting efficiency
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in ES cells (Van Deursen and Wieringa 1992; Te Riele et al. 1992)
Interestingly, in one experiment 78% of the cells that were transformed
by the targeting vector DNA underwent a targeting event (Te Riele et al.
1992). A targeting efficiency of this magnitude, if routinely attainable in
eggs, should be sufficient to modify endogenous genes without the use of
ES cells. One potentially important advantage of such a system would be
the possibility to diagnose the targeted embryos using PCR before
embarking upon the production of live animals. Such an approach, if
feasible, could tremendously reduce the cost of genetic manipulation of
farm animals. However, it should be noted that the use of isogenic DNA
in livestock species would be very difficult as no inbred strains exist in
these species. Cloning of the gene of interest directly from the putative
ES cell lines of farm animals would assure isogenicity of targeting vector
DNA to one of the two alleles in such cells.
A better understanding of the mechanisms of homologous
recombination and random integration in mammalian cells may lead to
improvements in gene targeting efficiency. It is not clear at what stage a
DNA molecule is committed to either random integration or the
homologous recombination pathway. Do these two apparently different
processes overlap? Do random integration events represent the failure of
homologous recombination or were the randomly integrated molecules
never available for long enough to be able to participate in the
homologous recombination reaction? The results presented in Chapter 4
of this thesis suggest that the fate of large terminal heterologies placed at
the DNA ends of an insertion vector depends on the type of integration.
While in targeted integration these heterologies are lost the integrity of
the DNA ends is more or less maintained in the random integration
events. Although both random and targeted integrations are stimulated
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by linearisation of the vector DNA, the underlying mechanisms of this
stimulation may very well be quite different in these processes.
Mammalian cells are very efficient in the ligation of DNA ends (see
review by Roth and Wilson 1988) and concatemerisation of DNA
molecules can be detected within 5-10 minutes after microinjection into
the mouse eggs (Burdon and Wall 1992). In COS-1 cells, the ratio of
intramolecular ligation of DNA ends to extrachromosomal homologous
events involving the same ends has been shown to be reduced by addition
of dideoxynucleotides at the 3' ends (Chang and Wilson 1987). Although it
is not possible to conclude from these results that addition of
dideoxynucleotides suppressed the ligation reaction (the alternate
explanation, which is unlikely but cannot be excluded, may be that intra¬
molecular recombination was enhanced) it may be worth examining the
effect of this modification on the frequency of random integration. In view
of the removal of terminal heterologies from insertion-type gene targeting
vectors as shown in the present study, it will be interesting to study the
effects on gene targeting of placing dideoxynucleotides at the DNA ends.
The mechanisms of targeting by replacement vectors is not
understood at all except that it is known that linear molecules target
more efficiently than circular DNA and that the placement of terminal
heterologies is compatible with a gene targeting reaction. However, it is
not clear whether terminal heterologies reduce the targeting efficiency of
these vectors, and how the terminal heterologies are excluded from the
target gene (see Chapter 1: section 1.4.2.5). Both the single-strand
annealing model (Lin et al. 1984, 1990) and the double-strand break
repair model (Orr-Weaver et al. 1981; Szostak et al. 1983) would require
a double-strand break or gap in the target gene in the chromosome. Such
double-strand breaks may be produced either actively by the targeting
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vector after the homology search or may arise randomly. If a
chromosomal double-strand break is rate limiting in gene targeting by
replacement vectors, one prediction would be that the introduction of
sequence specific breaks in the endogenous genes should enhance
targeting. At present no methods are available to introduce in vivo site-
specific double-strand breaks that would enable the above hypothesis to
be tested.
The efficiency of gene targeting may need further improvements in
order to extend this technology to farm animals at a reasonable cost. The
available methodologies in mouse are useful to model the genetic
modifications intended in livestock species. Extrapolation of the results
from the p-casein-deficient mice to farm animals would suggest that to
achieve high level and mammary gland specific expression, foreign genes
may be targeted into this locus without any adverse effects on lactation,
and thus it may be possible to avoid position-effect, generally seen in the
context of transgenes. However, it may be noted that the optimum design
of a reconstructed hybrid gene cannot always be predicted. Poor
expression of a number of heterologous cDNA sequences inserted into the
otherwise efficiently expressed sheep (3-lactoglobulin gene in transgenic
mice (McClenaghan et al. 1991; Whitelaw et al. 1991) is a reminder that
much remains to be learnt about the design of transgenes. Although
extensive characterization of the properties of wild-type mouse milk
would be necessary prior to undertaking such projects, p-casein-deficient
mice may be a useful animal model to test the effect of genetically
engineered bovine P-caseins on physical properties ofmilk.
The genetic control of most traits of economic importance in
livestock is very complex. Current efforts in genome mapping have begun
to locate major genes controlling economic traits of farm animals.
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Progressive degenerative myeloencephalopathy (weaver syndrome) in
Brown-Swiss cattle is associated with higher milk and milk-fat yield
(Hoeschele and Meinert 1990). Recently, Georges et al. (1993) have
identified a linkage between a microsatellite and the weaver syndrome.
Gene targeting may allow positive identification of the candidate gene for
this syndrome. Also it may be possible to address the nature of
association between the weaver and favourable dairy phenotypes. More
importantly, if it turns out that these two traits are controlled by two
different but closely linked genes it may be feasible to break the
unfavourable linkage through gene targeting. Porcine stress syndrome
(PSS) is another such example (reviewed by MacLennan and Phillips
1992). This is a recessive trait and the homozygous animals are prone to
death as a result of stress but this trait is associated in heterozygotes
with leaner pork. Meat derived from homozygous affected animals is pale,
soft and exudes fluid. Strong linkage has been established between this
phenotype and a missense mutation in the skeletal muscle ryanodine
receptor gene (Fujii et al. 1991); efforts are underway to mutate this gene
in mouse ES cells to create a small animal model to understand the
molecular basis of PSS and its relationship to leanness (Alan Archibald
personal communication).
Once embryonic stem cells from farm animals become available,
gene targeting is likely to contribute to positive identification of major
genes of economic importance, and it would be feasible to modify
endogenous genes to manipulate the physiology of livestock species.
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ABSTRACT
We have examined the effects of placing non¬
homologous DNA on the ends of an insertion-type gene
targeting vector. The presence of terminal heterologies
was found to be compatible with insertion targeting,
and the terminal heterologies were efficiently removed.
Terminal heterologies reduced the frequency of gene
targeting to variable extents. The degree of inhibition
of targeting was dependent on the length and the
position of the heterology: 2.1 kb heterologous
sequences were more inhibitory than shorter regions
of heterology, and heterology placed on the end of the
long (4.8kb) arm of homology was more inhibitory than
heterology positioned on the end of the short (0.8kb)
arm. When heterology was placed on both arms of the
targeting vector the targeting efficiencies were similar
to or higher than when heterology was present on the
long arm only. These results suggest that terminal
sequences are removed simultaneously from both ends
of targeting vectors. The removal of terminal
sequences probably occurs by exonucleolytic
degradation of both strands at each end, and removal
of at least one of the strands is intimately coupled with
the process of homologous recombination. These
findings have implications for the design of gene
targeting vectors.
INTRODUCTION
DNA introduced into cells can undergo recombination with
homologous chromosomal sequences. The modification of
chromosomal sequences by homologous recombination is termed
gene targeting and is being widely used in embryonic stem (ES)
cells for the generation of mice carrying defined mutations (1—3).
There are broadly two types of gene targeting: replacement
targeting and insertion targeting (1—3). Replacement targeting
is used much more widely than insertion targeting, and results
in the substitution of chromosomal sequences by sequences from
the targeting vector. Insertion targeting on the other hand results
in the integration of the targeting vector with no loss of
chromosomal sequences, and a consequence of this is the presence
of a sequence duplication in the targeted locus. Mutations
generated by replacement targeting cannot revert to wild-type;
mutations generated by insertion targeting can excise the targeting
vector by homologous recombination between the duplicated
sequences. Targeting with insertion vectors which carry a
mutation within the homologous sequences, followed by selection
for excision of the vector results in either complete reversion
to wild-type or to reversion with the mutation retained in the
chromosome. The usual products of gene targeting experiments
are gross disruptions; the two-step insertion-excision method
(known as hit-and-run targeting [4], and as in-out targeting [5])
has been shown to be useful for the targeting of subtle mutations,
and is likely to be of increasing importance.
There have been many studies of the mechanism of homologous
recombination in mammalian cells (see ref. 6 for review). In the
majority of experiments the two substrates for the recombination
were introduced together; in individual studies, the experiments
are usually designed to assess either extrachromosomal
recombination (prior to integration) or intrachromosomal
recombination (between co-integrated homologous sequences).
A comparison of extrachromosomal and intrachromosomal
recombination has clearly demonstrated that fundamental
differences exist in the mechanisms of recombination in these
two experimental systems (7). Extrachromosomal recombination
proceeds predominantly by a non-conservative pathway (8—10).
Intrachromosomal recombination and gene targeting occur by a
conservative pathway (11,12). The currently most favoured
model for the mechanism of conservative recombination is
double-strand-break (gap) repair (DSBR) (13 — 16).
Valancius and Smithies (16) found that predictions of the
double-strand-break repair model hold for gene targeting in ES
cells. Adjacent homologous ends were found not to be required
for insertion vector gene targeting in ES cells, and that terminal
gaps were always repaired during integration. The presence of
small gaps in the targeting vector did not reduce the efficiency
of gene targeting, arguing that the same recombination pathway
is operating whether gapped or non-gapped targeting vectors are
used. Further, it was shown that internal sequence heterologies
within either of the arms of the targeting vector were repaired
during gene targeting. The efficiency of such repair was very
high for heterologies a short distance (0.2kb) from the double
strand break, approaching 100%, while heterologies 0.8kb from
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the double strand break were repaired, but at a significantly lower
frequency. The repair of heterologies was unidirectional: the
vector-borne heterologies were always corrected by the
chromosomal target. Together, the data suggested that the normal
pathway of insertion vector gene targeting includes an
exonucleolytic mechanism for the removal of terminal sequences
from a targeting vector, and for the use of chromosomal target
sequences as template to repair gaps introduced by this process.
Chromosomal integration of exogenous DNA in mammalian
cells occurs predominantly by non-homologous recombination.
In order to minimise the amount of screening required in gene
targeting experiments, Mansour et al (17) devised the positive-
negative selection (PNS) method to select against cells in which
the gene targeting vector had been integrated at random. This
method is based on the finding that random integration occurs
predominantly via the ends of the exogenous DNA molecule,
whereas targeting of a replacement vector results from
recombination within the two arms of homology. To adopt the
PNS approach, a negatively selectable gene is placed on the end
of one or both arms of homology; selection is applied for the
positively selectable marker included within the targeting vector
and against the negatively selectable gene. Very significant
enrichment for gene targeting can result from the use of this
method.
In principle, it would be possible to use a PNS approach to
the enrichment of gene targeting with insertion vectors. A
prerequisite for the application of PNS to insertion vectors is that
the presence of a long heterologous DNA tail on one or both
ends of the vector should not interfere with gene targeting. In
the experiments described here, we have used the properties of
the HPRT gene (negatively selectable and hemizygous in male
cells) to allow the facile determination of targeting frequencies
and isolation of targeted clones. We find that the presence of
terminal heterologies does have effects on the frequency of
insertion vector targeting of the HPRT gene, and that the effects
depend on the position and length of the heterologous sequences.
Gene targeting with vectors carrying terminal heterologies is
similarly accurate as targeting with the control vector, the terminal
heterologies are removed in the majority of targeted clones. We
discuss these results in particular with respect to the mechanism
of removal of the terminal heterologous sequences.
MATERIALS AND METHODS
Targeting vectors
The mutation in the neomycin resistance gene (18) in the
pMClneo and pMClneopola (19, Stratagene) cassettes was
corrected by exchange of an Xmalll—Ncol fragment with the
equivalent fragment form pSV2neo; the corrected plamids,
pMClneo(C) and pMClneopola(C), gave significantly higher
transformation frequencies than the original plasmids. The BamHl
site in pMC 1 neopola(C) was destroyed by filling in, to yield
pMC 1neopola(C)AB.
pIV was constructed by sequential insertion into pGEM4 of
a 254bp EcoBI-Sau3A PCR-derived fragment from intron 2 and
exon 3 of the HPRT gene (inserted into EcoBl and BamWl-
digested vector), the 5.4kb EcoVl fragment (intron 1, exon 2,
intron 2) of the mouse HPRT gene (20), inserted into the EcoRI
site, and the SaR—Xhol cassette from pMClneopola(C)DB,
inserted into the SaR site. Digestion of pIV with BamHl yielded
vector IV.
pIV + was constructed by linearisation of IV with BamHl,
filling in and insertion of an Xhol linker (cctcgagg). Insertion
of the 2.1kb SaR—Xhol HSVtk cassette from pSPTK into the
Xhol site of pIV+ yielded pIV+2.1L and pIV+2.1S, which
differed in the orientation of the insert. pIV+0.7L and pIV +0.7S
were derived from pIV+2.1L and pIV+2.1S respectively by
digestion with Xhol and Smal, filling in and religation.
pIV+0.33L and pIV+0.33S were derived by insertion into the
Xhol site of pIV+ in either orientation of a 334bp SaR—Xhol
fragment from pMClneoD, itself derived from pMClneopola(C)
by deletion of the Xmalll—BamHl fragment. pIV+0.19L
and pIV+0.19S were obtained by insertion into the Xhol site
of pIV+ in either orientation of a 194bp SaR—Xhol
fragment which contains the enhancer from pMClneo. Digestion
of these plasmids with Xhol gave the corresponding targeting
vector (e.g. pIV+2. IS XXhol = vector IV2.1S); pIV+2.1L
when digested with Smal, yielded targeting vector IV+
0.7L1.4S. For experiments H and I (table 1) the targeting
vectors were all derived from pIV+2.1L: Vector IV was
pIV + 2. ILxBamHl, IV+2.1L was pIV+2. ILxXhol; IV +
0.7L was pIV+2.VLxXhol + Smal and IV+0.7L1.4S was
pIV+2. ILxSmal.
The control vector (WAPneoTK) is a replacement vector
designed for targeting of the whey acidic protein (WAP) gene
which contains an unique Xhol site, and comprises the pSP72
vector, 6kb of WAP sequences, the neo cassette from
pMClneopola(C), the HSVtk cassette from pSPTK.
Cell culture and electroporation
E14 embryonic stem cells (21) were cultured in gelatin-treated
flasks or petri dishes in the absence of feeder cells in DMEM
(high glucose formulation, Life technologies), supplemented with
NEAA, O.lmM /3-mercaptoethanol, 5% FCS and 5% NBCS,
and recombinant DIA/LIF (22). For electroporation, plasmids
were digested with the appropriate restriction enzymes and
purified by phenol extraction, ethanol precipitation and washing
with ethanol. Growing cells (passage 24 to 40) were harvested
by trypsinisation and resuspended at i08 mi 1 in PBS with DNA
at a concentration of 5nM. Each electroporation consisted of 0.8
ml cells which were electroporated using a Bio-Rad Gene Pulser
at 500fiF, 230V (575 Vcrrr') (experiments A—F) or 3/iF,
800V (2000 Vcm-1) (experiments G—J). After 10 minutes at
room temperature, the cells were diluted to 106 ml-1 in
complete medium and 5xl06 cells were plated per 6cm
diameter petri dish (in experiment C, 3.2 X 106 cells were plated
in each dish). G418 selection was either applied after 2 days
(0.5mg Geneticin ml^1 [~0.25mg/ml active G418],
experiments A—F) or after 24 hours (0.3mg Geneticin ml-1
[ —0.15mg/ml active G418], experiments G—J). Six days after
electroporation, 2.0mM 6-TG selection was applied to 80% of
the plates, plates were fixed and stained for colony counts after
a further four days (G418-selected) or after a further eight days
(G418- and 6-TG-selected). When required, colonies were picked
immediately prior to fixation from independent plates, and
expanded for preparation of DNA.
Southern blot analysis
DNA was isolated, digested and electrophoresed according to
standard methods and blotted onto HybondN (Amersham). Probes
were labelled by random priming, and hybridised at 65°C by
the method of Church and Gilbert (23); post-hybridisation washes
were performed with 40mM sodium phosphate pH7.2, 1% sds,
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ImM EDTA at 65°C. The probes used were a 339bp
Hincll—Hpall fragment of mouse HPRT cDNA clone pHPT5
(24) which is essentially specific for exons 2 and 3 (20), linearised
pGEM4-neo which contains the neo gene from pMClneo(C) in
pGEM4, and a 1.5kb EcoRN HSV-tk fragment from pSPTK.
RESULTS
Insertion vector targeting of the mouse HPRT gene
An insertion type targeting vector, designated IV, was constructed
for targeting of the mouse HPRT gene. This vector contains
approximately 5.6kb of (non-isogenic) HPRT sequences, the
neor gene from pMClneoPolA(C) and the plasmid pGEM4 (see
Figure 1). There is an unique BamHl site 0.8kb from the 5' end
of the HPRT sequences; linearisation at this site yields an insertion
vector with asymmetric homologous arms: a long arm of 4.8kb
and a short arm of 0.8kb. The structure predicted following
targeted integration of IV is shown in figure 1. The region of
homology in the unmodified endogenous HPRT gene lies within
an 8.0kb Pstl fragment. Following targeted integration of IV,
the absence of the 8.0kb wild-type Pstl fragment and new 10.4kb
Wild-type HPRT gene
Targeting vector IV
pGEM4f B B ^LNci 1Kb
and 6.4kb Pstl fragments diagnostic of targeting are predicted.
The 6.4kb fragment contains the 5' recombination junction and
the 10.4kb fragment contains the 3' recombination junction; these
fragments are derived from recombination with the target locus
of the long and the short arms (respectively) of the targeting
vector.
Cells of the male ES cell line E14 were electroporated with
IV, and with the control vector WAPneoTK, which contains no
HPRT sequences and which yields G418-resistant colonies at a
similar frequency to IV. G418 and 6-thioguanine (6-TG) selection
were applied to select transformed cells which did not express
HPRT. In each experiment, IV yielded numerous 6-TG-resistant
colonies whereas WAPneoTK yielded at most one colony per
experiment (Table 1), strongly suggestive of HPRT targeting by
IV. To confirm that the 6-TG resistant colonies obtained following
electroporation with IV were HPRT-deficient due to targeting,
representative colonies were picked and expanded for Southern
blot analysis. None of the thirteen clones analysed gave the 8.0kb
Pstl fragment as found in the wild-type HPRT gene after probing
with HPRT cDNA; twelve gave the 10.4 and 6.4kb Pstl
fragments (see Figure 2), as predicted if targeted integration had
occurred. One of the clones yielded, in addition to the predicted
fragments, an extra — 8.7kb fragment (Figure 2, lane 5),
consistent with targeted integration of multiple copies of the
targeting vector in a head-to-tail tandem array (Figure 3A). The
1 2 3 4 5 6
Targeted HPRT gene g.7ld,
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Figure 1. Targeting of the HPRT gene with insertion vector IV. Integration of
IV into the HPRT gene by homologous recombination results in the insertion
of the entire vector, with the loss of the wild-type 8.0Kb Pstl fragment, and new
fragments of 6.4kb and 10.4kb. Thick lines: HPRT sequences; boxes numbered
2, 3 and (3): HPRT exons 2, 3 and incomplete exon 3. Boxes labelled Neo: Neor
gene; thin line, pGEM4 plasmid vector sequences. P: Pstl sites; B: BamHl sites.
Figure 2. Southern blot analysis of clones targeted with IV. Prrl-digested DNA
from representative clones hybridised with an HPRT cDNA probe. Lane 1: wild-
type E14 DNA; lanes 2-6: DNA from G418- and 6-TG-resistant clones. Eight
further clones gave patterns indistinguishable from those in lanes 3, 4 and 6. The
10.4kb and 6.4kb fragments are diagnostic of gene targeting; the 8.7kb fragment
indicates the presence of a head-to-tail repeat of the targeting vector (see
Figure 3A).
Table 1. Targeting frequencies
Relative targeting efficiency (No. of colonies)
Experiment A B C D E F G H I J
Vector Comments
rv 1.0 (65) 1.0 (50) 1.0(141) 1.0(431) 1.0 (21) 1.0(154) 1.0(112) 1.0 (272) 1.0 (179) 1.0 (108) No heterology: positive control
rv+ 0.98 (64) 0.88(95) Xhol linker
IV+2.1L 0.28 (18) 0.36 (18) 0.29 (41) 0.28 (121) 0.33 (89) 0.36 (65) 2. lkb on long arm
IV+2.1S 0.64 (32) 0.71 (101) 0.72 (311) 2. lkb on short arm
IV+0.7L 0.40 (20) 0.59 (160) 0.57 (102) 0.55 (59) 0.7kb on long arm
IV+0.7S 0.70 (35) 0.83 (90) 0.7kb on short arm
IV+0.33L 0.57 (21) 0.30 (32) 0.33kb on long arm
IV+0.33S 1.03 (38) 0.53(57) 0.33kb on short arm
IV+0.19L 0.57 (12) 1.02 (114) 0.19kb on long arm
rV+0.19S 0.76 (16) 1.16 (130) 0.19kb on short arm
IV+0.7L1.4S 1.03 (38) 1.10 (23) 0.85 (131) 0.59 (161) 0.54 (97) 0.7kb on long arm, 1.4kb on short
WAPneoTK 0.02 (1) <0.02 (0) <0.072 (0) <0.03 (0) <0.05 (0) <0.007 (0) 0.009 (1) 0.004 (1) <0.006 (0) 0.009 (1)
31*111
Negative control
Summary of the relative targeting efficiencies with each vector. For each experiment (A-J), the targeting frequencies were normalised to the positive control
vector IV (relative targeting efficiency =1.0), and were calculated from the total number of colonies resistant to G418 and 6-TG on 12 petri dishes (except 1:
14 petri dishes). Each petri dish received 5X106 electroporated cells, except in experiment C in which 3.2XlO6 cells were plated per dish. The figures for
the negative control vector represent frequencies of spontaneous HPRT- mutations, and are not targeting frequencies.
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Figure 3. Structures of targeted loci in abnormally targeted clones. A) Structure of the targeted HPRT gene in one clone, abnormally targeted with vector IV (see
Figure 2, lane 5). Tandemly repeated (Head-to-tail) copies of the vector were integrated (two copies are shown here). B) Structure of the targeted HPRT gene in
one clone, abnormally targeted with vector TV+2.1L (see Figure 5A, lane3 and 5B, lanes 1 and 3). Tandemly repeated (Head-to-tail) copies of the vector were
integrated; the terminal heterology (HSVtk) was retained internally, and removed from the end copy of the targeting vector. C) Structure of the targeted HPRT
gene in two clones abnormally targeted with vector IV+2.1S (see Figure 5C, lanes 1 and 5; 5D, lanes 1—4). Targeting ocurred by homologous recombination
within the long arm, and the HSVtk terminal heterology was retained. A single copy of the targeting vector was integrated in one clone, tandem head-to-tail repeats













Figure 4. Targeting vectors with terminal heterology. The vectors illustrated carry:
no heterology (TV); Xhol linker heterology on both ends (IV+); 2. lkb of heterology
on the long arm and Xhol linker heterology on the short arm (IV+2.1L); 2. lkb
of heterology on the short arm and Xhol linker heterology on the long arm
(TV+2. IS); and 0.7kb of heterology on the long arm and 1.4kb of heterology
on the long arm (TV+0.7L1.4S). The vectors which are not shown here are similar
to IV+2.1L and IV+2.IS, with shorter regions of terminal heterology. Thick
straight lines: HPRT sequences; boxes labelled 2 and (3): HPRT exon 2 and
incomplete exon 3; thin lines: pGEM4 sequences; unlabelled boxes neor gene;
wavy lines: terminal heterologies; B: BamHl; X: Xhol; S: Smal.
intensity of the 8.7kb fragment is higher than either the 6.4 or
10.4kb fragments, suggesting that at least three copies of the
targeting vector were integrated into the HPRT gene in this clone.
The remaining clone gave a fragment of 6.4kb, indicative of
homologous recombination of the long arm of the vector; the
10.4kb band was absent, and a fragment of approximately 1 lkb
was observed (Figure 2, lane 2); the intensity of this fragment
indicates the integration ofmultiple copies of the targeting vector.
Although this clone is the product of a complex integration event
and the structure cannot be precisely determined, the absence
of the 8.0kb fragment and the presence of the 6.4kb fragment
make it likely that the HPRT gene in this clone underwent one¬
sided homologous recombination, being targeted by the long arm
of the vector.
To confirm this interpretation of the results, the blots were
reprobed with pGEM4neo, a plasmid containing all of the
sequences in IV other than those derived from the HPRT gene
(data not shown). As expected, in the twelve clones which gave
the 10.4kb fragment when probed with HPRT cDNA, this
fragment also hybridised strongly using pGEM4neo as probe.
In the two clones which gave fragments which were not predicted,
these fragments also hybridised to pGEM4neo, as expected if
the interpretation is correct. Although only eleven out of the
thirteen clones were targeted by simple insertion, the two other
clones were both targeted.
These results demonstrate that the targeting vector IV integrates
into the HPRT gene by homologous recombination, and show
that the frequency of 6-TG-resistance is a good approximation
to the targeting frequency.
The effects of terminal heterologies on insertion vector
targeting efficiencies
To examine the effects of terminal heterologies on the efficiency
of insertion vector targeting, a series of derivatives of IV were
made. In addition to the sequences present in IV, these vectors
contain inserts at the BamHl site; varying from 12nt (Xhol linker)
to 2.lkb (HSVl-tk). By digestion with Xhol, these vectors can
be opened to leave very short heterology on both arms (vector
IV+), or short heterology on one arm and long heterology on
the other (see Figure 4). The designation of these vectors indicates
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Figure 5. Southern blot analysis of clones targeted with vectors carrying terminal
heterology. A) Clones derived from electroporation with IV+2.1L. Lanes 1 —10:
/Vl-digested DNA from representative clones hybridised with an HPRT cDNA
probe. The 10.4kb and 6.4kb fragments are diagnostic of gene targeting; the 5. lkb
fragment indicates retention of the terminal heterology (see Figure 3B).
B) Confirmation of the presence of the terminal heterology in two clones derived
from electroporation with IV+2.1L. Lanes 1 and 3: DNA from the clone shown
in Figure 5A, lane 3; lanes 2 and 4: DNA from the clone shown in Figure 5A,
lane 5. Lanes 1 and 2: Pstl digests; lanes 2 and 4: BamHl digests. Probed for
HSVtk sequences. C) Clones derived from electroporation with IV +2.IS. Pstl-
digested DNA from representative clones hybridised with an HPRT cDNA probe.
Lane 6: wild-type E14 cell DNA; lanes 1—5 and 7: G418- and 6-TG-resistant
clones. The 10.4kb and 6.4kb fragments are diagnostic of gene targeting; the
wild-type gene yields a fragment of 8.0kb; head-to-tail integration of the targeting
vector without removal of the terminal heterology gives a 7.8kb fragment (see
Figure 3C). D) Confirmation of the presence of the terminal heterology in two
clones derived from electroporation with IV+2. IS. Lanes 1 and 3: DNA from
the clone shown in lane 1 of Figure 5C; lanes 2 and 4: DNA from the clone
shown in Figure 5C, lane 5. Lanes 1 and 2: Pstl digests; lanes 2 and 4: BamHl
digests. Probed for HSVtk sequences. E) Clones derived from electroporation
with IV+0.7L1.4S. PsrI-digested DNA from representative clones hybridised
with an HPRT cDNA probe. Lanes 1 and 9: wild-type E14 DNA; lanes 2-8:
DNA from G418- and 6-TG-resistant clones. Sixteen further clones gave patterns
indistinguishable from those in lanes 2-5, 7 and 8. The 10.4kb and 6.4kb
fragments are diagnostic of gene targeting with removal of terminal heterology
from both arms; the 8.7kb fragment in lane 6 indicates the presence of a head-
to-tail repeat of the targeting vector (see Figure 3A).
the length and position of the heterology (e.g. IV+2.1L carries
2. lkb of heterology on the long arm).
The frequency of targeting into HPRT with these vectors was
measured and the data are summarised in table 1. In common
with others (25—27) we observed significant variability between
experiments of absolute targeting efficiency with any given
vector. Targeting efficiencies are consistent within experiments
and therefore we have normalised the results relative to a positive
control (IV) included in each experiment. Targeting efficiencies
are expressed as a ratio of targeting frequency obtained with each
vector to that obtained with the IV control.
Two experiments were performed with vector IV+; the short
(one base pair and four nucleotides) linker heterologies which
were present on both arms of the vector had little or no effect
on the targeting frequency (Table 1, experiments A & J). In
contrast, long terminal heterology consistently reduced the
efficiency of gene targeting (Table 1). This effect was most
pronounced with the vector carrying 2. lkb of heterologous
sequences on the long arm (IV+2.1L): in six experiments, the
relative targeting efficiencies ranged between 0.28 and 0.36.
Suppression of gene targeting by 2. lkb of heterology on the short
arm (vector IV+ 2.IS) was also observed: in each of three
experiments the relative targeting efficiencies ranged from 0.64
to 0.72. Similarly, in each of six experiments with shorter regions
of terminal heterology (0.7kb, 0.33kb or 0.19kb), the relative
targeting efficiency was higher when the heterology was on the
short arm than when it was on the long arm. The data (Table
1) also suggest a possible effect of the length of the heterologous
sequences on the degree of suppression of gene targeting: the
shorter heterologies suppressing targeting to a lesser degree.
The effect on targeting efficiency of long heterologies on both
arms
Given that long terminal heterology on either arm of the targeting
vector reduces the targeting efficiency, it may be expected that
this effect would be compounded by the presence of heterology
on both arms. To examine this, experiments were performed
using a vector carrying 0.7kb of heterologous sequences on the
long arm and 1.4kb on the short arm (IV+0.7L1.4S). The
relative targeting efficiencies in five experiments ranged from
0.54 to 1.10 (Table 1). This contrasts with the relative targeting
efficiencies with 0.7kb of heterology on the long arm, which
ranged between 0.40 and 0.59 (four experiments). In four of the
experiments, other vectors were assessed in parallel. Without
exception, vectors which carried 0.7kb or less heterology on the
long arm gave targeting efficiencies which were similar to or
lower than IV+0.7L1.4S (Table 1). Surprisingly, these data show
that when there is 0.7kb of terminal heterology on the long arm,
targeting is insensitive to, or is enhanced by the presence of 1.4kb
of heterology on the short arm.
Terminal heterologies and the fidelity of gene targeting
Southern blot analysis was performed to determine the structures
of the HPRT gene in representative clones targeted with the
vectors IV+2.1L, IV+2.1S and IV + 0.7L1.4S.
Of the ten clones analysed from targeting with IV+2.1L none
gave the wild-type 8.0kb Pstl fragment, and nine gave 10.4 and
6.4kb Pstl fragments when probed with HPRT cDNA
(Figure 5A), as predicted if targeting was accompanied by
removal of the terminal heterologous DNA. One of the nine
clones gave an additional band of approximately 5.lkb
(Figure 5A, lane 3); the presence of three hybridising fragments
indicates the integration of at least two copies of the targeting
vector. A Pstl fragment of 5. lkb is expected if the heterologous
HSV-tk sequences were retained. Psfl- and BamHI-digested
DNAs were probed for 3' HSV-tk sequences; respectively, lkb
and 2. lkb fragments were detected (Figure 5B, lanes 1 and 3),
confirming the incorporation of the heterology. A 2. lkb BamHl
fragment is predicted on recircularisation or head-to-tail ligation
of the targeting vector. A further prediction of recircularisation
or head-to-tail ligation is a 4.8kb Pstl fragment containing
pGEM4 sequences; a band of this size was obtained following
probing with pGEM4-neo (data not shown). Together, these
results suggest that recombination has occurred either by insertion
of a head-to-tail vector multimer with removal of the heterology
from the end copy, or by replacement recombination of a head-
to-tail multimer. The probable structure of the HPRT locus in
this clone is shown in Figure 3B.
2-ikb-*- gfJEHp
1.0 kh —
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The tenth clone, when probed with HPRT cDNA (Figure 5A,
lane 5) gave the predicted 10.4kb Pstl fragment, indicative of
homologous recombination of the short arm of the targeting
vector, and two other fragments of 7.4 and 5.1kb. These data
again indicate the involvement of more than one copy of the
targeting vector and incorporation of HSV-tk sequences. Probing
of Pstl- and flamHI-digested DNAs confirmed the presence of
HSV-tk sequences. The internal lkb Pstl fragment was detected
(Figure 5B, lane 2); with BamHl, a large fragment was detected
(Figure 5B, lane 4), the origin of which cannot be accounted for
by a simple vector ligation event. The short-arm origin of the
10.4kb Pstl fragment was confirmed by hybridisation with
pGEM4-neo (data not shown). This clone is thus the product of
an imprecise targeting event, and the precise structure of the
modified HPRT locus is not clear.
Six clones from targeting with IV+2. IS were analysed
(Figure 5C). Four of the clones gave both the predicted 6.4kb
and 10.4kb Pstl fragments when probed with the HPRT cDNA
probe, demonstrating that these clones were targeted and that
the terminal heterology was removed. The remaining two clones
gave the 6.4kb fragment indicative of targeting via the long arm
and a fragment of approximately 8.0kb (Figure 5C, lanes 1 and
5). The presence of the wild-type 8.0kb Pstl fragment is
incompatible with gene targeting which is indicated by the
presence of the 6.4kb fragment. This inconsistency can be
reconciled if recircularisation or head-to-tail ligation of this
targeting vector occurred. This would be predicted to give a
fragment of 7.8kb; targeting via the long arm of such an
intermediate would yield Pstl fragments of 6.4kb and ~ 8kb, with
integration of the HSVtk terminal heterology (Figure 3C).
Probing for HSV-tk sequences of Psrl- and Aa/nHI-digested
DNAs gave fragments of lkb and 2. lkb (Figure 5D), as predicted
by this explanation. This explanation is further supported by the
presence of a 3.7kb Pstl fragment which hybridises to
pGEM4-neo (data not shown); a fragment of this size is predicted
by the above explanation, but because this size of fragment would
also be obtained following random integration of IV +2. IS, this
support is weak. The intensity of the 7.8kb Pstl band in one clone
is higher (Figure 5C, lane 1), indicating that this band is derived
from multiple copies of the vector. Of the six IV+ 2. IS clones
alysed, four clones were targeted with removal of the terminal
heterology. The other two clones were also targeted, but with
retention of the terminal heterology. In these two clones
recombination occurred within the long arm of the vector, and
in one it appears that multiple copies of the targeting vector were
integrated in a head-to-tail tandem array.
Twenty three G418- and 6-TG-resistant clones obtained with
vector IV+0.7L1.4S were analysed. None gave the 8.0kb wild-
type Pstl fragment when probed with the HPRT cDNA probe.
Remarkably, all of these clones gave the 6.4 and 10.4kb Pstl
fragments (see Figure 5E); one clone gave a single intense
additional band of approximately 8.7kb (Figure 5E, lane 6).
When DNA from this clone was analysed further, no
hybridisation was detected in Pstl- and fla/nHI-digested DNA
probed for HSV-tk (data not shown), showing that the terminal
heterology had been removed. Taken together, these data suggest
that the HPRT gene in this clone carries multiple copies of the
targeting vector from which the terminal heterology has been
removed (see Figure 3A). This interpretation of the data was
confirmed by hybridisation with pGEM4neo (data not shown).
All of the IV+0.7L1.4S clones were targeted with removal of
the terminal heterology: twenty two carry a single copy of the
targeting vector and one carries multiple copies.
With each of three vectors carrying terminal heterology, the
terminal heterologies were removed during gene targeting in most
or all clones.
DISCUSSION
We have shown that the presence of terminal heterologies is
compatible with insertion vector gene targeting and that the
heterologous sequences are usually removed from the vector
during gene targeting. The presence of terminal heterologies was
associated with reduced targeting frequencies, the extent of the
reduction being dependent on the position and length of the
heterologies. Heterologies positioned on the long arm of
homology consistently reduced the targeting frequency to a
greater extent than did heterologies on the short arm; longer
heterologies reduced the targeting frequency more than shorter
heterologies. Unexpectedly, a vector carrying heterologies on
both arms gave targeting frequencies which were similar to or
greater than vectors bearing heterology on only one arm.
Hasty et al (25) targeted the HPRT gene in mouse ES cells
with insertion vectors possessing a 5.6kb long arm of homology
and a 1.2kb short arm; one of the vectors carried 2.3kb of
heterologous sequences on the long arm of homology. The
heterology reduced targeting efficiency in each of four
experiments, giving relative targeting efficiencies from 0.13 to
0.46. The terminal heterology was removed in most clones. The
data of Hasty et al (25) are consistent with the results we present
here.
Gene targeting by a single targeting vector can occur by
different pathways, and this can result in different structures of
the targeted gene. For example, one targeting vector designed
for replacement type gene targeting was found to undergo the
predicted simple replacement targeting in only a minority of
clones (28). The structures ofmost of the targeted genes suggested
either replacement targeting by a head-to-tail multimer of the
original vector, or insertion type recombination of a recircularised
vector. With an insertion vector such as IV, it is not possible
to distinguish between simple insertion targeting, recircularisation
and insertion targeting or replacement recombination between
the target gene and adjacent copies of IV in a multimer, because
all three pathways would yield the same structure. Targeting by
vectors carrying terminal heterology by either of the latter two
possible pathways would however be detectable by the absence
of one of the junction fragments and the retention of the terminal
heterologous sequences. In our experiments, the majority of
clones had undergone a simple insertion whether the vector
carried heterology on the long arm, the short arm or both arms,
showing that simple insertion targeting with removal of terminal
heterologies is more efficient than targeting by either of the above
alternative pathways.
Although we have shown that long terminal heterologies
reduced the frequencies of gene targeting, the degree of
suppression was not very great: at most 3.6-fold. This, together
with the efficient removal of the terminal heterologies argues that
targeting proceeds by essentially the same pathway of
recombination whether or not the vector ends carry terminal
heterologies. A prediction of this argument is that the pathway
of insertion vector targeting must include the means for removal
of terminal heterologies.
How are the terminal heterologies removed? A trivial
explanation would be that random physical or endonuclease-
induced double strand DNA breaks separate the terminal
heterologous sequences from the homology. This is unlikely for
the following reasons. Firstly, frequent random double strand
breaks would lead to a low frequency of incorporation of full
length molecules; randomly integrated DNA is usually integrated
without suffering deletions (29 — 33). Secondly, targeting
efficiencies are significantly increased following the introduction
of double strand breaks into the targeting vector (16,25); if
random double strand breaks were common, pretreatment of
targeting vectors would have little or no effect on targeting
frequencies. Because both strands of the terminal heterologies
must be removed, there are three alternative explanations for the
removal of heterologies: exonuclease digestion of both strands,
non-random double-strand endonuclease cleavage, and single-
strand exonuclease digestion with non-random single-strand
endonuclease cleavage of the other strand.
Are these alternative mechanisms compatible with the effects
we observed on targeting frequency? Non-random endonuclease
digestion could act before the homology search at preferred sites
within the targeting vector, or alternatively endonuclease could
act after the homology search, recognising the presence of
terminal heterology. For the first explanation to be valid, there
would have to be at least one preferred recognition site for the
endonuclease within each arm of the targeting vector, and
cleavage of both sites would have to be efficient; this is unlikely.
Further, a prediction of this mechanism is that with the vectors
used, the heterology would be removed efficiently in non-targeted
clones. We have found that the majority of randomly integrated
copies retain the terminal heterologies (data not shown), arguing
strongly against this mechanism. This argument applies for both
double-strand endonuclease, and single-strand exonuclease with
single-strand endonuclease, and effectively rules out the
possibility of non-random endonuclease cleavage prior to the
homology search. There is no simple way to reconcile double
strand endonuclease recognition and removal of terminal
heterologies after the homology search with the observed
differential effects of heterologies on targeting frequencies.
Removal of both strands of terminal heterologies by
exonuclease(s) is compatible with the effects we observed of
heterologies on targeting efficiency if exonuclease digestion
occurs concurrently from both ends of targeting vectors. Removal
of terminal heterology from one arm of the vector would be
accompanied by removal of sequences from the other arm. If
for example we take the case of vector IV+2.1L, which carries
2. lkb of terminal heterology on the long arm, then if exonuclease
digestion from the two ends is precisely synchronous, the 0.8kb
short arm of homology would be completely removed before
complete removal of the 2. lkb heterologous sequences, and this
would have profound effects on targeting. Complete removal of
one arm of homology is not compatible with the structures of
targeted loci that were predominantly obtained. Partial removal
of homologous sequences would lead to a gap within the region
of homology: it is known that such gaps are repaired efficiently
during gene targeting (16). Concurrent but not precisely
synchronous exonuclease digestion from both ends could explain
the reduced targeting frequency observed with this vector. If we
consider the case of vectors carrying terminal heterology on the
short arm, removal of the heterology would be accompanied in
general by incomplete removal of homologous sequences from
the long arm, and therefore a smaller reduction in targeting
frequency. Again, this accords with the results we obtained. The
effect of terminal heterology on both arms of a targeting vector
would be to reduce the extent of degradation of sequences from
the arms of homology when compared with the same amount
of total heterology positioned on a single arm. Another way of
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looking at this is that, given terminal heterology on one arm of
a targeting vector, heterology on the other arm would be
protective against removal of the homologous sequences. Again,
this is entirely consistent with the effects we observed on targeting
frequencies. All of the observed effects of length and position
of terminal heterologies on targeting frequencies can be accounted
for by removal of both strands of the heterologous sequences
by exonuclease(s).
The exonuclease digestion would have to be coupled with
recombination for this mechanism to be compatible with the
efficient removal of terminal heterologies during gene targeting
and with the usual retention of terminal sequences after random
integration. This coupling could be by exonuclease digestion
occurring after the homology search. Alternatively, exonuclease
digestion could proceed until a homologous target is found; failure
to find homology would result in complete degradation of the
vector. A requirement of the homology search preceding
exonuclease digestion is that free homologous ends are not
required for the search. Recombinase activity in human cell
extracts has been found to require free homologous ends (34)
arguing against this possibility although it remains possible that
other recombinase activities exist which do not require free ends.
A second activity which promotes DNA strand exchange has been
identified and purified (homologous pairing protein-1 or HPP-1
[35]), which possesses 3'-*5' exonuclease activity in addition
to its pairing activity (36). An activity like HPP-1 could couple
the removal of heterology with the homology search.
Let us now consider the third possible mechanism for removal
of terminal heterologies: single-strand exonuclease digestion
followed by non-random single-strand endonuclease cleavage.
Random removal of one strand by single strand exonuclease
activity is compatible with randomly integrated DNA retaining
terminal sequences, because ligation of single-stranded vector
ends to chromosomal DNA could occur followed by filling in
of the single strand gap(s). The argument used above, of
simultaneous exonuclease digestion from both ends of targeting
vectors could apply, but this would not explain the effects on
targeting efficiencies with the different vectors, because
homologous sequences would remain on the second strand. If
however, for efficient targeting there is a requirement for a region
of double stranded DNA within both arms of homology, this
mechanism would fit the data. Complete removal of one strand
from the one arm of homology would preclude the formation
of a Holliday junction by that arm, as predicted by the DSBR
model of recombination (13); the absence of a Holliday junction
however need not be incompatible with recombination. Removal
of a single strand by 3'-*5' exonuclease would lead to a single
stranded 5' end. Although according to the Meselson-Radding
model of recombination, the target sequence would be invaded
by a 5' end, this is incompatible with gap repair, which we invoke
and which has been shown to occur (16). Thus, if one strand
is removed by exonuclease and the other by endonuclease, the
polarity of the exonuclease would have to be 5'—3'.
The findings of Valancius and Smithies (16) that internal
heterologies are frequently lost during gene targeting and that
the heterologies are always corrected to the chromosomal
sequence suggested that the terminal sequences are subjected to
exonucleolytic degradation during gene targeting. The loss of
terminal homologous (and internal heterologous) sequences is
likely to occur by the same mechanism as the removal of terminal
heterologies. The unidirectional correction of internal heterologies
(16) argues against the presence of the heterologies within regions
of heteroduplex DNA, because repair or replication of heterology-
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containing heteroduplexes would give bidirectional correction.
This argument would be invalidated if repair of heteroduplexes
is highly efficient and intrinsically directional. The removal of
terminal (homologous or heterologous) sequences from insertion-
type targeting vectors is thus probably due to exonucleolytic
digestion of both DNA strands.
The results of our experiments suggest that PNS could be of
use for insertion vector gene targeting. Even if gene targeting
is suppressed by terminal heterologies, a level of enrichment
significantly greater than the degree of suppression would suffice
to increase the proportion of targeted clones amongst those
analysed. Although we have used only one target locus, the results
suggest guidelines which could be of use in the design of insertion
vectors intended for PNS: the heterology should be as short as
possible, and if the arms are of different sizes, the heterology
should be positioned on either the shorter arm or on both arms.
In preliminary experiments however, we obtained only poor
enrichment with vectors IV+2.1L and IV+2.IS when
ganciclovir selection was applied. We do not understand the
reason for the low level of enrichment, but this result is consistent
with the results of others (37 — 39) and with our experience with
replacement vectors.
Finally, the hit-and-run/in-out method (4,5) for the generation
of subtle mutations may be complicated by the unwanted
correction of the subtle mutation during the insertion step (16).
If this proves to be a problem, positioning terminal heterology
on the arm of the vector which carries the mutation could be
useful to reduce the frequency of the correction.
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